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Patients in the intensive care unit (ICU) and in the peri-operative phase are dependent on 
physicians and nurses for their fluid intake. Moreover, alterations in volume status due to 
disease, co-morbidity, anaesthetic and surgical manipulations are to be compensated by 
inotropic support, additional fluid administration or diuretic therapy since sympathetic and 
hormonal auto-regulation are depressed and frequently myocardial dysfunction is present. 
Volume status optimization is required to maximize oxygen delivery to vital organs, like brain, 
kidneys and heart. Prolonged oxygen deficit can ultimately result in multi-system organ 
dysfunction [1]. On the other hand unnecessary fluid administration can lead to general and 
pulmonary oedema, cardiac failure, infections, prolonged hospitalization and death [2]. 
However, it is still not possible to directly determine volume status at the bedside. The quest for 
a method to directly or indirectly assess volume status continues.
Frank-Starling and Guyton physiology
Starling and Bayliss stated in 1894, that “the venous circulation was an important but 
disregarded chapter in physiology of circulation” [3]. Arthur Guyton, among others, tried to 
break with dominance of cardiac function in conceptual thinking about the circulation. In 
1955, half a century later then Starling and Bayliss, Guyton postulated a conceptual model 
for flow in the (human) circulation [4]. In his model of flow, Guyton defines venous return, 
i.e. the flow towards the right atrium, to be largely dependent on the pressure gradient 
between central venous pressure (CVP) and mean systemic filing pressure (MSFP). MSFP 
was defined as the pressure that exists in the whole systemic circulation if flow is stopped 
and the blood volume is spread over the circulation at equal pressure. In their first 
experiments Guyton and co-workers arrested blood flow by heart defibrillation [5]. They 
avoided effects of circulatory control mechanisms by pumping blood from the arterial part to 
the venous part in a few seconds until blood pressures were equal. This pressure was called 
mean systemic filling pressure.
Using this technique as a reference technique they tested another technique in which right 
atrial pressure (or central venous pressure) was increased stepwise and the resulting 
decrease in venous return (VR) was measured (Figure 1). 
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Figure 1  The relationship of venous return and right atrial or central venous pressure at different mean 
systemic filling pressure (MSFP or here named MCFP) values in one normal dog from Guyton [4]. 
The relationship between CVP and VR was found to be linear. Extrapolation of the linear 
regression line to VR=zero, or the pressure were this line crosses the x-axis, gives mean 
systemic filling pressure (MSFP). The extrapolated value of CVP appeared to be equal to the 
value of MSFP determined with the method of cardiac arrest by defibrillation. The linear fit 
of the line through the data points is called the venous return curve and can be described 
according to:
VR = (MSFP – CVP )/ Rsf
Were Rsf represent the flow resistance between MSFP and CVP. During steady state 
conditions VR becomes equal to cardiac output. In Figure 1 adapted from Guyton and 
co-workers, the effect of fluid loading on the venous return curve and MSFP is shown. 
Increasing circulatory volume shifted the venous return curve and increased MSFP. 
Different authors confirmed these findings in animal studies [6-8]. MSFP values between 7 
and 20 mmHg were reported. Versprille and Jansen showed that these findings also hold for 
an intact circulation [6]. To arrange this they introduced inspiratory hold manoeuvres, i.e. 
inflations followed by and pause of 7 seconds. During such manoeuvres intra-thoracic 
pressure is increased, causing an increase in CVP and therefore a decrease in venous return 
and after a few heart beats in cardiac output. With seven different tidal volumes between 0 
and 30 ml∙kg-1 the resulting seven pairs of CVP and cardiac output (CO) values showed a 
linear relationship as mentioned above. Recently, we showed that MSFP can be determined 
in intensive care patients with an intact circulation with use of these inspiratory pause 
procedures, making estimations of circulatory compliance and serial measures of circulatory 
stressed volume feasible [9].
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Analysis of cardiac output and right atrial pressure
Cardiac output is traditionally represented by the Frank-Starling heart function curves, which 
are dependent on heart rate, contractility and afterload. Another major contribution of 
Guyton and colleagues to the understanding of cardiac output regulation was that the venous 
return and heart function curve could be represented in the same graph (Figures 2-3). 
Figure 2  Effect of the pressure gradient for venous return on cardiac output (MSFP is mean systemic 
filling pressure or named MCFP here; RAP is right atrial pressure equal to central venous 
pressure) and the effect of increasing peripheral resistance on venous return when the peripheral 
resistance is increased by occluding the small arteries with 250 micron glass beads in a normal 
dog [4]. The two graphs are the result of separate studies (points in the left and right graph do not 
correspond with the same measurement). 
Indeed, in the complete circulation the heart and the systemic circulation must operate 
together. Thus, in steady state, VR and cardiac output are equal and the right atrial pressure 
is the same for both the heart and the systemic circulation. Therefore, actual cardiac output 
and right atrial pressure can be found at the intersection of the venous return curve and 
heart function curve as is shown in Figure 3. The two bold curves depict both the normal 
cardiac function curve and the normal function curve. The intersection is the working point 
of the circulation; venous return equals cardiac output at a certain right atrial pressure.
Effect of increased blood volume on cardiac output 
A rapid volume loading of about 20% of total blood volume increases cardiac output to about 
2.5 times normal [10]. The effect of increasing blood volume is depicted in Figure 3 by the 
venous return curve marked with increased MSFP. The intersection with the normal heart 
function curve shifted upwards increasing cardiac output and right atrial pressure. However 
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in the heart function curve damaged myocardium the intersection point B is on the flat part 
of the function curve. Additional fluid loading will not improve cardiac output. Furthermore, 
compared to the normal heart function curve, the change in right atrial pressure with 
volume loading is much greater. 
Figure 3  Equilibration of various venous return curves with different cardiac  
response curves adapted from Guyton [4].
In summary, the work of Arthur Guyton is an important step forward to the determination 
of volume status directly or at least the development of an accurate surrogate marker as will 
be discussed below and in the following chapters of this thesis.
Measurement of cardiac output  
Besides signs like skin turgor, dieresis and skin colour, hemodynamic measurements like 
CVP and mean arterial pressure (MAP) are most often used for hemodynamic management. 
Organ perfusion is dependent on flow rather than pressure but flow is much more difficult 
to measure than pressure. CO is the amount of blood pumped through the circulation by the 
heart per minute. There are several reasons to use cardiac output in clinical practice. Cardiac 
output values, and trend, are often used as a substitute for volume status. The general 
conception is that an increase in cardiac output will improve perfusion of vital organs. 
Increased flow might also imply improved oxygen delivery to the tissues. This is the basis of 
the fluid loading responsiveness strategy that will be discussed later on in this introduction. 
Hence, an accurate determination of cardiac output is essential to allow not only for good 
patient assessment.
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In the first chapter of this thesis we provide an overview of some of the most-often-used 
methods to measure cardiac output. We describe the Fick-method, ultrasound, indicator 
dilution techniques, arterial pulse contour analysis and bio-impedance. Characteristics like 
accuracy, precision, operator variability, invasiveness, interval of measurements, robustness 
and complications are reviewed. Thermodilution with a pulmonary artery catheter (PAC) is 
the de-facto gold standard for the measurement of cardiac output. The use of a PAC is 
however associated with several complications, like infection, pulmonary artery dissection, 
lung infarction, valvular lesion and pneumothorax [11]. In recent years, several less invasive 
methods have been developed. Pulse contour analysis is one of them and requires only a 
radial or femoral artery catheter [12]. In chapter two results are shown of an evaluation of the 
accuracy of the measurement of cardiac output using three methods (FloTrac–Vigileo, 
Modelflow and HemoSonic system) with thermodilution as the reference method [13]. 
Another parameter that can be estimated from the arterial pulse wave is stroke volume 
variation (SVV). Mechanical ventilation causes cyclic changes in venous return, pulmonary 
artery blood flow, and aortic blood flow. The changes in these parameters due to ventilation 
seem to be an indirect reflection of effective volume status [14]. SVV is the difference between 
the minimal and the maximum stroke volume divided by the mean stroke volume over a 
certain period of time. SVV is displayed as a percentage value. In some studies [15,16], stroke 
volume variation has been shown to have high sensitivity and specificity to predict of fluid 
loading responsiveness, i.e. the prediction of an increase in cardiac output with fluid loading.
However, SVV requires full mechanical ventilation of the lungs and absence of arrhythmias 
when fluid loading responsiveness (FLR) is assessed [17]. Moreover, since stroke volume 
cannot be measured directly without a PAC, pulse contour methods are used. Different 
pulse contour methods are available but reports on their accuracy are rare. In chapter three, 
we present a comparison of the accuracy of SVV measured with the LiDCOplus and 
FloTrac-Vigileo system [18].
Parameters used in hemodynamic management in the ICU
Hemodynamic instability caused by relative or absolute intravascular volume deficiency are 
common in the ICU and OR. Physicians use several surrogate parameters to select patients who 
will benefit from fluid loading. We performed a survey to evaluate the use of these parameters by 
Dutch intensive care physicians. Results of this survey are shown in chapter four.
Fluid loading responsiveness
Traditional filling pressures like CVP often fail as a predictor [19-21]. Therefore, new methods 
are being developed or traditional parameters are used in a different setting to prevent fluid 
overloading by an accurate prediction of the response to fluid loading. 
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Relatively few strategies exist to assist the physician in hemodynamic management. One 
such strategy has recently received broad attention. This strategy is fluid loading 
responsiveness (FLR). FLR is used to predict whether cardiac output will significantly 
increase or not with fluid loading. A parameter that can accurately predict FLR has been 
sought for many years. New parameters like SVV have been developed and used in the FLR 
strategy. In chapter five we review the accuracy and limitations reported of the most 
frequently used methods in clinical practice to predict fluid responsiveness in patients 
undergoing mechanical ventilation. We provide a straightforward overview of determinants 
that can be used to predict a clinically significant effect of fluid administration on cardiac 
output. 
Treating hypovolaemia
When hypovolaemia occurs and is diagnosed. Treatment is initiated. This will comprise the 
rapid administration of fluids. Fluid resuscitation is however not achieved immediately. The 
Trendelenburg position or head-down tilt, and passive leg raising (PLR) are routinely used in 
the initial treatment. In chapter six a meta-analysis is described into the hemodynamic 
effects of PLR and Trendelenburg. We asked ourselves which manoeuvre has the optimal 
effect on cardiac output (CO) while awaiting fluid resuscitation? 
Mean systemic filling pressure
As we described above Arthur Guyton is responsible for some major steps in the 
development of a method to determine volume status directly. He defined mean systemic 
filling pressure as the mean pressure throughout the circulatory system under conditions of 
no flow. Together with the shape of cardiac output function curve, dimensions of the 
vascular system and blood viscosity, mean systemic filling pressure can be considered as a 
primary determinant of venous return and thus cardiac output. In chapters seven to nine, we 
present the results of three studies into mean systemic filling pressure. Ultimately, MSFP 
can be used to calculate stressed volume and, hence, quantify effective volume status in a 
specific patient [5]. 
However, in line with its definition determination of MSFP will require zero flow conditions 
throughout the circulatory system. Creating zero flow conditions at the bedside is unethical. 
We therefore developed a method to determine MSFP indirectly with two new methods; an 
arm model and a mechanical ventilator manoeuvre. In chapter seven, we studied the effect 
of dobutamine and hypovolemia on the circulation and tested the model of ventilatory holds 
with increasing airway pressure in pigs. In this model, CVP values can be used to extrapolate 
pressure at zero flow conditions. In chapter eight, we expanded on earlier work by Versprille 
and Jansen [6] to estimate MSFP with a ventilatory manoeuvre in humans. In chapter nine, 
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we use the second model (i.e. the arm model) to predict FLR in patients who underwent 
coronary artery bypass surgery. 
Challenges to predict fluid loading responsiveness
In chapters ten to thirteen we study several challenges to predict FLR; +10 cmH2O (chapter 
ten), the fluid challenge (chapter eleven), passive leg raising (chapter twelve) and the 
respiratory ventilator manoeuvre (chapter thirteen). New parameters like SVV and PPV are 
being developed to prevent fluid over-loading. But these parameters have their own 
limitations like inaccuracy in predicting FLR during low tidal volume ventilation [22] or in 
patients with arrhythmias [17]. In recent years traditional filling pressures like CVP often 
failed as a predictor for FLR [19-21]. We looked to re-use these traditional parameters, i.e. the 
changes induced by a challenge, to predict FLR. 
A PLR-, fluid- or PEEP-challenge is aimed at determining the working point of the 
circulation on the Frank-Starling curve. It is assumed that when the patient is on the 
ascending portion of the Frank-Starling curve an (auto)transfusion will increase cardiac 
output. Once the heart is functioning near the ‘‘flat’’ part of the Frank-Starling curve fluid 
loading has little effect on cardiac output and central venous pressure will increase more. A 
PEEP-challenge on the other hand will give incrementally greater decreases in CO when the 
heart functions toward the flat part of the Frank Starling curve. We studied whether changes 
in parameters like CVP or CO as a result of a challenge can be used to estimate the working 
point on the Starling curve and consequently predict FLR.
In the discussion (chapter fourteen) of this thesis, we concentrate on the definition of fluid 
loading responsiveness and look for solutions and research directions for the future.
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Accuracy of the measurement of cardiac output  
and stroke volume variation
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Chapter 1 
Methods in pharmacology: measurement of cardiac output
Bart Geerts, Leon Aarts and Jos Jansen
British Journal of Clinical Pharmacology 2011; 71(3): 316-330
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“It is a source of regret that measurement of flow is much more difficult than measurement of 
pressure. This has led to an undue interest in blood pressure measurements. Most organs 
however, require flow rather than pressure.” This statement by Jarisch in 1928 [1] is still fully 
valid. Many methods of cardiac output measurement have been developed, but the number of 
methods useful for human pharmacological studies is limited. Methods proposed to achieve 
this goal include; the Fick principle; ultrasound; indicator dilution techniques; arterial pulse 
contour analysis; and bio-impedance. To gain widespread acceptance, these methods should 
ideally be accurate, precise, operator independent, fast responding, non-invasive, continuous, 
easy of use, cheap and without complications. The methods may allow testing of circulatory 
changes on pharmacological interventions. In this review on cardiac output, the methods used 
in pharmacology are described.
Fick’s cardiac output measurement
Direct Fick for oxygen
In 1870, Adolf Fick described a method to estimate cardiac output based on a mass balance 
for oxygen. He postulated that oxygen uptake in the lungs, i.e. the oxygen (O2) consumption 
in ml of pure gaseous oxygen per minute, is entirely transferred to the blood stream through 
the lung. With no consumption of oxygen in the lungs the oxygen consumption of the body 
is equal to the product of blood flow (cardiac output) and arterio-venous oxygen content 
difference. Therefore cardiac output can be computed as follows:
Where VO2 is the oxygen uptake, CaO2 and CvO2 (ml O2∙L
-1 blood) are the oxygen content of 
arterial and venous blood respectively (also see Figure 1).
Figure 1  Graphical description of the Fick principle; oxygen enters the lungs (VO2) en is transported to 
peripheral tissue of the body (CvO2-CaO2), at the same time carbon dioxide produced by the rest 
of the body (CaCO2-CvCO2) is cleared by the lungs (VCO2). From these concentrations blood 
flow can be calculated using the formula described in the text.
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At first sight the method seems simple to execute. VO2 can be determined by breathing or 
mechanical ventilation within a spirometer incorporating a carbon dioxide absorber or, more 
conveniently, via an indirect calorimetry monitor. Also, the calculation of the arterial and 
venous oxygen content of the blood is a straightforward process and is readily available to 
physicians. However, the method is laborious and many variables need to be determined. 
During the acquisition of data the circulation needs to be stable. Considerations: 1; the large 
number of variables involved in the computation result in a large chance on permutation of 
errors, 2; ventilation of subjects with inspiratory O2 fractions larger than 60% have been 
reported to decline the accuracy of the method [2], 3; the technique requires an invasive 
pulmonary artery catheter to sample mixed venous blood. Accurate measurement of VO2 as 
well as reliable sampling of arterial and venous blood sample is labor-intensive. 
Nevertheless, in a laboratory with skilled researchers, the method is considered the most 
accurate method to which other methods are compared. 
Partial carbon dioxide rebreathing
The Fick principle can be applied to all gasses that obey Henry’s law and diffuse through the 
lungs, especially carbon dioxide (CO2). The NICO (Novametrix Medical Systems Inc. 
Wallingford, CT, USA) is the most studied cardiac output monitor based on the Fick 
principle for CO2 and uses intermittent partial rebreathing of CO2. This monitor utilizes a 
specific disposable rebreathing loop in which a CO2 infra-red light absorption sensor, a 
differential pressure transducer for air flow measurement and a pulse oximeter are placed. 
VCO2 is calculated from the simultaneously measured minute ventilation by the differential 
transducer and its CO2 concentration (Figure 2). The arterial content of CO2 (CaCO2) is 
estimated from end tidal CO2 (EtCO2) after a correction (S), i.e. the slope of CO2 dissociation 
curve. Measurement of under normal and under rebreathing conditions allows elimination 
of measurement of CvCO2. Fick’s equation applied to carbon dioxide is:
Where VCO2 is the CO2 production, CaCO2 and CvCO2 the arterial and mixed venous CO2 
content in blood.
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Figure 2 The measurement of cardiac output with the use of carbon dioxide rebreathing.
Assuming cardiac output not changed by CO2 rebreathing, CvCO2 does not differ between 
normal and rebreathing conditions (CO2 diffuses very fast in blood, 22x faster than O2) and 
arterial CaCO2 can be approximated by end-tidal CO2 multiplied by the slope (S) of the CO2 
dissociation curve the equation above can be rewritten to: 
Where ∆VCO2 is the change in VCO2 and ∆EtCO2 is the change in end-tidal CO2 between 
normal breathing and CO2 rebreathing.
The method actually calculates effective lung perfusion. The effects of unknown ventilation/ 
perfusion inequality and anatomic shunts may explain underestimation of CO and the 
method shows a lack of agreement with reference techniques [3]. To correct for shunt 
behaviour the subjects must be fully under mechanical ventilation and arterial blood 
samples are needed, making this method (less) invasive. However, clinically acceptable 
cardiac output estimation seems possible in intubated mechanically ventilated patients with 
minor lung abnormalities [4].
Indicator dilution techniques
Today four different modalities of the indicator dilution technique are commercially 
available, i.e. the pulmonary artery catheter (PAC) thermodilution method with bolus 
injection of cold fluid, the PAC continuous thermodilution method, the transpulmonary 
bolus thermodilution method and the transpulmonary lithium bolus dilution method. All 
these methods have in common that the computation of cardiac output is based on a mass 
balance:
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Where; mi is the amount of indicator injected, q(t) is instantaneous blood flow and c(t) is 
concentration as function of time. 
Application of this equation assumes complete mixing of blood and indicator, no loss of 
indicator between place of injection and place of detection. If we further assume blood flow 
to be constant than we found the well-known Stewart-Hamilton equation:
Where ∫c(t)dt is the area under the indicator dilution curve. Errors made in the application of 
indicator dilution methods are primarily related to violation of the assumption mentioned 
above, inaccurate implementation of the method [5] and anatomic abnormalities [6].
Intermittent Pulmonary Thermodilution 
Since the introduction of the pulmonary artery catheter (PAC) equipped with a thermistor by 
Swan and Ganz in 1970 [7] the thermodilution method has become the standard method to 
determine cardiac output in patients. The thermodilution method is based on the law of 
conservation of thermal energy. With the intermittent thermodilution technique a certain 
amount of cold fluid is injected into the blood stream near the entrance of the right atrium 
and the resulting dilution curve is detected in the pulmonary artery. With temperature as 
indicator the Stewart-Hamilton equation can be rewritten as follows:
Where COtd is cardiac output by thermodilution, Tb is the temperature of blood in the 
pulmonary artery before injection of injectate, Ti the temperature of the injectate, and  
(∫∆Tb(t)dt the area under the dilution curve (Figure 3) and cc is the computation constant. 
The computation constant contains corrections for specific mass and heat of injectate and 
blood respectively, injected volume and loss of indicator in the PAC and has to be entered in 
the thermodilution cardiac output computer. 
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Figure 3  Indicator dilution to measure cardiac output. A dye solution or cold saline is injected and 
detected by a (dye or thermal) sensor downstream of the injection site. The dilution signal is fed 
to a cardiac output device. To compute cardiac output the dose injected is divided by the area 
under the indicator dilution curve. The inset shows the difference in temperature changes for 
two different locations of detection (see text). 
Investigators have previously explored methods of minimizing the errors in the intermitted 
thermodilution technique [8-12]. The best method is to average the results of three or four 
thermodilution measurement with the injection of cold fluid equidistantly distributed over 
the ventilatory cycle. For such an approach injections of fluid must be done with an injector 
under computer control. Use of such a set-up results in a coefficient of variation or 
1SD-precision of 3.5%. Whereas the averaged result of three randomly applied 
measurements have a 1SD-precision of about 10% and single measurements a 1SD-precision 
of 15%. After 40 years of clinical experience, the conventional thermodilution method has 
been generally accepted as the clinical standard to which all other methods are compared. 
However, some serious complications can arise from PAC insertion like arrhythmias, 
valvular lesions, rupture of the pulmonary artery and lung infarction.
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Figure 4 Schematic diagram of the working principle of the continuous thermodilution method.
PAC continuous cardiac output
The Vigilance system, (Edwards Lifescience, Irvine, CA, USA) combines heat-dilution 
principles with stochastic system identification to measure cardiac output [13]. Small amounts 
of thermal energy (heat-indicator) are transported directly into the blood in a pseudo random 
on-off pattern to form the input signal (see Figure 4). The resulting blood temperature 
changes are detected with a thermistor in the pulmonary artery. This signal is small in 
proportion to the resident pulmonary artery thermal noise. To overcome this problem, a 
cross correlation is carried out on the input signal and the temperature data measured in the 
pulmonary artery, resulting in a thermodilution curve, as would have been found after a 
bolus injection. From this dilution curve, cardiac output is computed using the classical 
Stewart-Hamilton equation. The entire process is automated, requiring no user intervention. 
A detailed explanation of the technique is given by Yelderman et al. [13]. The “continuous” 
cardiac output measurement makes extensively use of averaging techniques, therefore, the 
displayed cardiac output number represents the averaged value of the previous 1 to 6 
minutes [13]. Under extreme clinical situations this delay can run up to 12 minutes [14]. This 
property of the technique makes the method continuous but not instantaneous.
Concerns for the pulmonary thermodilution techniques 
Recently, the use of both pulmonary artery thermodilution cardiac output methods has been 
under discussion. Many physicians believe that the PAC due to its multi-purpose role is 
useful for the diagnoses, treatment and assessment of volume status in critical ill patients [15]. 
However, this is not confounded by studies. In contrast, different investigators raised doubts 
about the safety of the PAC. Indeed, most recent studies do not show a difference in 
morbidity and mortality between patients with and without a PAC [16-18]. On the other hand, 
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in these trials the introduction of the PAC could not be associated with an increase in 
morbidity and mortality. The inability to demonstrate the merit of the PAC in predicting 
outcome does not necessarily mean that our monitors using the PAC are not functioning [17]. 
It may also indicate a persisting lack of correct and consistent interpretation of PAC-derived 
data among physicians [19] or ineffectiveness of our current therapeutic options in reversing 
critical disease states. Thus, further investigation into the role of the PAC is feasible, likely 
safe, and should proceed forthwith [15,20]. 
Intermittent Transpulmonary Thermodilution
With this intermittent thermodilution technique a certain amount of cold fluid is injected into 
the blood stream near the entrance of the right atrium and the dilution curve is detected in the 
femoral artery [21-23]. CO is computed with the Stewart-Hamilton equation equal to the 
intermittent pulmonary thermodilution technique. In theory, the transpulmonary 
thermodilution technique should be less accurate due to unpredictable lost of indicator over 
the lungs, but more precise than pulmonary thermodilution [8,9] because the dilution curves 
are less affected by the respiration cycle. However the decreased signal-to-noise ratio of the 
dilution curve, i.e. a broader but smaller high of the curve (see Figure 3), may undo this 
advantage. 
The transpulmonary thermodilution method is vulnerable to the same sources of error and 
variability as the pulmonary thermodilution because the two techniques rely on the same 
physical principles. But, CO by the transpulmonary method slightly overestimates the results 
of the pulmonary method due to a small extra loss of indicator between injection and 
detection site in the aorta or femoral artery. To gain sufficient precision the results of three 
measurements need to be averaged. These three measurements take approximately 3-10 
minutes. Therefore, this transpulmonary thermodilution method lacks the ability to monitor 
cardiac output continuously, equal to the pulmonary method. The Intermittent 
Transpulmonary Thermodilution is incorporated in the PiCCO-system (Pulsion Medical 
Systems, Munich, Germany).
Transpulmonary Lithium dilution
The lithium dilution method is based on the venous bolus injection of a small dose (1-2 ml) 
of an isotonic lithium chloride (LiCl) solution (150-300 mmol) and the resulting arterial 
lithium concentration-time curve is measured by a lithium sensor in a pre-existing 
peripheral arterial line. Cardiac output is calculated by the Stewart-Hamilton equation:
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Where Li,dose is amount of lithium injected, ∫∆c,li(t)dt the area under the lithium dilution 
curve and PCV the packed cell volume (calculated as the haemoglobin concentration (g.dL-1) 
divided by 34). This correction is needed because lithium is only diluted in the plasma and 
not in the red and white cells of blood [24]. The pharmacokinetics of intravenous lithium 
administration is described [25]. No side effects have been reported. To achieve a good 
precision with this technique, the results of three measurements should be measured [26]. 
The lithium dilution method is incorporated in the LiDCO system (LiDCO, London, UK).
Some of the concerns relate to the lithium dilution method are the need for repetitive blood 
draws. Furthermore, the lithium dilution technique is contraindicated in patients using high 
doses of neuromuscular blocking agents, because of interference with the sensing electrode. 
The technique can not be used in patients receiving lithium therapy and is not licensed in 
subjects weighing less than 40 kg.
Pulse contour cardiac output
The pulse contour devices are perhaps the most promising with respect to their ease of use. 
The estimation of cardiac output via pulse contour analysis is an indirect method; CO is 
computed from an arterial pressure pulsation on basis of a criterion or model. The origin of 
the pulse contour method for estimation of beat-to-beat stroke volume goes back to the 
classical Windkessel model described by Otto Frank in 1899 [27]. In principle the aortic 
pressure waveform is the input of the Windkessel models of the systemic circulation. In 
medical practice, the pressure waveform is not obtained from the aorta but from a peripheral 
artery (radial or femoral), which requires a backward filtering from the peripheral to aorta 
pressure. Not much is known about the algorithms applied. At present there are four 
commercial pulse-contour cardiac output computers available; PiCCO, PRAM, LidCO, 
Vigileo and Modelflow. 
The PiCCO system
The PiCCO-system (Pulsion Medical Systems, Munich, Germany) uses a modified version of 
Wesseling’s cZ algorithm [28,29]. It analyzes the actual shape and area under the pressure 
waveform and uses individual aortic compliance and systemic vascular resistance. The 
PiCCO algorithm is summarized in the following equation: 
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Where: COpi, cardiac output; K, calibration factor; HR, heart rate; P, arterial blood pressure; 
∫P(t)dt, area under the systolic part of the pressure curve; SVR, systemic vascular resistance; 
C(P), pressure dependent arterial compliance; dP/dt, describes the shape of the pressure 
wave. The calibration factor (K) is determined with transpulmonary thermodilution and 
recalibration is needed after profound changes in SVR and at regular (≥ 1-hour) intervals 
[30-32]. Invasive catheterization is thus still required. For the PiCCO device both the radial and 
the femoral artery approach can be used [33]. A basic overview of the computation of pulse 
contour cardiac output is shown in Figure 5.
Figure 5  General working principle to estimate cardiac output by pulse contour analysis. A pressure signal 
is conducted from the pressure sensor to a pulse contour cardiac output device. Together with 
either calibration values obtained by transpulmonary thermodilution (PiCCO) or lithium dilution 
(LidCO), and personal patient data the algorithm estimates aortic flow over a certain interval. 
This is shown on the device as cardiac output.
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The pressure recording analytical method (PRAM)
PRAM (Vytech Health, Padova, Italy) is a modified version of Wesselings cZ algorithm [28,29]. 
Stroke volume (SV) is proportional to the area under the diastolic part of the arterial pressure 
wave divided by characteristic impedance (Z). The proportionally factor is usually obtained 
by calibration with an independent SV measurement (for instant by intermitted 
thermodilution). However in contrast to other methods PRAM does not rely on calibration 
or demographic data. With PRAM characteristic impedance is obtained from morphological 
data of the pressure curve of a whole heart beat [34] and is calculated as Z = (P/t) ∙K(t). Stroke 
volume (SV) is therefore computed as: 
SV = A/[(P/t)∙K(t)] 
Where A is the area under the systolic part of the pressure curve, P/t is the analytical 
description of the pressure wave form of pressure (P) with time (t) for each heart beat and 
K(t) is a factor inversely related to the instantaneous acceleration of the cross sectional area 
of the aorta. 
The value of K(t) is found from the ratio between expected and measured mean arterial 
blood pressure. This relationship approached an arctangent function (similar to that of 
Langewouters et al. [35]. The expected mean blood pressure which is constant depends on the 
site of measurement, i.e. for adults 100 mmHg for the aortic pressure and 90 mmHg for a 
peripheral pressure. With PRAM stroke volume is calculated for each beat and CO per beat 
is then derived by multiplying SV with heart rate of the same beat. CO is presented as the 
mean value of 12 beats.
As the internal calibration of PRAM is derived from the morphology of the pressure curve, 
this makes the method vulnerable to sources of errors related to signal quality and in 
patients with heart diseases that are suspected to affect the arterial pressure waveform (for 
instance in patients with aortic valve stenosis or valve insufficiencies). 
The LiDCO’s pulsco system
The LiDCO-system (LiDCO, London, UK) calculates continuous cardiac output by analysis of 
the arterial blood pressure trace. Using a non-linear relationship between arterial pressure 
and volume, given by Remington et al. [36], nominal changes in arterial volume within every 
cardiac cycle are calculated from the pressure waveform. These nominal changes are 
converted to actual stroke volume by multiplying the nominal stroke volume or nominal 
cardiac output by a calibration factor. This patient-specific calibration is derived from an 
independently measured cardiac output, for instance by the conventional thermodilution or 
by the transpulmonary lithium indicator dilution method. In this case invasive 
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catheterization with a PAC or an additional peripheral venous catheter is still necessary. 
Recent data suggest recalibration every eight hours or whenever major hemodynamic 
changes occur [37].
Vigileo/FloTrac system
The FloTrac/Vigileo (Edwards Lifesciences, Irvine, CA, USA) is a pulse contour technique 
utilizing a dedicated pressure sensor (FloTrac) and a monitor to compute stroke volume and 
cardiac output (Vigileo). It does not require an independent calibration. The cardiac output 
algorithm is based on the principle that aortic pulse pressure is proportional to stroke 
volume and inversely related to aortic compliance. The system obtains the pressure signal 
from any standard peripheral arterial line. From the arterial pressure the standard deviation 
(σAP) around mean arterial pressure (MAP) is computed over a 20-second interval. This 
σAP is multiplied by a conversion factor Khi to calculated stroke volume. Khi incorporates a 
multivariate polynomial equation which assesses the impact of the patient’s ever-changing 
vascular tone on pulse pressure. It is calculated by analyzing the patient’s heart rate, 
standard deviation σAP, mean arterial pressure, pressure dependent arterial compliance 
estimated by patients demographics with the Langewouters equation [35], BSA body surface 
area calculated from weight and height, skewness (symmetry) and kurtosis (distinctness of a 
peak) of the beat-to-beat arterial waveform. Khi is updated and applied to the stroke volume 
algorithm on a rolling 60-second average: 
Stroke Volume (ml∙beat-1) = σAP (mmHg) ∙ Khi (ml∙mmHg-1) 
Cardiac output is calculated by multiplying stroke volume with heart rate. The extensive use 
of arterial pressure signal processing makes the FloTrac algorithm highly dependent upon a 
high fidelity pressure signal. Therefore, attention to the quality of the pressure monitoring 
signal by testing for optimal dampening and flushing of the arterial line is important. 
Modelflow method 
Fifteen years ago Wesseling and co-workers [29] discovered that a straightforward extension of 
the classical Windkessel model could be adequate for pulse contour analysis. Modelflow 
(FMS, Amsterdam, The Netherlands) is a three-element Windkessel model of the arterial 
circulation, the model includes three principal components of opposition: characteristic 
impedance which represents the opposition of the aorta to pulsatile inflow, Windkessel 
compliance which represents the opposition of the aorta to volume increases, and peripheral 
resistance which represents the opposition of the vascular beds to the drainage of blood. 
Aortic compliance is not constant but depends besides demographic data of the patient 
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(gender, age, weight and height) on arterial pressure itself [35]. Aortic characteristic 
impedance, in contrast to compliance increases moderately with pressure. Systemic 
peripheral resistance depends on many factors including circulatory filling, metabolism, 
sympatic tone and the presence of vasoactive drugs. The Modelflow method simulates this 
behaviour. The modelflow method uses a peripheral arterial pressure and can be applied 
uncalibrated by using demographic data of the subject as well as calibrated. For calibration 
an independent measure of cardiac output [38] or a measure of the cross sectional area of the 
aorta can be used [39]. A more detailed description of the method can be found elsewhere 
[29,38].
Figure 6  Effects of damped radial artery pressure on LidCO pulse contour output of an individual patient. 
Upper panel systolic (Sys), diastolic (Dia) and mean (MAP) radial artery pressure (Prad). Bottom 
panel cardiac output by PulseCO (CCO).
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General concerns for pulse contour methods.
All pulse contour systems are based on a mathematical model and not on a mass balance as 
the indicator dilution and Fick method do. This implies that deviations of the model to the 
physiological reality have consequences for the estimated cardiac output. Growing 
knowledge of the arterial circulation and increasing computation possibilities has led to 
different software versions of the different methods. This complicates reviewing these 
methods. We selected only those papers that make use of recent software versions. 
Furthermore, with a peripheral arterial pressure as input of the model instead of aortic 
pressure, loss of signal quality may be crucial. An example of the effect of loss of signal 
quality on blood pressure and cardiac output is shown in Figure 6. 
Echo-Doppler ultrasound methods
Transoesophageal Doppler
In the last decade the Transoesophageal Doppler (TOD) is most frequently used ultrasound 
method (Figure 7); a small ultra-sound transducer, mounted at the tip of a flexible probe, is 
orally or nasally positioned in the oesophagus along the descending aorta. Insertion depth is 
typical 35 to 45 cm for adults, depending on the route of insertion (oral vs. nasal). The 
transducer is pointed towards the aorta by rotation to obtain the optimal aortic velocity 
signal. The blood flow velocity is calculated with the Doppler equation.
Where V is the velocity of blood, Fo is the transmitted frequency, Fd is the change in 
frequency (Doppler shift), cosθ is the angle between the direction of the ultra-sound beam 
and blood flow and c is the velocity of ultra-sound in blood. Three different models of 
oesaphageal CO monitoring have been offered. Two of these systems i.e. the Deltex monitor 
(CardioQ, Deltex Medical, Chichester, UK) and the monitor of Medicina (TECO, Berkshire, 
UK), use a nomogram to obtain the cross sectional area (CSA) of the ascending aorta base on 
patient’s age weight and height, whereas the Hemosonic (Arrow International, Reading, PA, 
currently not available) uses the M-mode echo for the measurement of the diameter of the 
aorta at the point of the velocity measurement. From aortic diameter cross section area is 
calculated assuming a circular aorta. Aortic blood flow (L∙min-1) is found by multiplying 
velocity with heart rate and cross sectional area of the aorta at the insonation point. Cardiac 
output is calculated from aortic blood flow by assuming a constant distribution of blood 
between cephalic and caudal circulation. 
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Figure 7  Transoesophageal probe geometry. Blood flow velocity is measured by the Doppler beam using 
the well known Doppler principle. Aortic diameter is determined by the echographic beam by 
measuring the distance between the backward scatter of the proximal and distal aortic wall. From 
this distance the cross sectional area of the aorta is calculated.
It is however questionable whether this partitioning of blood streams is constant under a 
variety of patho-physiological circumstances [40,41]. Most obvious concerns with the technique 
are angle of insonation and the fixation of the transducer with respect to the blood flow, 
especially during subject movements. This has led to the conclusion that the method is 
operator dependent [42] and that additional training is required. Another point of concern is 
the use of a nomogram to estimated CSA. It is clearly that a nomogram for CSA is based on 
group averages with may include large individual difference. Also CSA has been found 
pressure dependent [35]. Lastly, the technique is poorly tolerated in awake non-intubated 
subjects and cannot be used in subject with an oesophageal disorder. 
In a meta-analysis of Dark and Singer in 2004 [43], the authors concluded that the TOD 
estimates absolute cardiac output with minimal bias but limited agreement. However, the 
semi-invasive TOD technique enables trend monitoring of CO as long as the probe position 
is not changed.
Transthoracic Doppler
Transthoracic Doppler (TTD) is an entirely non-invasive method using a ultrasound probe 
positioned in the jugular notch to obtain blood velocity in the outflow of the left ventricle. 
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The method is in essence equal to oesophageal Doppler technique. Cardiac output is 
calculated by measuring the cross sectional area of the aortic valve together with the velocity 
profile in the outflow track. However, is may be very difficult to identify the aortic root in 
some subjects. In these cases the outflow over the pulmonary valve may be used. Although it 
is possible to orientate the ultrasound beam in the assumed 0 degree direction of blood flow 
and perpendicular on the valve, in practice this is difficult to realize. The alignment is 
affected by operator skill, anatomy and subject movements (for instance during breathing). 
Consequently the technique has a larger inter- and intra-observer variability and larger limits 
of agreement compared to reference methods than the transoesophageal method. The 
portable and non-invasive character of the method allows use in many settings with patients 
in supine position. 
Thoracic electrical bioimpedance
Electrical bioimpedance was introduced five decades ago as an inexpensive and non-
invasiveness cardiac output method. A high-frequency alternating electrical current with low 
amplitude is applied to the thorax via two electrodes. The resulting voltage is measured with 
two other electrodes, positioned in between the current electrodes. The measured changes in 
bio-impedance are thought to be related to changes in cardiac related blood volume. A 
mathematical conversion is used to translate the change in bioimpedance into cardiac 
output. Several formulas exist for this conversion. These formulas and their nuances go well 
beyond the scope of this review. A more detailed description can be found in a review of de 
Waal and co-workers [44]. The over-simplifications of physiological reality by mathematical 
equations, motion artefacts, abnormal thoracic anatomy, cardiac valve disease, thoracic 
shunts and arrhythmias contribute to the inaccuracy of this method. In a large meta-analysis 
of three decades of validation studies on thoracic impedance cardiography Raaijmakers et al. 
[45] concluded that a better physical-physiological model in combination with improvements 
on the impedance CO-equation are still needed.
We expect this aspect accounts also for the recently developed bio-reactance technology 
(Biorectance, Cheetah Medical Inc., Indianapolis USA). This method is based on the 
observation that blood volume changes induce small changes in frequency and phase of the 
electrical signal propagating across the thorax. These small changes have been shown to 
correlate with stroke volume [46].  
How to evaluate the different cardiac output measurement methods?
Bland and Altman [47,48] proposed that bias (the mean difference between the techniques) 
±2SD-precision is an appropriate indication of agreement between techniques. Here bias is the 
systematic error and the standard deviation (SD) of the differences is the random error 
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between methods. Thus the limits of agreement (bias ± 2SD) involve the combination of errors 
of each measurement technique.
In the present review on cardiac output methods a lack of consistency was found in the 
presentation of results. Regularly the method under study is compared to thermodilution by 
linear regression analysis also known as calibration statistic, presenting the regression 
coefficients of the line together with the correlation coefficient. Bland and Altman [47,48] in 
their statistical notes pointed out that it could be highly misleading to analyse data pairs by 
combining repeated observations from several patients and then calculating standard 
regressions and correlation coefficients.
Critchley and Critchley [49], in an effort to establish objective criteria for judging the accuracy 
and reproducibility of cardiac output measurement state that: if a ‘new’ method is to replace 
an older, established method, the new method should itself have errors not greater than the 
older method. Therefore, knowledge and a careful application of the older method as a 
reliable reference method are essential for a good evaluation of a new technique. Otherwise, 
the difference between the evaluated method and the reference method could be determined 
mainly by the reference method. In an example Critchley and Critchley [49] showed that if the 
reference technique has a 2SD-precision of ±20%, then a new method may have also a 
2SD-precision of 20% to be acceptable. According to Pythagoras’ law, the limits of 
agreement in the Bland-Altman plot should be less than ±28%, i.e. √(202+202), to conclude 
for agreement between methods. This example has led to an oversimplification in 
comparison of methods and many authors conclude that the Bland-Altman limits of 
agreement should be less than ±30% to accept the new measurement technique. Based on 
the fact that the 2SD-precision of reference method may be less than 20%, the criteria of 
30% derived from Bland-Altman analysis is highly misleading. Therefore, evaluation studies 
should provide the precision of the reference method. In addition to the above discussion 
about the evaluation of new methods, we should realize that a proper evaluation method of 
continuous cardiac output methods is still awaited [50].
In Table 1, we summarized results of different methods to estimate cardiac output against 
the results of the intermittent pulmonary thermodilution method as reference method. 
From each peer reviewed study we noted or recalculated the bias and limits of agreement for 
cardiac output, hereto cardiac index was converted to cardiac output. For each method we 
took the median results of the included studies. Furthermore, we calculated the 2SD-
precision for the difference methods assuming the reference method having a 2SD-precision 
of 10%, 20% and 30% respectively. A 2SD-precision of 10% correspond to the averaged 
results of three thermodilution measurements equally spread over the ventilatory cycle 
whereas 20% correspond to the average result of three measurement randomly applied and 
30% to single estimates [5]. The number of studies included in Table 1 are: CCO-vigilance 
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thermodilution method 13 [13,51-62]; transpulmonary thermodilution method 5 [62-66]; 
transpulmonary lithium dilution method 4 [67-70]; the Fick CO2-rebreathing method 5 
[3,71-75]; 
calibrated Modelflow method 5 [29,38,76-78]; uncalibrated Modelflow 4 [38,78-80]; PiCCOplus 7 
[62,76,81-84], only results with software version 4.x and later are used; LiDCOplus 5 [69,70,85-87]; 
PRAM 3 [34,88,89]; FloTrack-Vigileo 9 [79,84,90-96], only results of software version 1.07 and later are 
selected. No data of ultrasound methods are included because not enough of these methods 
were compared to thermodilution cardiac output except for the HemoSonic [79,97-99] which is 
however out of production at the moment. Also, the results of the impedance method were 
excluded because Raaymakers et al. [45] in a meta-analysis concluded already for insufficient 
agreement with reference methods. From the data given in Table 1, we may learn that none of 
the methods can replace the averaged results of three measurement with pulmonary artery 
intermittent thermodilution equally distributed over the ventilatory cycle (2SD<10%). 
Transpulmonary thermodilution, transpulmonary lithium dilution both with the averaged 
results of three measurements, calibrated Modelflow and LiDCOplus pulse contour may replace 
the pulmonary artery thermodilution with the results of 3 randomly applied measurements. All 
methods can replace single thermodilution estimates with a 2SD-precision of 30%.
Table 1  Median results for different methods in comparison to intermitted pulmonary thermodilution 
cardiac output.
Method N observations Differences with COpa











L∙min-1 % % % % %
Indicator dilution
CCO-Vigilance 3439 0.03 0.55 27 25 18 6
transpulmonary TD 818 0.43 7.74 21 18 7 0
transpulmonary LiD 245 -0.03 -0.55 26 23 16 0
Fick
CO2-rebreathing 601 -0.25 -4.35 35 34 29 19
Pulse Contour
Modelflow-calibrated 995 0.00 0.00 17 16 0 0
Modelflow-
noncalibrated 924 0.31 5.63 31 29 23 7
PiCCOplus 1802 0.04 0.73 32 30 25 10
LiCCOplus 452 0.05 0.91 24 22 13 0
FloTrac-Vigileo 1777 0.25 4.55 41 40 36 29
N obs, total number of obersevation; COpa, cardiac output by intermittent pulmonary thermodilution
(37
Table 2 Overview of characteristics for different methods to measure cardiac output.
CO method Invasiveness Response Accuracy Precision Limitations
Fick O2 +++ Intermittent High Moderate Requires a PAC for 





Fick CO2 + Slow Low Low Subject must be on 
ventilator 
Errors due to shunts
PAC Td bolus +++ Intermittent High High Special precaution 
during mechanical 
ventilation  
Requires a PAC and 
triplicate measurement
PAC CCO +++ Continuous Moderate Moderate Requires a PAC and 
triplicate measurement
TP Td bolus ++ Intermittent High High Requires a PAC and 
triplicate measurement
TP Li bolus ++ Intermittent Moderate Moderate Requires only arterial 









LiDCO ++ Beat-to-beat Moderate Moderate Requires frequent 
calibration with 
independant (other) 
method or lithium 
indicator method
Vigileo ++ Beat-to-beat Moderate High Needs specific sensor
Modelflow ++ Beat-to-beat High High Needs femoral or radial 
arterial catheter
TOD + Continuous High Low Not well tolerated in 
awake subjects and 
transducer position 
difficulty
TTE - Continuous Moderate Low Large inter-operator 
variability




CO is cardiac output, CCO is continuous cardiac output, Li is Lithium, PAC is pulmonary artery catheter, Td 
is thermodilution, TOD is transoesophageal Doppler, TP is transpulmonary, TTE is transthoracic echography.
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Conclusion
Many methods to measure cardiac output are available (see Table 2). None of the methods 
studied fulfil the criteria of accuracy, precision, operator independence, fast responding, 
non-invasiveness, continuous measurement, easy of use, low cost and without 
complications. The Fick for O2, for instance, is labor intensive and invasive but highly 
accurate and precise. The continuous thermodilution method does not have a fast response, 
needs skilled physicians to introduce the PAC and is invasive. The pulse contour methods 
add no invasiveness give beat-to-beat cardiac output and are easy to use. The ultrasound 
methods have large inter-intra observer variability. The transpulmonary indicator dilution 
methods score better in accuracy and precision. The ultrasound methods are limited by large 
inter-intra observer variability. With respect to precision and accuracy, all methods can 
replace single thermodilution estimates with a 2SD-precision of 30%, most can replace the 
averaged result of three randomly applied intermittent thermodilution measurements but 
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Ideally cardiac output monitoring is accurate, precise, operator-independent, rapid, 
non-invasive, continuous, easy to use, and cost-effective. Methods that follow changes in 
cardiac output may provide an early warning on changes in circulatory function or allow 
‘interrogation’ of the circulation with interventions. 
Cardiac output has perhaps traditionally been monitored by using a thermodilution 
pulmonary artery catheter (PAC) using intermittent bolus thermodilution (COtd) and this is 
still considered by some the best reference method. However, it may not be feasible to follow 
changes on interventions or applied challenges, due to its time delay [1,2]. Devices based on 
beat-to-beat assessment of stroke volume are better equipped to monitor changes in cardiac 
output and two technologies currently available are based on arterial pulse contour and 
transoesophageal ultrasound.
The recently introduced auto-calibrated FloTrac/Vigileo (Edwards Lifesciences, Irvine, CA, 
USA) is a pulse contour method for cardiac output monitoring that, in contrast to devices 
like the PiCCO™ (Pulsion Medical, Munich, Germany) and LiDCO™ (LiDCO Ltd, 
Cambridge, UK), does not require an independent calibration [3] and is thus relatively 
non-invasive using the pressure signal from a standard peripheral arterial line. The standard 
deviation (SD) of the pulse pressure is correlated to stroke volume based on the patient’s 
age, gender, body height and weight after an automatic adjustment related to an estimate of 
vascular compliance. Early validation showed conflicting results, but after the introduction of 
newer software (version 1.07), results became more uniform [4-8]. 
In some respects the Modelflow method is similar, deriving an aortic flow waveform from 
arterial pressure by using a three-element input impedance model. Stroke volume is 
integrated from the flow waveform. The parameters of the model are based on aortic 
pressure, gender, age, height and weight of the patient. The Modelflow (or pulse contour) 
method can follow beat-to-beat cardiac output changes, both after calibration by 
thermodilution as well as in a non-calibrated setting [9-12]. 
The HemoSonic monitor (HemoSonic 100, Arrow International, Reading, PA, USA) 
comprises an ultrasound probe with both M-mode and pulsed Doppler transducers [13,14]. The 
former measures (in real time) the diameter of the descending aorta while the latter measures 
blood velocity in the aorta. From these, aortic blood flow (ABF) is computed which in turn 
enables estimation of cardiac output [15].
The aim of our study was to compare the accuracy, precision and monitoring ability of cardiac 
output measurements by FloTrac-Vigileo, Modelflow and HemoSonic with intermittent 
pulmonary artery thermodilution as the reference method. 
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Methods
Patients and anaesthesia 
After ethical approval and written informed consent, 13 patients were studied after coronary 
arterial bypass grafting or mitral valve reconstruction. All patients had symptomatic coronary 
artery disease without previous myocardial infarction but patients with a history of abnormal 
ventricular function, aortic aneurysm, extensive peripheral arterial occlusive disease, aortic 
valve pathology, and pharyngeal or oesophageal pathology were excluded. Patients with 
persistent postoperative arrhythmia or the necessity for artificial pacing or heart assist 
devices were also excluded. All patients were included in the study during their initial 
post-operative period in the Intensive Care Unit (ICU).
Anaesthesia during surgery and ICU stay was generally with appropriate doses of propofol, 
sufentanil and vasoactive medication. The lungs were mechanically ventilated (Dräger 
EVITA 4, Dräger AG, Lübeck, Germany) in a volume-control mode with settings aimed to 
achieve normocapnia with a tidal volume of 8-12 ml∙kg-1 and a respiratory frequency of 12-14 
breaths∙min-1. The fraction of inspired oxygen was maintained at 0.4 and PEEP 5 cmH2O. 
During the observation period ventilator settings, sedation and vasoactive medication, when 
used, were unchanged.
Monitoring techniques 
Before ICU admission, a radial artery was catheterized with a 20G catheter (Arrow, Reading, 
PA, USA) to monitor arterial pressure (Pa) and a pulmonary artery catheter (Edwards 
Lifesciences, Irvine, CA, USA) introduced into the right jugular vein to monitor central 
venous pressure (CVP), pulmonary artery pressure (PAP) and to estimate cardiac output 
(CO) by the intermittent thermodilution method (COtd). 
COtd measurements were performed with an automated system under computer control 
and measured in triplicate (10 ml saline solution at room temperature) in 2 minutes, with 
the measurements equally spread over the ventilatory cycle. These three individual COtd 
measurements were averaged [16]. Blood pressure transducers were referenced to the level of 
the tricuspid valve and zeroed to atmospheric pressure. 
The radial artery pressure (Pa) from the radial artery catheter was also connected to a FloTrac 
pressure transducer (Edwards Lifesciences) with a bifurcated lead, one limb connected to the 
Vigileo system (Edwards Lifesciences) to measure pulse contour cardiac output (COed) and 
the other limb connected to a bedside monitor pressure module (Hewlett Packard model 
M1006A) whose output was used as the input signal to the modified Modelflow system 
(BMEYE, Academic Medical Center, Amsterdam, the Netherlands) to estimate pulse contour 
cardiac output (COmf). Detailed information about the FloTrac-Vigileo system [3] and 
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Modelflow system [17,18] can be found elsewhere.
An ultra-sound probe (HemoSonic100, Arrow, Reading, Pa, USA) to monitor aortic blood 
flow (ABF) was inserted through the mouth and advanced in the oesophagus to the level of 
the 4th intercostal space and its position adjusted to obtain the highest Doppler velocity 
signal along with simultaneous optimal visualization of aortic wall images [12,14]. The final 
position of the probe was checked by chest X-ray, and readjusted after changes in position of 
the patient, if necessary. All measurements were made by the same clinician under 
supervision of team members experienced with HemoSonic100 cardiac output monitoring. 
Cardiac output (COhs) was calculated from ABF [14].
COtd, COed, COmf, COhs, Pa, PAP, CVP, blood temperature, heart rate (HR), were 
continuously recorded and stored on a personal computer for documentation and offline 
analysis.
Figure 1  Different positions of the patient during the interventions. A: During supine position VT was 
increased with 50% and PEEP was increased with 10 cmH2O. B: PLR, Passive legs raising is 
performed by maintaining the patient in a supine position and raising the legs by repositioning 
of the bed. C: HUT, head up tilting. During all interventions except for HUT, the heart (symbol 
♥) and baroreceptors (symbol o) are in-level and blood pressure transducers do not have to be 
re-referenced. The Doppler probe may move during PLR and HUT and a repositioning of the 
probe is needed.
Study protocol
Measurements were carried out within 2 h of arrival in ICU and after hemodynamic 
stabilization post-surgery. Characteristics and treatment data of each patient were collected. 
During ‘Baseline 1’ (Figure 1) a series of measurements of HR, MAP, CVP, PAP, COtd, 
COed, COmf, and COhs were obtained. To change cardiac output, four interventions were 
applied. First, the tidal volume setting of the ventilator was increased by 50% for 5 minutes. 
Then 2 minutes later, the same series of measurements were repeated (‘VT-series’). Then, 
5 minutes after values returned to baseline another series of measurements were performed 
(‘Baseline 2’). Next, positive airway pressure (PEEP) was increased by 10 cmH2O for 
5 minutes, and after 2 minutes the next series of measurements was taken (‘PEEP-series’). 
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Then, 5 minutes after return from increased PEEP, a ‘Baseline 3’ series of measurements 
was carried out. Next, passive leg raising was performed from the supine position by lifting 
both legs at a 30° angle and holding them there for 5 minutes: 2 minutes later, with legs still 
elevated the series of measurements were repeated (‘PLR-series’). Five minutes after return 
from passive leg raising, ‘Baseline 4’ measurements were performed. Lastly, a head up tilt 
was induced by raising head of the bed to 30o: 2 minutes later a series of measurements 
(‘HUT-series’) were made. Five minutes after return from HUT, during, the last series of 
(‘Baseline 5’) measurements were performed. 
Statistical analysis
After confirming a normal distribution of data with the Kolmogorov–Smirnov test, 
agreement between COed, COmf, COhs and COtd as well as agreement in changes in 
cardiac output was evaluated with Bland-Altman statistics. The agreement between COmf or 
COed or COhs and COtd was computed as the bias (i.e., accuracy) and precision (i.e., 
standard deviation), with the limits of agreement (LOA) computed as the bias ±2SD [19]. The 
coefficient of variation was computed as [COV=100*(SD/mean)]. We also applied the 
method of Myles and Cui [20], and used a random effects model to calculate precision and 
limits of agreement. We included the effects of intervention (VT, PEEP, PLR and HUT) as a 
covariate in order to get a more precise estimate of the residual within-subject variation.
Differences in cardiac output were analysed further with factorial ANOVA, and there were three 
factors; monitoring method (fixed factor, four levels); intervention (fixed factor, eight levels, 
repeated) and subjects (random factor, 13 levels). If ANOVA indicated a statistically significant 
(p<0.05) result in cardiac output between baseline and intervention, a post-hoc test (Tukey-HSD 
in multiple comparison, LSD in pairwise comparison) was used to identify the significant effect. 
The ability of the monitors to measure the change in cardiac output change (∆CO) due to 
our interventions was calculated by subtracting the averaged cardiac output values during 
the relevant baselines from the mean cardiac output during the intervention (both as 
absolute and percentage changes). We regarded a ‘positive trend’ as being when the change 
in value of the new monitor was in the same direction as those found for COtd, whereas, a 
‘negative trend’ was one where these changed in opposite directions. Ideally, only positive 
scores should be present. These scores were analysed using 2x2 tables and presented as 
percentages. Separate scores were counted for changes when thermodilution cardiac output 
values differed by at least a clinically relevant 5 and 10%. 
Results
We included 13 cardiac surgical patients, 11 after coronary arterial bypass grafting and 2 after 
mitral valve reconstruction. A total of hundred seventeen paired CO data sets with COtd, 
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COed, COmf and COhs were obtained during 5 baselines periods and, VT, PEEP, PLR and 
HUT interventions. Averaging the baseline value before and the baseline value after the 
intervention resulted in 104 paired values for statistical evaluation. The data were normally 
distributed. Mean COtd was 5.28 L∙min-1 (range 2.57 to 8.61 L∙min-1). The coefficient of 
variation for averages of three thermodilution measurements equally distributed over the 
ventilatory cycle was 5%.
Agreement of methods with thermodilution cardiac output
Figure 2 shows Bland-Altman plots for difference between COtd and COed, COmf or COhs. 
Bias between COtd and COmf and between COed and COmf was 0.33 and 0.30 L∙min-1 
respectively which was significantly different from the bias between COtd and COhs (-0.41 
L∙min-1, p < 0.001). From Figure 2 it is observable that the distribution of errors is different 
among the methods. COmf has best precision (0.69 L•min-1) and smallest range of the 
limits of agreement (-1.08 to 1.68 L∙min-1, 26%, Figure 2B) whereas values of precision and 
limits of agreement for COed and COhs are larger (-1.47 to 2.13, 34%, Figure 2A and –2.62 
to 1.80 L•min-1, 44%, Figure 2C, respectively). 
Figure 2  Bland-Altman plots of the difference of cardiac output (CO) values between conventional 
thermodilution (COtd) and three minimal invasive methods (n = 104). In panel A, COed, CO by 
auto-calibrated FloTrac-Vigileo system. In panel B, COmf, CO by non-calibrated Modelflow method. In 
panel C, COhs, CO by HemoSonic 100 ultrasound system. Solid line represents the bias, dotted lines 
absolute limits of agreement and dashed-dotted lines the limits of agreement in percentage.
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Result based on the random effects model of Myles and Cui [20] are shown in Figure 3. The 
residual within-subject standard deviation was substantially smaller after adjustment for 
baseline. For example, the original within-subject standard deviation was 0.41 and 0.79 for 
COtd and COed, respectively. After adjusting for the relevant covariates, the within-subject 
standard deviation reduced to 0.21 and 0.20, respectively. This reduced the width of the 95% 
limits of agreements accordingly (Figures 2 and 3). Bias and precision of both, the original 
and modified Bland-Altman methods are presented in Table 1. 
Figure 3  Modified Bland-Altman plots of the difference of cardiac output (CO) values between 
conventional thermodilution (COtd) and three minimal invasive methods, based on a random 
effects model (n = 13). In panel A, COed, CO by auto-calibrated FloTrac-Vigileo system. In panel 
B, COmf, CO by non-calibrated Modelflow method. In panel C, COhs, CO by HemoSonic 100 
ultrasound system. Solid line represents the bias, dotted lines absolute limits of agreement and 
dashed-dotted lines the limits of agreement in percentage
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Table 1  Comparison of bias and precision between the original and modified Bland-Altman methods. 
COtd, intermitted thermodilution cardiac output (reference method); COed, CO measured with 









COed – COtd 0.33 0.90 34
COmf – COtd 0.30 0.69 26
COhs – COtd -0.41 1.11 44
Modified Bland-Altman statistics (Random effects model)
COed - COtd 0.33 0.69 25
COmf - COtd 0.30 0.64 24
COhs - COtd -0.41 1.07 42
Effects of intervention on CO
The effects of the four applied interventions on our measures are shown in Table 2. 
Increasing tidal volume did not result in a change in cardiac output with any method. Other 
interventions did, however, change CO. With Factorial ANOVA the main effects on cardiac 
output values related to the measurement techniques was (F = 23.73, p < 0.001), and related 
to the interventions was (F = 13.85, p < 0.001). Differences between methods were consistent 
across all interventions (F = 0.19, p = 1.000). 
As expected, cardiac output changes by all three methods correlate significantly (p ≤ 0.001) 
with cardiac output changes by COtd (COed v COtd, slope 1.46, CI95% 1.07 to 1.81; COmf v 
COtd, slope 0.82, CI95% 0.61 to 01.01; COhs v COtd, slope 0.88, CI95% 0.62 to 1.15). COed 
significantly overestimates the change (compared with COtd) but changes in COmf and 
COhs were similar to COtd.
Regarding direction of change, the score for agreement was 86% for COmf and 81% for 
COed and COhs. These scores greatly improve if clinically irrelevant changes of <5% or 
<10% are excluded from counting. For a 5% threshold, agreement is found in 96%, 85% and 
93% with COmf, COed and COhs respectively. For a 10% threshold, these values are 100%, 
89% and 100% respectively.
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Figure 4  Bland-Altman plots with percentage changes in cardiac output in three minimal 
invasive methods and percentage changes by conventional thermodilution. For 
abbreviations see Figure 2. Solid line presents bias and dotted lines limits of 
agreement. 
The Bland-Altman plots for changes in cardiac output with LOA are shown in Figure 4. Bias 
between change COtd and change COed, change COmf or change COhs is not significantly 
different (-3.03, -3.28, and -2.01 % respectively). COed (-29.59 to 23.52 %) has the largest 
range of the limits of agreement in contrast to COmf (-17.23 to 10.67 %) and COhs (-20.28 to 
16.27%), respectively changes between COed and COtd clearly depends on the level of 
averaged change of COed and COtd (Figure 4A).
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Table 2  Changes in cardiac output (CO) related to increase of tidal volume, increase of PEEP, passive leg 
raising and head up tilt intervention. COtd, intermitted thermodilution cardiac output; COed, CO 
measured with FloTrac-Vigileo; COmf, CO measured with non-calibrated Modelflow; COhs, CO 
measured with HemoSonic 100; CO difference is difference between CO intervention and CO 
baseline. Results of post-hoc analysis, pairwise comparison (LSD) of cardiac output differences 
related to interventions, factorial ANOVA (F = 13.85, p < 0.001).
CO Baseline CO Intervention CO difference
Mean (SD) L∙min-1 Mean (SD) L∙min-1 in % p - value 
Increased tidal volume
COtd 5.28 (1.28) 5.28 (1.44) 0.0 0.954
COed 5.72 (0.88) 5.89 (1.47) 3.0 0.507
COmf 5.75 (1.38) 5.43 (1.48) -5.6 0.052
COhs 4.83 (0.93) 4.75 (0.98) -1.7 0.669
Increased PEEP
COtd 5.37 (1.35) 4.66 (1.47) -13.3 < 0.001
COed 5.99 (0.93) 4.61 (1.51) -23.0 < 0.001
COmf 5.73 (1.45) 4.88 (1.47) -14.8 < 0.001
COhs 4.86 (0.89) 4.17 (1.04) -14.2 0.001
Passive leg raising
COtd 5.39 (1.33) 5.79 (1.37) 7.4 < 0.001
COed 5.61 (0.93) 6.07 (0.97) 9.6 0.078
COmf 5.72 (1.44) 5.97 (1.46) 4.4 0.133
COhs 5.11 (0.74) 5.56 (0.76) 8.8  0.025
Head up tilt
COtd 5.34 (1.20) 5.16 (1.21) -3.8 0.089
COed 5.78 (1.06) 5.23 (1.35) -9.5 0.041
COmf 5.81 (1.31) 5.38 (1.30) -7.4 0.009
COhs 5.14 (1.13) 4.55 (1.01) -11.5 0.004
Discussion
Our main finding is that only Modelflow yields limits of agreement (26%) that are below the 
30% criteria for limits of agreement for a theoretically acceptable alternative to 
thermodilution cardiac output [21]. Monitoring changes or trends in cardiac output can, 
however, be performed reasonably well with the non-calibrated Modelflow and HemoSonic 
(the auto-calibrated FloTrac-Vigileo performs less well in this regard). 
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Any error in our reference method (COtd) might influence the comparison between cardiac 
output by thermodilution and FloTrac-Vigileo, Modelflow or HemoSonic. Individual 
thermodilution cardiac output estimates show substantial scatter (10-15%) in value even 
under stable haemodynamic and ventilatory conditions [22]. An average of at least three 
measurements – over the respiratory cycle - is advised to obtain cardiac output estimate with 
acceptable precision [11,16] (this can require injections to be performed by a motor driven 
syringe under computer control) [23]. 
The results of the present study did not show conflicting results with respect to the results of 
previous reports, obtained with either the FloTrac-Vigileo system version 1.07 [4-8], the 
non-calibrated Modelflow method [11,12] or Hemosonic 100 system [24,25]. 
Myles and Cui [20] criticized in a recent editorial the use of standard Bland-Altman analysis to 
compare methodologies (such as ours in this study) where repeated measurements are used. 
We feel, however, that multiple observations in a patient really only apply when taken under 
the same experimental conditions. Where conditions are changing with time, it seems valid 
to take several observations and then assess response over time. Nonetheless, we took the 
precaution of applying both the ‘classical’ Bland-Altman statistics [19] and the random effects 
model proposed by Myles and Cui [20]. The differences in results of analysis are presented in 
the Figures 2 and 3. For all three methods the limits of agreement of the classical Bland-
Altman analysis are larger than with the random effects model. This can be explained by the 
removal of within patient variation in cardiac output. Especially the difference between COed 
and COtd (Figure 2A) decreased considerably with the random effects model (Figure 3A). 
This is account for the overestimation of changes in cardiac output by the FloTrac-Vigileo 
system (Figure 4A).
Passive leg raising as an intervention in combination with oesophageal ultra-sound blood 
flow measurement has been used to identify those patients that likely beneficially respond to 
fluid challenge with an increase in cardiac output [26-28]. Monnet at al. [27] demonstrated that 
the HemoSonic device could reliably predict such responders. Our data suggests that this 
may also be the case with FloTrac-Vigileo and Modelflow. 
One concern was that during passive leg raising (or even head up tilt), the oesophageal probe 
position may change. We were careful to reposition the probe regularly to obtain an optimal 
signal. However, the position of baroreceptors in relation to the heart is also changed by 
these manoeuvres and this may influence arterial blood pressure by auto-regulation (Figure 




The non-calibrated Modelflow method showed best performance in estimation of cardiac 
output. Changes in cardiac output by thermodilution were also tracked well by the non-
calibrated Modelflow and also by the HemoSonic device, whereas the auto-calibrated FloTrac-
Vigileo overestimated the changes in cardiac output. Directional changes in cardiac output 
by thermodilution were detected with a high score by all three methods. Encouraged by the 
simplicity of setup procedure and advantage for the patient, we suggest future work focuses 
on the Modelflow system. 
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Since the introduction of continuous cardiac output measurement by arterial pulse contour 
analysis, real time measurement of stroke volume (SV) stroke volume variation (SVV) and 
pulse pressure variation (PPV) during mechanical ventilation have evolved in clinical practice. 
Most studies have shown SVV and PPV to be good indicators of fluid responsiveness [1-3]. 
However, in two separate publications [4,5] Pinsky advised caution in the clinical use of SVV 
based on the fact that beat-to-beat SV by the pulse contour technique has not been validated 
to monitor rapid changes in SV, such as occurs within a single breath. This is further 
complicated by the use of different algorithms to calculate SV and SVV by different 
monitoring systems. In this light, a clinical validation study on SVV seemed important. 
The aim of our study was to compare SVV estimates by the LiDCOplus system (SVVli) 
(LiDCO Ltd. Cambridge, UK) with SVV estimates by the FloTrac-Vigileo system (SVVed) 
(Edwards Lifesciences, Irvine, CA, USA) in post operative cardiac surgery patients. To induce 
changes in SVV we applied five different interventions to the patients. These interventions 
were: increase of tidal volume, increase of positive end-expiratory pressure (PEEP), a head 
up tilt procedure, passive leg raising and fluid loading. In between these interventions 
patients returned to the baseline condition prior to undertaking the next intervention. 
Methods
After approval of the study protocol by the University Medical Ethics committee, fifteen 
patients were studied after coronary arterial bypass grafting with or without mitral valve 
repair. The study was conducted according to the principles of the Helsinki declaration and 
written informed consent was obtained from all patients the day prior to surgery. Patients 
were only selected if they were scheduled to receive a pulmonary artery catheter and a radial 
artery cannula for peri-operative monitoring and care. All patients had symptomatic 
coronary artery disease without previous myocardial infarction and were on β-adrenergic 
blocking medication. Patients with a history of abnormal ventricular function, aortic 
aneurysm, extensive peripheral arterial occlusive disease, or postoperative valvular 
insufficiencies were not considered for this study. Patients with postoperative severe 
arrhythmia or a requirement for artificial pacing or cardiac assist devices were also excluded. 
The final inclusion of the patients was during their initial post-operative period in the ICU.
In the operating room, the radial artery was catheterized with a 20G catheter (Arrow, 
Reading, PA, USA) to monitor arterial pressure and a pulmonary artery catheter (Edwards 
Lifesciences, Irvine, CA, USA) was introduced into the right internal jugular vein to monitor 
central venous pressure (CVP), pulmonary artery pressure (PAP) and to estimate cardiac 
output (CO) by the intermittent thermodilution method (COtd). 
Anaesthesia during surgery and the ICU-stay was maintained with propofol  
(2.5 mg∙kg-1∙h-1), sufentanil (0.06-0.20 mg∙kg-1∙h-1) and vasoactive medication according to 
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institutional standards. The lungs were mechanically ventilated (EVITA 4, Dräger AG, 
Lübeck, Germany) in a volume-control mode with settings aimed to achieve normocapnia 
with a tidal volume of 8-12 ml∙kg-1 and a respiratory frequency of 12-14 breaths∙min-1. The 
administered fraction of inspired oxygen was 0.4 with PEEP of 5 cmH2O. During the 
observation periods, sedation and vasoactive medication, when used, were unchanged.
Measurements
Measurements started in the postoperative period. The radial artery pressure, derived via the 
radial artery catheter was measured with a FloTrac pressure transducer (Edwards 
Lifesciences). Of the bifurcated cable, one limb was connected to the Vigileo system 
(Edwards Lifesciences, software version v1.07) to measure pulse contour cardiac output and 
SVVed and the other limb was connected to a bedside monitor pressure module (Hewlett 
Packard model M1006A, Hewlett Packard Company, Palo Alto, CA, USA) of which the 
output signal was used as input to the LiDCOplus (LiDCO Ltd, Cambridge, UK) pulse 
contour system to deliver cardiac output, pulse pressure variation (PPVli) and SVVli. 
Detailed information about both pulse contour techniques can be found in recent literature 
[6-9]. Radial artery pressure, PAP and CVP were recorded online on computer disk for 
documentation and offline calculations. Radial artery pressure, PAP and CVP transducers 
were referenced to the intersection of the anterior axillary line and the 5th intercostal space. 
After changes in position of the patient the transducers were re-referenced. Airway pressure 
was measured at the proximal end of the endotracheal tube with an air-filled catheter 
connected to a pressure transducer. Airway pressure was balanced at zero level against 
ambient air. 
COtd measurements were performed with an automated system under computer control 
and measured in triplicate (10 ml saline solution at room temperature) in 2 minutes, with 
the measurements equally spread over the ventilatory cycle. These three individual COtd 
measurements were averaged [10,11].
We calibrated the LiDCOplus system with thermodilution cardiac output measurements at 
the start of the observation period. The FloTrac-Vigileo system used its internal auto-
calibration. From the beat-to-beat cardiac output values with the LiDCOplus and FloTrac-
Vigileo system, stroke volume (SVli and SVed), stroke volume variation (SVVli and SVVed) 
and pulse pressure variation (PPVli) were determined. SVV and PPV were calculated over 
20-second periods of radial artery pressure data. 
Study protocol
Measurements were carried out within 2 hours of arrival in ICU and after hemodynamic 
stabilization. Characteristics and treatment data of each patient were collected. During the 
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‘Baseline-1’ period, a series of measurements of HR, COtd, PPVli, SVVli and SVVed were 
obtained. To change SVV, five interventions were applied. First, the tidal volume setting of 
the ventilator was increased by 50% for 5 minutes. Two minutes after onset of the increase 
tidal volume challenge, the same series of measurements were repeated (‘VT-series’). Then, 
5 minutes after the ventilation values were returned to baseline another series of 
measurements were performed (‘Baseline-2’). For the second intervention, positive airway 
pressure (PEEP) was increased by 10 cmH2O for 5 minutes, and after 2 minutes at the 
increased PEEP the next series of measurements was obtained (‘PEEP-series’). Five minutes 
after return from increased PEEP to baseline, a ‘Baseline-3’ series of measurements was 
carried out. For the third intervention, passive leg raising was performed from the supine 
position by lifting both legs at a 30° angle and holding them there for 5 minutes. Two 
minutes after the onset of leg raising the series of measurements were repeated (‘PLR-
series’). Five minutes after return from passive leg raising, ‘Baseline-4’ measurements were 
performed. For the fourth intervention, a head-up-tilt was performed by raising head of the 
bed to 30o. After 2 minutes of head-up-tilt the next series of measurements were made 
(‘HUT-series’). Five minutes after return from head-up, the last series of baseline 
measurements were performed (‘Baseline-5’). Lastly, the fifth intervention, a fluid loading 
with 500 ml Hydroxyethyl Starch (HES 130/0.4) over 15 minutes, was undertaken. Five 
minutes after ending fluid loading the last series of measurements were made (‘FL-series’). 
Fluid loading was only performed in eight patients. In the other patients it was not indicated. 
The study protocol lasted about 75-90 minutes following which sedation was stopped and 
weaning procedures were started. During the protocol we encountered no adverse events. All 
patients were discharged from the intensive care unit on the first postoperative day.
Statistical analysis
After confirming a normal distribution of data with the Kolmogorov–Smirnov test, 
differences between SVVed and SVVli during baseline and interventions were analyzed 
using a paired t-test. Calculations of bias and precision and limits of agreement between 
SVVed and SVVli were performed using Bland and Altman analysis [12] in which bias was the 
difference between SVVli and SVVed and precision the standard deviation (SD) of this 
difference. The upper and lower limits of agreement were calculated as the bias ±2SD. The 
coefficient of variation was calculated as 100%∙SD/mean. The percentage limits of 
agreement were calculated as twice the coefficient of variation. The differences in precision 
between the two methods were tested by using correlated variances in paired samples [13,14]. 
Repeatability of SVVli and SVVed was calculated using the data from the baseline 
measurements. A p-value of less than 0.05 was considered statistically significant. Unless 
otherwise stated, data are presented as mean ± SD.
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Results
Fifteen postoperative cardiac surgery patients were included. Patient demographics were; 
male to female ratio of 12:3, mean age 66 (range 55 to 82) years, and mean body surface area 
(BSA) 1.98 ± 0.20 m2. Only eight patients received fluid loading. A total of 136 paired data 
sets were obtained. The data was normally distributed. COtd ranged from 2.6 to 7.7 with an 
average of 5.0 ± 1.1 L∙min-1. Heart rate ranged from 54 to 92 (average 75 ± 8 min-1). SVVli 
ranged from 1.4 and 26.8% (average 8.7 ± 4.6%), SVVed from 2.0 to 26.0% (average 10.2 ± 
4.7%) and PPVli from 1.9 to 25.3 (average 8.8 ± 4.7%). 
Figure 1  Bland-Altman plot, representing agreement between stroke volume variation (SVV) by the 
LiDCO system (SVVli) and by Edwards FloTrac-Vigileo system (SVVed). The solid line represents 
the bias and the dotted lines the limits of agreement, dashed lines the limits of agreements in 
percentage. 
Agreement of SVVli and SVVed
The error diagram for difference between SVVli and SVVed is shown in Figure 1. Bland-
Altman statistics are indicated in the Figure by bias and limits of agreement. The bias is 
significantly different from zero, at 1.5 ± 2.5%, < 0.001, (95% confidence interval 1.1 to 1.9). 
The upper and lower limits of agreement are 6.4 and – 3.5%. The coefficient of variation for 
the differences between SVVli and SVVed was 26% giving a relatively large range for the 
percentage limits of agreement of 52%.
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Interventions
Data on COtd, HR, PPVli, SVVli, SVVed and the differences between SVVli and SVVed for 
the different interventions and baseline conditions are shown in Table 1. With Factorial 
ANOVA the main effects on SVV values related to the measurement techniques was  
(F = 14.49, p= 0.02), and related to interventions was (F = 8.29, p < 0.001). Differences 
between SVV measurement methods were consistent across all observations  
(F = 1.54, p = 0.142). 
Table 1  Differences in cardiac output (CO), heart rate (HR), pulse pressure variation (PPV) and stroke 
volume variation (SVV) at interventions. The interventions are; increase of tidal volume with 50% 
(VT); increase in PEEP with 10 cmH2O (PEEP); passive leg raising (PLR); head-up tilt (HUT) and 
fluid loading (FL); Method of measurement: CO thermodilution (COtd), PPV LiDCO system 




























Baseline 1 4.9 ± 1.0 76 ± 7 7.9 ± 4.3 7.8 ± 3.4 9.4 ± 3.9 1.6 ± 1.7 20 0.003
VT 4.9 ± 1.0 78 ± 9 11.2 ± 5.6 10.6 ± 5.8 12.9 ± 6.5 2.3 ± 2.9 24 0.009
Baseline 2 5.1 ± 0.9 74 ± 8 7.5 ± 3.6 7.6 ± 3.0 8.5 ± 3.3 1.0 ± 2.4 30 0.134
PEEP 4.3 ± 1.1 75 ± 8 12.4 ± 5.8 12.4 ± 5.6 13.3 ± 5.0 0.9 ± 2.4 19 0.171
Baseline 3 5.2 ± 0.9 75 ± 7 7.7 ± 3.7 7.6 ± 2.9 8.9 ± 3.4 1.7 ± 1.9 34 0.010
PLR 5.4 ± 1.0 74 ± 8 6.5 ± 3.3 5.9 ± 2.8 8.7 ± 3.1 2.9 ± 3.2 44 0.004
Baseline 4 5.2 ± 1.0 75 ± 8 8.5 ± 3.9 8.3 ± 4.2 10.0 ± 4.1 1.7 ± 1.9 21 0.004
HUT 4.9 ± 1.0 75 ± 9 9.7 ± 5.0 10.8 ± 4.5 11.6 ± 8.3 0.8 ± 2.9 26 0.287
Baseline 5 4.9 ± 1.3 75 ± 11 8.6 ± 4.0 9.0 ± 6.1 10.1 ± 5.4 1.2 ± 1.9 20 0.009
FL 5.6 ± 1.2 74 ± 12 6.7 ± 4.0 5.9 ± 2.9 6.5 ± 3.3 0.7 ± 1.0 15 0.095
One-way ANOVA statistics showed no significant difference between five baseline 
measurements for CO (F = 0.203, p = 0.936), HR (F = 0.094, p = 0.984), PPVli  
(F = 0.184, p = 0.946), SVVli (F = 0.254, p = 0.906) and SVVed (F = 0.390, p = 0.815), 
indicating no significant effects over time. 
On average, the tidal volume challenge showed no change in COtd and an increase in 
PPVli, SVVli and SVVed. During the PEEP challenge we observed a decrease in COtd and 
an increase of PPVli, SVVli and SVVed. Passive leg raising resulted in increased COtd and 
decreased PPVli, SVVli and SVVed. The head-up challenge resulted in a decreased COtd 
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and increased PPVli, SVVli and SVVed. Fluid loading increased COtd and decreased PPVli, 
SVVli and SVVed. Heart rate did not change significantly during study interventions.  
The most significant result was the difference between SVVli and SVVed for the different 
interventions (Table 1). We considered the results obtained during the five baseline 
observations as repeated measures. Analysis of these repeated measurements showed the 
following coefficients of variation: SVVli = 21%, SVVed = 22% (no difference between 
SVVli and SVVed, = 0.024, = 0.779), and PPVli = 23%.
Discussion
We found SVVli and SVVed to differ significantly. With percentage limits of agreement of 
52% we conclude that the LiDCOplus and FloTrac-Vigileo devices are not interchangeable. 
Furthermore, the determination of SVVli and SVVed appeared to be ambiguous as can be 
concluded from the high value of coefficients of variation (21 and 22%) for repeated 
measures. These findings underline Pinsky’s warning to be careful in the clinical use of SVV 
by pulse contour techniques, and to be restrained in using SVV (as a solitarily variable) in 
the management of individual patients [4].
The significant mean difference between SVV measured by the LiDCO and FloTrac-Vigileo 
device is most probably not caused by the calculation of SVV because both systems use a 
similar computation i.e. SVV = 100∙(SVmax – SVmin)/SVmean (where SVmax is the 
maximum, SVmin is the minimum and SVmean is the mean stroke volume). Therefore it is 
most likely explained by the difference in the calculation of SVmin, SVmax and SVmean by 
the two systems. The main difference in computation of SV is based on the correction for 
individual arterial compliance. The LiDCO system uses a pressure dependent correction for 
compliance based on Remington’s equations [15] whereas the FloTrac-Vigileo uses 
Langewouter’s equations [16]. There is a large similarity between the computations of SV 
(Figure 2). With both systems these equations lead to a diminished SV at higher pressure 
levels compared to lower pressure levels with the same arterial pressure curve. However, this 
correction for compliance may differ between the two systems. A difference in calibration 
between the two systems has no influence on SVV, indeed, assuming a calibration constant 
k, leads to SVV = 100∙ (k∙SVmax – k∙SVmin)/ k∙SVmean. With k in the nominator and 
denominator the calibration factor is ruled out in the determination of SVV.
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Figure 2  Similarity of calculation of cardiac output by the LiDCO system and by Edwards FloTrac-Vigileo 
system. Arterial volume (V) changes derived after transformation of the radial artery pressure 
(Prad) with Remington’s equations. Edward’s corrects cardiac output after SD calculation with 
Langewouter’s equations.
In a recent paper Hofer et al. [17] compared the FloTrac-Vigileo and the PiCCOplus system 
(Pulsion Medical Systems, Munich, Germany) for assessment of SVV to predict fluid 
responsiveness. The authors found SVV measured by the PiCCO system to be higher than 
the SVV by the FloTrac-Vigileo system. Besides this bias, we calculated from their Bland-
Altman analysis percentage limits of agreement of approximately 40% between the two 
systems. The authors concluded that there was similar performance of the two investigated 
systems in terms of predicting fluid responsiveness although the SVV threshold level in 
predicting fluid responsiveness by the PiCCO system (12.1%) differed from the FloTrac-
Vigileo system (9.6%). The differences in absolute SVV values were explained by the 
difference in signal detection sites (radial artery for FloTrac-Vigileo system and femoral 
artery for PiCCO system) as well as difference in signal analysis techniques. In our study we 
can exclude the influence of different detection sites because we used the same site for both 
techniques, i.e. the radial artery. Thus the difference between SVVli and SVVed was most 
probably related to differences in signal analysis. We did not calculate receiver operating 
curves to calculate differences in thresholds for predicting fluid responsiveness because we 
consider our number of fifteen patients too low. However, we expect different threshold 
levels for the LiDCO and FloTrac-Vigileo system as well. 
A wide range for the percentage limits of agreement (approximately 40%) can also be 
observed in the study by de Castro et al. [18], in which SVV measured by the PiCCOplus 
system was compared with SVV measured by aortic Doppler echocardiography. 
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Given these margins of error, we conclude that none of the above mentioned systems is 
interchangeable with the other. It seems that the calculation of SVV is prone to propagation of 
errors [18]. This is supported by the high coefficients of variation for repeated measures, SVVli 
of 21% and SVVed of 22%, observed in our study. As the errors in the measurements of SVVli 
and SVVed are not completely independent we cannot estimate the coefficient of variation for 
the difference between the two techniques from the coefficients of variation of both systems [19]. 
The coefficient of variation for the difference may vary between 1% and 43%. In our study we 
observed a coefficient of variation for the difference of 26%, which lies within this range.
Nevertheless the changes in SVV induced by our interventions were in agreement with what 
was clinically expected (Table 1). During the increase in tidal volume we observed, in 
comparison to baseline, no change in cardiac output but an increase in SVV. A similar 
increase in SVV to the increase of tidal volume was observed by Kim and Pinsky [20] in a well 
controlled animal study. During both the increased PEEP and head-up-tilt manoeuvres, CO 
decreased and SVV increased. Following both passive leg raising and fluid loading we 
observed an increase in CO and decrease in SVV with both systems. However, the difference 
between SVVli and SVVed fluctuated considerably.
Despite these shortcomings, SVV still seems a variable of considerable interest. Several 
authors have shown that SVV can predict the effects of fluid loading on cardiac output, albeit 
using different thresholds (ranging from 9.5 to 12.5%) to separate responder and non 
responders [17,21-23]. Although there is no reason to doubt the general principle of SVV as a 
predictor of fluid responsiveness, we conclude from our results that some caution in the use 
of SVV in individual patients is justified. Indeed, based on Bland-Altman analysis for 
repeated measurements for SVV with percentage limits of agreement, the value of SVV may 
differ by up to 40% between measurements. Thus an initial observed SVV of 10% may 
subsequently change to 14% or 6% without any change in the patient’s condition. This has 
important clinical implications: to improve cardiac output, a SVV of 14% may favour fluid 
loading, whereas a SVV of 6% may favour the use of catecholamines.
Conclusions
In this study, SVV measurements made by the LiDCOplus system (SVVli) and by the 
FloTrac-Vigileo system (SVVed) differed significantly. With percentage limits of agreement of 
52% the two methods did not agree and should not be used interchangeably. Furthermore, 
the determination of SVVli and SVVed appeared to be ambiguous as illustrated by the high 
values of their respective coefficient of variation (21% and 22%) for repeated measures. 
These findings limit clinical usefulness in individual patients and limit the comparability of 
results on fluid loading responsiveness from different studies. 
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The prolonged presence of hypovolaemia seriously impairs oxygen delivery to vital organs, 
hence fluid loading is indicated [1]. However, unnecessary fluid administration can lead to 
general and pulmonary oedema and cardiac failure [1,2]. Therefore, the selection of patients that 
will benefit from fluid administration is critical. 
This selection is traditionally based on clinical signs such as urine colour and production, as 
well as on filling pressures such as central venous pressure (CVP) and pulmonary artery 
wedge pressure (PAWP). In 1998, Boldt and colleagues performed a survey and reported 
that 93% of all ICU physicians in Germany used CVP and 58% used PAWP to assess volume 
status [3]. Nevertheless, neither clinical signs nor filling pressures have unambiguously been 
shown to discriminate between those patients who benefit from fluid loading and those who 
do not [4-6]. In most studies, this beneficial effect was defined as a significant increase in 
cardiac output. Because, in principle, nearly all patients will experience an increase in 
cardiac output after fluid loading [7], there is a necessity to differentiate between an increase 
in measured cardiac output (CO) after fluid loading and a “clinically” significant increase in 
CO. In fluid-loading-responsiveness studies, responders and non-responders are divided by 
an increase of 10% in CO after approximately 500 ml of fluid loading. Furthermore, the 
presence of fluid-responsiveness does not imply the need for fluid loading. Not only the 
ability to accurately predict the effect on CO after fluid loading is important but, for instance, 
also tissue O2 in the different organs and outcome need more attention.
In recent years, new variables based on heart-lung interaction, i.e. respiratory-induced stroke 
volume variation (SVV), pulse pressure variation (PPV) and systolic pressure variation (SPV), 
have been introduced [8]. These variables have been studied extensively but results regarding 
their predictive value in identifying responders and non-responders on fluid loading have 
been contradictory [9-11]. In addition, loading the circulation with small amounts of fluid (up 
to 500 ml) [12], or by passive leg raising (PLR) [7, 13-17] have become the subject of intense 
interest in assessing fluid loading responsiveness (or in other words to identify patients who 
will benefit from fluid loading). 
We evaluated the impact of newly derived variables (SVV, PPV and SPV), fluid challenges 
and PLR, and new cardiac output devices in daily practice in Dutch intensive care units. 
Finally, we investigated the use of guidelines to monitor volume status and fluid 
responsiveness in the ICU. 
Materials and methods
A questionnaire was sent via the Dutch Society of Intensive Care (NVIC) to 446 Dutch 
intensive care physicians (i.e. intensivists and fellows) working in one of the 99 hospitals 
with an ICU in the Netherlands. In the Netherlands, most intensive care physicians are 
members of the NVIC. A cover letter was included to provide background information and a 
(75
stamped addressed return envelope was added. The questionnaires were sent by regular 
mail in March 2008. 
The questionnaire was designed to be answered within 10 minutes. The questionnaire was 
checked by a sociologist with experience in the design of surveys. The majority of questions 
were multiple choice. The questionnaire consisted of seventeen questions and covered three 
topics: 1. General characteristics of ICU physicians; prior specialty training, experience level, 
type of hospital; 2. Assessment of haemodynamic condition and treatment of patients; use of 
clinical signs, haemodynamic parameters and challenges to the circulation; 3. Guidelines 
used in the ICU; definitions of hypovolaemia and hypervolaemia, use of guidelines, date of 
guideline update. The questionnaire was in Dutch. A translation is shown in the appendix. 
Questionnaires were collected up to one month after being sent. The completed 
questionnaires were returned anonymously. 
Because of the exploratory character of the data, analysis consisted of descriptive techniques 
and chi-square tests when appropriate (SPSS 14.0.1 for Windows, SPSS Inc., Chicago, IL). 
Results are expressed in frequencies. A p-value of ≤ 0.05 was regarded significant.
Results
General characteristic of ICU physicians 
Altogether 176 of 446 (39%) questionnaires were returned. Respondents were 
predominantly specialized in internal medicine and anaesthesiology, the experience level 
within these two specialties was not significantly different (χ2, p=0.079). Characteristics of 
respondents are shown in Table 1.
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Experience level Fellow 7
0-5 years 40
5-10 years 14
> 10 years 38
Type of hospital Non-university 76
University 24
Assessment of haemodynamic condition and treatment of patients 
The clinical signs most often used by Dutch ICU physicians in their initial assessment are 
shown in Table 2. Urine colour and production as well as capillary refill were the most used. 
Combinations of clinical signs used were urine production and blood pressure (19%), 
capillary refill and blood pressure (10%), capillary refill and heart rate (8%). We requested 
respondents to circle up to two clinical signs, however, 10% of respondents marked more 
than five clinical signs. These respondents indicated to use a wide variety of clinical signs in 
their assessment. 
To estimate the need for volume expansion, the haemodynamic status was further 
investigated using the parameters mentioned in Table 3. Clearly, CVP is the most used 
parameter (70%). Surprisingly, SVV, SPV or PPV were used by 47% of all respondents. MAP 
and CO were considered by 33% and 19% of the physicians to be the most important 
predictive parameters. At 31%, the combination of CVP and SVV or PPV or SPV was the 
most used (Table 4). Remarkably, CVP was mentioned in most combinations.
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Table 2 Clinical signs used in the assessment of volume status.
Clinical signs Frequency (in %)
Urine colour or production 39
Capillary refill 28
Blood pressure 7






Table 3 Parameters used in the assessment of volume status.
Parameter Frequency (in %)*
CVP 70
SVV, PPV or SPV 47
MAP 33









Shape of arterial wave 1
*  Total frequency exceeds 100% since multiple parameters can be used 
by a respondent 
78)
Table 4 Most used combinations of parameters in the assessment of volume status.
Parameters Frequency (in %)
CVP & SVV, PPV, SPV 31
CVP & MAP 22
CVP & Urea/ creatinine 17
SVV, PPV, SPV & CO 11
CVP & Urine sodium 11
CVP & CO 10
CVP & SvO2 10
MAP & SVV, PPV, SPV 10
CVP & TEE 7
CVP & Lactate 6
MAP & Urine sodium 6
SVV, PPV, SPV & SvO2 6
SVV, PPV, SPV & TEE 7
SVV, PPV, SPV & Urea/ creatinine 6
If cardiac output was monitored: the pulmonary artery catheter was used by 65%, PiCCO 
(Pulsion Medical Inc., NJ, USA) by 15%, trans-oesophageal echocardiography by 11%, Vigileo/ 
FloTrac (Edwards Lifesciences, CA, USA) by 5%, NICO (Novametrix Medical Systems Inc, CT, 
USA) by 4%, and trans-thoracic echocardiography by 2%. Forty-four percent of these 
respondents could choose from two or more devices to monitor cardiac output.
To predict which patients would benefit from fluid loading, the effect of passive leg raising 
(PLR) was used as an integral part of volume status monitoring by 2% of the respondents. 
Twenty-seven percent never used PLR, 21% seldom used PLR, 35% occasionally used PLR 
and 17% often used PLR. Interestingly, 10% of respondents always used a fluid loading 
challenge, 66% used it often, 21% sometimes and 3% seldom or never.
When a PLR or fluid challenge was applied, the majority of respondents monitored changes 
in heart rate, MAP and CVP to predict fluid loading responsiveness. Forty-two percent used 
one parameter, 34% used two parameters, and 24% used three or more parameters to make 
their assessment. In Table 5, an overview is given of the parameters used in the passive leg 
raising and fluid challenge. 
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Table 5  Eight most often used parameters during a fluid loading challenge or passive leg raising to predict 
fluid loading responsiveness.






SVV, PPV or SPV 10
SAP 6
SvO2 3
*  Total frequency exceeds 100% since multiple parameters can be used 
by a respondent 
Prior specialty training, experience level or type of hospital did not influence the selection of 
clinical signs or use of haemodynamic parameters to assess volume status. Exceptions were 
blood pressure and serum lactate which were used more often by physicians with less than 
five years of experience during initial assessment (10/ 84 vs. 3/ 92 with p < 0.001 and 10/ 84 
vs. 12/ 92, p=0.029, respectively). Skin turgor was used less in the less-than-five-years 
experience group than in the group of physicians with more than five years experience (2/ 
84 vs. 12/ 92 with p<0.009). 
Guidelines used in ICU
A quarter (n=44) of all physicians have departmental guidelines to assess the hypo- or 
hypervolaemic status of a patient. Where guidelines were in place, 57% of respondents 
indicated that they almost always followed these guidelines, whereas 43% seldom followed 
them. The parameters used in the available guidelines are described in Table 6. Twenty-one 
percent used a single parameter from their guidelines 24% used two, 41% used three and 
14% used four parameters.
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Table 6  Frequency of use of haemodynamic parameters in active haemodynamic monitoring guidelines in 
Dutch intensive care departments.










* Total frequency exceeds 100% since multiple parameters can be used by a 
respondent
Eighty percent of these guidelines had been updated within the past year. Thirty-four percent 
of the respondents were unaware which authority was responsible for updating the 
guideline. A total of 48% of the guidelines were updated by a committee within the 
Intensive Care department, and 18% were updated by the head of the department. 
Surprisingly, none of the guidelines had been directly adapted from those of intensive care 
or anaesthesiology societies. The type of hospital did not influence whether a guideline for 
haemodynamic assessment was in place or not (p=0.092).
Discussion
In 2006, the Dutch Ministry of Health registered 238,022 adult-patient ventilation-days in 
ICUs in the Netherlands [18]. We may assume that these patients were continuously 
monitored and volume status was assessed regularly to optimize tissue perfusion. The aim 
of this survey was to evaluate the impact of recently introduced parameters and challenges  
in the daily practice of Dutch intensive care physicians. We mapped the current use of 
haemodynamic parameters in the assessment of volume status of intensive care patients.  
In addition, we researched the use of guidelines for haemodynamic monitoring.
Recent publications might have had a relatively high impact on the use of haemodynamic 
parameters in the assessment of volume status. Although the use of CVP measurement is 
still high (70%), 47% of physicians use SVV, PPV or SPV and 76% regularly use fluid 
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challenges in their assessment. There is no uniformity or consensus on the use of 
parameters in evaluating volume status. This is supported by the low number of ICUs with 
guidelines for haemodynamic monitoring of volume status and fluid loading. In addition, 
43% of physicians reported that they barely used the available guidelines. 
The incidence of use of SVV, PPV or SPV is remarkable for several reasons. First, we found 
that pulse contour devices are used less than thermodilution devices to measure CO. This 
contrasts the finding that SVV, PPV and SPV are used by 47% and CO by 19%. Second, the 
use of these parameters in haemodynamic monitoring has primarily been studied in cardiac 
surgery patients [10, 19, 20]. Third, the use of these parameters is restricted to sedated patients 
fully dependent on mechanical ventilation [21]. Moreover, the average duration of mechanical 
ventilation is decreasing due to fast track protocols [22]. Fourth, arrhythmia, a common 
phenomenon in ICU patients, hampers the use of SVV, PPV and SPV. Fifth, variations in 
stroke volume and arterial pressure are found to be reliable only when ventilation with  
larger tidal volumes (> 8 ml∙kg-1) are used [8] while ventilation with lower tidal volumes 
(< 6 ml∙kg-1) are advocated in the ARDSnet study for ARDS/ALI patients. 
CVP is still frequently used although its use is controversial. In a recent review the authors 
calculated a pooled area under the receiver operating curve to predict fluid loading 
responsiveness for CVP of 0.56. They proposed the discontinuation of the routine 
measurement of CVP to monitor volume status of the patients in the ICU or operating  
room [23]. Moreover, several studies have shown SVV to be a better predictor of fluid loading 
responsiveness than CVP [10, 24, 25]. 
Passive leg raising has been studied for a number of years, and in this survey its use was 
limited to 17% of the responding intensivists. Although one advantage of PLR over fluid 
challenge could be the reversibility of the fluid challenge, 76% of respondents indicate using 
a fluid challenge. These findings become less surprising when we consider that the fluid 
challenge as well as SVV, PPV or SPV have been the subject of investigation since the 
1990’s. We hypothesize that considerable time has to elapse before experimental findings 
become a routine part of clinical care. Nevertheless, it can also be argued that the difference 
in use of PLR and fluid challenge is explained by the robustness of the fluid challenge. 
When a challenge to the circulation is used to assess volume status, heart rate, MAP and CVP 
are most often used parameters to monitor and predict fluid loading responsiveness. Several 
of the most-often-used parameters, however, do not concur with recent literature. Change in 
CVP due to PLR for instance, has been shown to be an unreliable predictor [15]. The reliability 
of other parameters such as urine production and SvO2 has not been studied during a 
challenge. This could also imply that some of the respondents performed another type of 
fluid challenge. 
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It must also be noted that the use of lactate is mentioned by only 8% of respondents even 
though “surviving sepsis” and “early goal directed therapy” clearly advocate the use of lactate 
[26,27]. This could be explained by the limitation of the number of answers that could be given 
in this survey. However, SvO2 is used by 19% of respondents and this parameter is also 
advocated in both guidelines [26,27].
Other surveys
In Germany in 1997, Boldt and colleagues performed a survey to assess fluid loading 
strategies in ICUs [3]. In this survey CVP was used by 93% of respondents and PAWP by 58%, 
while the dynamic parameters SVV, PPV or SPV were barely used [3]. We assume that similar 
strategies have been used in haemodynamic management in Dutch and German ICUs. In the 
current survey, the incidence of use of CVP and especially PAWP, is lower and a large group of 
ICU physicians used SVV, SPV or PPV as parameter.
More recently, in 2006, Kastrup and colleagues sent a questionnaire to the leading physicians 
of 80 cardiac surgery ICUs in Germany [28]. In this subgroup, CVP, MAP and PAWP were 
used more frequently (89%, 84% and 33% respectively), while SVV, SPV or SPV was used by 
only 15% [28]. We attribute differences in Kastrup’s and our findings to differences in the 
surveyed subgroup, time, and/or the country in which the survey was performed, and 
concomitant differences in the setup of post-registration education programmes.
Considerations 
Firstly, although an acceptable return rate of 39% was achieved, inherent to this type of 
survey, it must be noted that it may not represent all physicians. In contrast, Boldt [3] and 
Kastrup [28] achieved return rates of around 60%. Secondly, the completed questionnaires 
were returned anonymously. Hence, we could not determine a no-response bias. Thirdly, 
some answers could have been ‘desired’ answers. The finding that 47% of respondents use 
SVV, PPV and/or SPV to evaluate volume status seems to be at odds with the actual use of 
pulse contour methods (20% of respondents). Lastly, the group of physicians with an 
academic position seems overrepresented as we got 24% respondents from academic 
hospitals whereas actually only 8% of ICU physicians have an academic position [18]. 
However, we could not detect a difference in response, for any of the questions (including 
usage of guidelines), between the two groups. Therefore, we do not regard this 
overrepresentation as a significant bias.
Conclusions 
The present survey shows that CVP is still the most often used parameter to guide fluid 
loading. However, Dutch ICU physicians are remarkably compliant in using recently 
developed and published dynamic parameters as SVV and PPV as well as fluid challenges.
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Appendix Questionnaire volume status assessment and fluid loading
1.  What is your specialty training, besides intensive care medicine? Circle your choice:
 a. Anaesthesiology
 b. Cardiology
 c. Cardiac surgery
 d. Surgery




 i. Other, ____________________________________
2. How long have you been an intensive care physician? Circle your choice:
 a. Fellow
 b. 0-5 years
 c. 5-10 years
 d. > 10 years
3. In what type of hospital do you work? Circle your choice:
 a. University hospital
 b. Non-university hospital
4.  Which clinical indicators do you use to decide on further analyses of a patient’s volume status? 
Please circle a maximum of two choices:
 a.  Skin turgor
 b.  Dry mouth
 c.  Dry axillae
 d.  Urine colour and/or production
 e.  Body temperature
 f.  Capillary refill
 g. Colour of the extremities
 h.  Fluid balance
 i. Blood pressure
 j. Heart rate
 k. Other, ____________________________________
86)
5.  Which indicator(s) do you use to determine the volume status of the patient? 
Please circle up to three of your choices:
 a. Central venous pressure
 b. Mean arterial pressure
 c. Pulmonary arterial pressure
 d. Systolic arterial pressure
 e. Pulmonary arterial wedge pressure
 f. Dynamic parameters: SVV, PPV or SPV
 g. Cardiac output
 h. PaO2 
 i. SvO2
 j. Trans-oesophageal Doppler echography
 k. Plasma urea, creatinine or electrolytes
 l. Urine sodium
 m. Serum lactate
 n. Other, ____________________________________
6.  When you determine cardiac output, which device do you use? Circle your choice(s):
 a. None
 b. Pulmonary artery catheter (thermodilution bolus/ continue)
 c. Trans-pulmonary thermodilution
 d. Trans-oesophageal Doppler
 e. Pulse contour - PiCCO
 f.  - LidCO
 g.  - Vigileo/ Flotrac
 h. Other, ____________________________________
7.  Do you use passive leg raising (PLR) to determine the volume status of your patients? Circle your choice: 
 a. Never 
 b. Seldom
 c. Once in a while
 d. Often
 e. Always
8.  Do you use fluid challenges to assess the volume status of your patients? Circle your choice:
 a. Never 
 b. Seldom
 c. Once in a while
 d. Often
 e. Always




10.  Are there guidelines or protocols in your ICU in which parameters for hypo- or hypervolaemia are used. If 
yes, which parameters? Please circle your choice:
 a. No
 b. Yes, the parameter(s) are: ______________________________________
11.  If such guidelines exist, do you use the definition for hypo- or hypervolaemia? 
 Please circle your choice:
 Hypovolaemia: Hypervolaemia:
 a. Always a.  Always
 b. Often b. Often
 c. Once in a while c. Once in a while
 d. Seldom d. Seldom
 e. Never e. Never
 f. Not defined f.  Not defined
12.  Are there guidelines in use in your ICU on how to perform fluid loading? Please circle your choice:
 a. Yes, please continue with the next question
 b. No, this is the end of the questionnaire
13.  Do you use these guidelines for fluid loading in your treatment? Please circle your choice: 
 a.  Always
 b.  Often
 c.  Once in a while
 d.  Seldom
 e.  Never
14. If yes (question 12), when were these guidelines last updated? ____/____/____
15.   Who is responsible for keeping these guidelines up to date? Please circle your choice: 
 a. A committee related to the ICU
 b. A committee related to another department in the hospital
 c. A society or organization, namely; ________________




Fluid loading responsiveness: what parameter can we use? 
Bart Geerts, Leon Aarts and Jos Jansen
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On a daily basis physicians asses the volume status of individual patients. Volume status 
optimization is required to maximize oxygen delivery to vital organs, like brain, kidneys and 
heart. Prolonged oxygen deficit can lead to an inflammatory cascade resulting in multi-
system organ dysfunction [1]. Conversely, unnecessary fluid administration can lead to 
anasarca, pulmonary oedema, cardiac failure, anastomotic leakage, infections prolonging 
hospitalization or even causing death [2]. In these cases, pharmacological support may be 
indicated instead of fluid replacement. Several studies have shown the beneficial effects of 
restrictive use of fluids during and after operations resulting in a reduction of hospital stay 
up to 10% [3]. Therefore, the selection of critically-ill patients that will benefit from fluid 
loading is essential. This selection can be made with the use of fluid loading responsiveness 
(FLR). In this review, we ask ourselves: “Which measurable determinant(s) can be used to 
predict a clinically significant effect of fluid administration on cardiac output (CO)?”
Methods
MEDLINE, EMBASE and CENTRAL databases were searched for all publications on 
prospective observational studies in adult patients in the intensive care unit (ICU) or 
operating room (OR) that assessed FLR up to 2010. To maximise the practical guidance for 
the ICU clinician with this review, studies were included only when a specific cut-off value to 
predict FLR and its respective sensitivity and specificity derived from receiver operating 
curves (ROC) was reported. ROC curves describe sensitivity and specificity characteristics 
over a spectrum of cut-off points. An area under the ROC curve of 1.00 is optimal; both 
sensitivity and specificity are 100% [4].
Fluid loading responsiveness
The selection of patients that are likely to respond to fluid loading is traditionally based on 
clinical signs. Subsequently, other parameters are taken into consideration like central venous 
pressure (CVP) and pulmonary artery occlusion pressure (PAOP) [5]. In recent years, new 
variables based on heart-lung interaction, i.e. respiratory-induced stroke volume variation 
(SVV) and pulse pressure variation (PPV) have been introduced in the ICU. Reversible 
autotransfusion by passive leg raising (PLR) has also become the subject of intense interest.  
In this review, a wide range of parameters is assessed for its value for the prediction of FLR. 
Clinical signs and symptoms
The initial assessment of volume status is most often based on clinical signs and symptoms, 
like skin turgor, urine colour or production, fluid balance and the presence of peripheral 
oedema. Stephan et al. [6] measured circulating blood volume (CBV) with human-serum 
albumin in 36 patients. Hypovolaemia, defined as a 10% lower CBV compared to a control 
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population, was present in 53% of the patients. However, clinical signs did not prove to be 
useful to discriminate between hypovolaemic and normovolaemic individuals. For instance, 
the presence of skin mottling had a sensitivity of 28% and specificity of 78%, while absence 
of peripheral oedema had a sensitivity of 64% and specificity of 56% to predict 
hypovolaemia. The definition of hypovolaemia could be subject of critique in this study and 
fluid loading responsiveness was not measured. However, there is a clear indication that the 
use of isolated or combinations of clinical signs are unreliable to predict FLR. 
Static/ filling pressures
Besides clinical signs, traditional hemodynamic parameters, like central venous pressure and 
pulmonary artery occlusion pressure (PAOP) are often used in the assessment of FLR [5,7]. 
Although multiple studies have reported positive results, the use of these parameters in 
patients with sepsis, trauma, acute respiratory failure, and in the per-operative phase of 
cardiovascular surgery is found controversial. Moreover, these studies could not show that 
changes in CVP and PAOP after volume loading are correlated with changes in stroke volume 
or cardiac output [8-13]. CVP was found to have clinical significance (i.e. it correlates to CBV) 
only for extreme values (<2 mmHg or >18 mmHg) [14]. PAOP studied by Lattik and Wyffels 
showed a poor predictive values for FLR in cardiac surgery patients with area under the ROC 
curves of 0.63 (95% CI between 0.44 and 0.82, n=15) and 0.58 (95% CI between 0.39 and 
0.75, n= 32) respectively [15,16]. In Table 1 and 2 an overview is given of literature that reported 
on FLR and CVP and PAOP. 
Table 1 Reliability of baseline central venous pressure to predict fluid loading responsiveness.
N Patients Cut-off Sensitivity Specificity Area under ROC curve 
± SD (95% CI)
Barbier, et al. [8] 20 Sepsis 12 mmHg 90% 30% 0.57 ± 0.13
Cannesson, et al. [9] 25 Cardiac surgery * 3.5 mmHg 77% 63% 0.75 ± 0.11
Osman, et al. [10] 96 Sepsis * 8 mmHg 62% 54% 0.58 (0.49-0.67)
Reuter, et al. [11] 12 Cardiac surgery * 6 mmHg 50% 90% 0.71 (0.50-0.92)
Reuter, et al.[11] 14 Cardiac surgery * 10 mmHg 71% 62% 0.71 (0.54-0.88)
Biais, et al. [12] 35 Circulatory failure 9 mmHg 61% 82% 0.68 (0.50-0.83)
Vistisen, et al. [13] 23 Cardiac surgery 8 mmHg 35% 100% -
Muller, et al. [48] 33 Circulatory failure 7 mmHg 54% 100% 0.77 ± 0.10
* Multiple measurements in same patients
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Table 2  Reliability of baseline pulmonary artery occlusion pressure to predict fluid loading responsiveness.
N Patients Cut-off Sensitivity Specificity Area under ROC curve 
± SD (95% CI)
Osman, et al. [10] 96 Sepsis 11 mmHg 77% 51% 0.63 (0.55-0.70)
Reuter, et al. [11] 12 Cardiac surgery * 7 mmHg 79% 70% 0.77 (0.58-0.96)
Reuter, et al. [11] 14 Cardiac surgery * 8 mmHg 59% 75% 0.70 (0.52-0.88)
* Multiple measurements in same patients
 
It seems that CVP and PAOP are not suitable for standard evaluation of FLR. This is most 
like due to the large differences in myocardial function. Especially in critically ill, myocardial 
function is oftentimes depressed. Since CVP and PAOP are directly related to the function of 
the heart as well as mechanical ventilation, the absolute magnitude of these parameters in 
itself are not reliable in predicting FLR. 
Although mean arterial pressure (MAP) is a well-identified goal to maintain perfusion of 
vital organs, it has not been studied extensively for its value to predict FLR. There are only 
two studies available that report on the reliability of MAP to predict FLR; Preisman and 
Kramer studied the reliability of baseline mean arterial pressure to predict fluid 
responsiveness and found areas under the ROC curves of 0.73 (95% CI between 0.60 and 
0.87, n=18) and 0.81 (95% CI between 0.62 and 1.00, n=21) respectively [17,18]. Preisman 
found MAP at a cut-off of 76.5 mmHg to have a sensitivity of 64% and a specificity of 77% 
to predict FLR in 18 post-elective CABG surgery. 
The low predictive value of MAP is likely related to the influence of disease state, for 
instance vasoplegia in sepsis, and pre-existing differences in normotensive values in-
between individuals. These differences also complicate consensus on target blood pressures 
to guarantee perfusion of the brain and other vital organs. The International Consensus 
Conference on Hemodynamic Monitoring in 2006 found moderate to low evidence to 
implement target blood pressures in the management of shock [19]. This because relevant 
clinical studies were absent.
Heart rate
Heart rate (HR) has been studied on a small scale. Kramer et al. [18] reported baseline HR to 
predict FLR with an area under the ROC curve of 0.81 (95% CI between 0.61 and 1.00) in 
coronary by-pass grafting surgery patients. Berkenstadt [20] reported an AUC of 0.59 (95% CI 
between 0.44 and 0.64) under the ROC curve to predict FLR in patients undergoing 
neurosurgery. 
In theory, heart rate is considered to be a good predictor of FLR. For instance, in young 
spontaneous-breathing trauma patients, tachycardia is indicative of severe haemorrhage. 
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However, in patients fully under mechanical ventilation and anaesthesia, neuronal and 
humoral control seems completely blocked. Consequently a relation is lacking between 
baseline or change in HR and changes in CO due to fluid loading. Moreover, a large number 
of patients are receiving beta-blockade further complicating the possibility to use heart rate 
to predict FLR. 
Cardiac output 
CO has been used to predict FLR. However, results concerning the reliability of baseline 
cardiac output measurements to predict FLR are non-uniform. Baseline cardiac output to 
predict FLR has been predominantly studied in coronary by-pass surgery patients; AUC 
under the ROC curve vary from 0.52 ± 0.12 to 0.74 ± 0.07 [21,22]. In 30 septic patients, the 
AUC of the ROC of baseline triplicate trans-pulmonary thermodilution CO was 0.77 (95% 
CI between 0.60 and 0.94) to predict FLR [23]. Monnet et al. [24] reported a sensitivity of 78%, 
a specificity of 54% and a cut-off of 2.8 L∙min-1∙m-2 . Although the predictive value of 
different cardiac output methods have not been directly studied, Biais et al. [12] found 
responder classification with CO Vigileo (Edwards Lifesciences, Irvine CA, USA) to 
correspond in 97% of the cases with pulmonary-artery-catheter thermodilution or trans-
thoracic echography CO in liver-transplant patients. Research is needed that directly 
compares different cardiac output methods to determine their predictive value for FLR as 
accuracy of a CO method can vary between 3,5 and 25% [25,26]. 
Moreover, if we take in mind the Starling curve; a patient can be either on the upslope of the 
Starling curve, on the plateau or in-between. There is a large variability between patients for 
the maximum cardiac output that can be reached. This implies that a low baseline value for 
cardiac output does not necessarily mean that fluid loading will lead to an increase in cardiac 
output. Pharmacological or even mechanical intervention will probably have a similar 
chance to lead an improvement in CO.
Volumetric or echographic parameters 
The above parameters represent an indirect estimate of preload, more direct estimation 
could be provided by ventricular volumes determined with echographic measurement for 
instance. Hemodynamic parameters determined with trans-thoracic or trans-oesophageal 
echography have been used in daily clinical care for decades. We highlight the results of the 
most studied parameters here; results for left ventricular end-diastolic area (LVEDA) [11,27-30] 
vary with sensitivity reported to be between 60 to 89%, specificity between 58 and 91% and 
the AUC of the ROC curve between 0.24 ± 0.11 and 0.78 (95% CI between 0.59 and 0.97) 
[11,28]. For global end-diastolic volume index (GEDVI) [26,31-33] the AUC of the ROC curves is 
between 0.23 and 0.70 (0.46-0.94) [32,33].
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Other interesting parameters linked to echography are measurement of the inferior or 
superior vena cava. Vieillard-Baron and colleagues [34] reported that a superior vena cava 
collapsibility of 36% has a sensitivity of 90% and a specificity of 100% and an AUC of the 
ROC curve of 0.99 ± 0.01 in 66 patients after CABG surgery. Similar assessment of the 
inferior vena cava in 20 septic patients offered 90% sensitivity and specificity to predict FLR 
[8]. The vena cava diameter can only be properly assessed with the use transesophageal 
echography.
In theory, these echographically determined volume parameters of the heart are supposed to 
be highly reliable. The volume changes within the heart or vena cava are directly linked to 
cardiac function; when wall movement is limited inotropic assistance is warranted. And when 
filling of the ventricles is not optimal, fluid administration is indicated. Study results are very 
promising [35]. Several factors may frustrate these results. Operator-related factors, like level of 
experience, changes in probe position and intermittent application, greatly influence the 
reliability and robustness of echographic monitoring [36]. The predictive value for FLR of 
echographic parameters in patients receiving mechanical ventilation seems to outscore the 
results for these parameters in spontaneously-breathing patients [37].
Dynamic parameters: cyclic changes due to mechanical ventilation
In recent years dynamic parameters have been the focus of interest. Especially since more 
physicians use pulse contour methods that allow not only directly-available estimation of 
beat-to-beat cardiac output but also delivers stroke volume variation (SVV), pulse pressure 
variation (PPV) and systolic pressure variation (SPV) [38]. The results of literature review for 
the reliability of SVV to predict FLR is shown in Table 3. 
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Table 3 Reliability of stroke volume variation to predict fluid loading responsiveness.
N Patients Cut-off Sensitivity Specificity Area under ROC curve 
± SD (95% CI)
Hofer, et al. [26] 40 Cardiac surgery 12.5% 74% 71% 0.82 (0.68-0.97)
Reuter, et al. [11] 12 Cardiac surgery *,† 9.5% 71% 80% 0.76 (0.59-0.96)
Reuter, et al.[11] 14 Cardiac surgery *,† 9.5% 78% 85% 0.88 (0.77-0.99)
Preisman, et al. [17] 18 Cardiac surgery 11.5% 81% 82% 0.87 (0.79-0.96)
Hofer, et al. [31] 40 Cardiac surgery 9.6% 91% 83% 0.82 (0.68-0.97)
Hofer, et al. [31] 40 Cardiac surgery 12.1% 87% 76% 0.86 (0.75-0.97)
Berkenstadt, et al. [20] 15 Brain surgery 9.5% 79% 93% 0.87 (0.81-0.90)
Biais, et al. [12] 35 Liver transplant OR 10% 94% 94% 0.95 (0.81-0.99)
De Waal, et al. [33] 22 Cardiac surgery 8% 100% 78% 0.91 (0.78-1.00)
Cannesson, et al. [49] 25 Cardiac surgery 10% 82% 88% 0.87 ± 0.09
Biais, et al. [50] 30 ICU general 13% 100% 80% -
Biais, et al. [50] 30 ICU general 16% 85% 90% -
Derichard, et al. [51] 11 Major abd surgery 12% 86% 91% 0.95 (0.65–1.00)
Lahner, et al. [52] 20 Major abd surgery 8.5% 77% 43% 0.51 (0.32-0.70)
Monge Garcia, et al. [53] 38 Circulatory shock 13% 100% 80% -
* Multiple measurements in same patients
† spontaneous breathing
 
Pulse pressure (PP) is defined as the beat-to-beat difference between the systolic and the 
diastolic pressure. PPV is the amplitude of cyclic changes induced by mechanical ventilation. 
The variations in pulse pressure and stroke volume induced by mechanical ventilation have 
been linked to volume status [39]. PPV is thought to be directly proportional to stroke volume 
variation [40]. The reliability for SVV and PPV varies from lower sensitivity and specificity of 
70% to over 90% to predict FLR (Tables 3, 4 and 5). Although SVV is a direct measure of 
variation in cardiac output, results for SVV are scattered. Even though PPV is used as an 
indirect measure for SVV, results for PPV seem superior which may be especially true in 
septic patients [23], where vasoplegia is less likely to cause a reliable SVV measurement result. 
We need to consider that the calculation of SVV requires beat-to-beat SV measurements 
using a pulse contour analysis algorithm whereas PPV is measured directly from the arterial 
waveform. SVV will require an ongoing validation in clinic conditions as algorithms are 
developing with time [41]. In that context it is noteworthy that more recent publications report 
lower area under the ROC curves than older publications. Whether this depends on 
publication bias, a decrease in the accuracy of newer pulse-contour methods to determine 
SVV or more frequent improper use remains uncertain. 
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Table 4 Reliability of pulse pressure variation to predict fluid loading responsiveness.
N Patients Cut-off Sensitivity Specificity Area under ROC curve 
± SD (95% CI)
Cannesson, et al. [28] 18 Cardiac surgery 12% 92% 83% 0.91 ± 0.07
Feissel, et al. [54] 20 Sepsis ‡ 17% 85% 100% 0.96 ± 0.03
Kramer, et al. [18] 21 Cardiac surgery 11% 100% 93% 0.99 (0.96-1.00)
Feissel, et al. [55] 23 Sepsis ‡ 12% 100% 70% 0.94 ± 0.05
Cannesson, et al. [21] 25 Cardiac surgery 11% 80% 90% 0.85 ± 0.08
Soubrier, et al. [56] 32 Circulatory failure † 12% 92% 63% 0.81 ± 0.08
Hofer, et al. [26] 40 Cardiac surgery 13.5% 72% 72% 0.81 (0.67-0.95)
Auler, et al. [22] 59 Cardiac surgery 12% 97% 95% 0.98 ± 0.01
De Backer, et al. [57] 60 Critically ill, Vt ≤ 8 
ml∙kg-1
12% 60% 74% 0.89 ± 0.07
De Backer, et al. [57] 60 Critically ill 12% 88% 89% 0.76 ± 0.06
Preisman, et al. [17] 18 Cardiac surgery 9.4% 86% 89% 0.95 (0.89-1.00)
Wyffels, et al. [16] 32 Cardiac surgery 11.8% 95% 92% 0.94 (0.79-0.99)
Michard, et al. [58] 40 Sepsis 13% 94% 96% 0.98 ± 0.03
Cannesson, et al. [9] 25 Cardiac surgery 12% 88% 100% 0.92 ± 0.06
Vieillard-Baron, et al. [34] 66 Sepsis 12% 90% 87% 0.94 ± 0.04
Feissel, et al. [55] 23 Sepsis 12% 100% 70% 0.99 (0.98-1.00)
Lafanachere, et al. [59] 22 Circulatory failure † 12% 70% 92% 0.78 ± 0.12
Huang, et al. [32] 22 ARDS 11.8% 68% 100% 0.77
Vistisen, et al. [13] 23 Cardiac surgery 7.5% 94% 83% -
Derichard, et al. [51] 11 Major abd surgery 13% 88% 92% 0.96 (0.70–1.00)
Monge Garcia, et al. [53] 38 Circulatory shock 10% 95% 95% 0.97 ± 0.03
De Waal, et al. [33] 22 Cardiac surgery 10% 64% 100% 0.88 (0.74-1.00)
Hofer, et al. [26] 40 CABG 12.5% 74% 71% 0.82 (0.68-0.97)
Reuter, et al. [11] 12 Cardiac surgery *,† 9.5% 71% 80% 0.76 (0.59-0.96)
Reuter, et al. [11] 14 Cardiac surgery *,† 9.5% 78% 85% 0.88 (0.77-0.99)
Preisman, et al. [17] 18 CABG 11.5% 81% 82% 0.87 (0.79-0.96)
Hofer, et al. [31] 40 CABG, SVV flotrac 9.6% 91% 83% 0.82 (0.68-0.97)
Hofer, et al. [31] 40 CABG, SVV picco 12.1% 87% 76% 0.86 (0.75-0.97)
Berkenstadt, et al. [20] 15 Brain surgery 9.5% 79% 93% 0.87 (0.81-0.90)
Biais, et al. [12] 35 Liver transplant OR 10% 94% 94% 0.95 (0.81-0.99)
de Waal, et al. [33] 22 CABG 8% 100% 78% 0.91 (0.78-1.00)
Cannesson, et al. [49] 25 CABG OR 10% 82% 88% 0.87 ± 0.09
Biais, et al. [50] 30 ICU general 13% 100% 80% -
Biais, et al. [50] 30 ICU general 16% 85% 90% -
Lahner, et al. [52] 20 Major abd surgery 8.5% 77% 43% 0.51 (0.32-0.70)
Monge Garcia, et al. [53] 38 Circulatory shock 11% 79% 89% 0.89 + 006




Several restrictions apply to the use of dynamic parameters. First, cardiac arrhythmias 
significantly decrease the reliability of SVV and PPV [36]. Second, the use of these dynamic 
parameters has been validated in sedated and mechanically ventilated patients without 
spontaneous breathing activity. Third, SVV, and probably PPV, is not only influenced by 
intravascular volume but also by the depth of the tidal volume used in mechanical 
ventilation of the lungs [11].
N Patients Challenge Parameter Cut-off Sensitivity Specificity Area under ROC 
curve 
± SD (95% CI)
Monnet, et al. [24] 34 Circulatory shock 15-s end-exp occlusion dPP 5% 87% 100% 0.96 (0.83-0.99)
Monnet, et al. [24] 34 Circulatory shock 15-s end-exp occlusion dSP 4% 67% 82% 0.71 (0.53-0.86)
Perel, et al. [60] 14 Abd aorta surgery RSVT RSVT 0.24 88% 83% 0.90 (0.73-1.00)
Preisman, et al. [17] 18 CABG RSVT RSVT 0.51 93% 89% 0.96 (0.92-1.00)
Monge Garcia, et al. [53] 30 General ICU 10 s Valsalva dPPV 52% 91% 95% 0.98 (0.84-0.99)
Monge Garcia, et al. [53] 30 General ICU 10 s Valsalva dSPV 10% 73% 90% 0.90 (0.73-0.98)
Maizel, et al. [61] 34 Circulatory shock Passive leg raising dCO 5% 94% 83% 0.89 (0.73-0.97)
Monnet, et al. [24] 34 Circulatory shock Passive leg raising dCI 10% 91% 100% 0.94 (0.80-0.99)
Monnet, et al. [24] 34 Circulatory shock 15-s end-exp occlusion dCI 5% 91% 100% 0.97 (0.85-1.00)
Maizel, et al. [61] 34 Circulatory shock Passive leg raising dSV 8% 88% 83% 0.90 (0.74-0.97)
Lamia, et al. [37] 24 Circulatory failure Passive leg raising dSV 12.5% 77% 100% 0.96 ± 0.04
Biais, et al. [50] 34 Circulatory shock Passive leg raising dSV TTE 13% 100% 80% 0.96 ± 0.03
Biais, et al. [50] 34 Circulatory shock Passive leg raising dSV 16% 85% 90% 0.92 ± 0.05
Thiel, et al. [62] 89 General ICU Passive leg raising dSV 15% 81% 93% 0.89 ± 0.04
Lafanechere, et al. [59] 22 Circulatory failure Passive leg raising dABF 8% 90% 83% 0.95 ± 0.04
Monnet, et al. [42] 71 General ICU Passive leg raising dABF 10% 97% 94% 0.96 ± 0.02
Monnet, et al. [42] 71 General ICU Passive leg raising dPP 12% 60% 84% 0.75 ± 0.06
Monnet, et al. [24] 34 Circulatory shock Passive leg raising dPP 11% 48% 91% 0.68 (0.50-0.83)
Monnet, et al. [42] 19 General ICU Passive leg raising dPP 8% 88% 46% 0.56 ± 0.14
Monnet, et al. [42] 30 General ICU Passive leg raising dPP 12% 88% 93% 0.91 ± 0.05
Cannesson, et al. [28] 18 Cardiac surgery Passive leg raising dSA 16% 92% 83% 0.91 ± 0.07
** Mixed spontaneous breathing and mechanical ventilation population
† Spontaneous breathing
‡ During surgery additional fluids were administered and measurements were repeated within individuals 
dPP is change in pulse pressure, dSP is change in systolic pressure, RSVT is respiratory systolic variation test, dPPV is change in 
pulse pressure variation, dSPV is change in change in systolic pressure variation, dCO is change in cardiac output, dCI is change in 
cardiac index, dSV is change in stroke volume, dABF is change in aortic blood flow, dSA is variations in left ventricular stroke area
Table 5  Reliability of changes in parameters after a hemodynamic challenge to predict fluid loading 
responsiveness.
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Figure 1  Cardiac function curve: a small fluid challenge or autotransfusion provocation with passive leg 
raising (PLR) is used to predict the effects of fluid loading. On the Y-axis cardiac output is shown 
and central venous pressure on the X-axis. The effects of fluid loading on central venous pressure 
(CVP) and cardiac output (CO) are shown. The heart of the non-responder will operate near or at 
the plateau of the Starling curve. A responder will show a larger change in CO when either PLR 
or a small fluid challenge are performed compared to a non-responder. The changes in CVP and 
CO caused by PLR or small fluid provocation will mimic changes of significant fluid loading. 
Dynamic parameters: other challenges to the circulation
Another approach to determine FLR is a provocation method; the application of increased 
PEEP or an auto-transfusion with 30° to 45° passive leg raising (PLR). Particularly, the 
groups of Boulain, Monnet and Teboul studied the reliability of parameters during PLR to 
predict FLR [42,43]. The robustness and reliability of the “static parameters” during the 
challenge can be explained by the direct use of the Starling curve. These challenges change 
the working point on the Starling curve of the patient (Figure 1). The amplitude of the 
change in CO can be used to predict FLR. These challenges are reversible, standardized and 
easily performed. Results for these challenges are shown in Table 5.
Since the Starling-curve characteristics are different for each individual, with its own 
pathophysiological constitution, we can make use of challenge-induced changes to pinpoint 
the working point on the curve and answering the question: Will this patient be a responder? 
Conclusions
Two adequate candidate parameters for FLR in everyday medical practise seem present. 
First, PPV and SVV in patients fully dependant on mechanical ventilation and secondly an 
auto-transfusion challenge with PLR using changes in CO, MAP or CVP. However, trials 
have to be performed to determine the effect of the fluid loading responsiveness strategy on 
hospital stay and mortality.
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Hypovolaemia is a common problem in many clinical situations. The mortality of 
hypovolaemic shock is directly related to the severity and duration of organ hypoperfusion, 
which means that prompt volume replacement is the hallmark of success for managing the 
hypovolaemic patient [1] However, since fluid resuscitation will require some time to 
accomplish, manoeuvres like Trendelenburg position or passive leg raising (PLR) are 
commonly used as the initial treatment of shock and hypotension [2]. 
Trendelenburg position is the elevation of the pelvis above horizontal plane in the supine 
position. This position was originated by Bardenhauer of Cologne but a surgeon named 
Friedrich Trendelenburg popularized the position in the 19th century for facilitating surgery 
on the pelvic organs [3]. In World War I, the position was used as an anti-shock manoeuvre. 
In a survey by Ostrow and co-workers in 1997 99% of surveyed American nurses used the 
Trendelenburg position and approximately 80% had used PLR [4]. The Trendelenburg 
position is probably one of the most often used treatments in medicine.
Passive leg raising is straight passive elevation of both legs above cardiac level with the 
patient in a supine position. PLR is not only used to treat hypvolaemia but it is also used for 
its hemodynamic response to augment the murmur of heart valves and, to facilitate 
gynaecological and urological surgery. 
Both manoeuvres are used either as a diagnostic tool to assess fluid loading response or as a 
therapeutic manoeuvre pending fluid resuscitation. It is the assumption that body inversion 
produces shifting of blood from the legs (and with Trendelenburg position also from the 
abdomen) towards the heart by gravitational displacement leading to an ‘auto-transfusion’ 
thereby increasing venous return to the heart and promoting cardiac output (CO) and 
ultimately increase perfusion of the vital organs [5,6]. With the advantage of auto-transfusion 
readily available both PLR and the Trendelenburg position are used for their expected 
instantaneous effect on cardiovascular performance. 
The aim of the review is to evaluate whether PLR and Trendelenburg position supports the 
mechanism of auto-transfusion and to assess the effect of these manoeuvres on cardiac output. 
Methods
This review was performed using the Cochrane Handbook for Systemic Reviews of 
Interventions [7]. We included prospective observational studies in normo- or hypovolaemic 
humans investigating the effects of hemodynamic parameters within 10 minutes after 
change from supine position. 
The MEDLINE, EMBASE and CENTRAL databases were searched for relevant articles from 
1960 up to 2010. We used (combinations of) the following search terms; passive leg raising, 
leg raising test, lower extremities elevation and passive leg elevation; Trendelenburg, 
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Trendelenburg position, head tilt-down, head-down; cardiac output and cardiac index (CI). 
Articles were collected by one reviewer and were crosschecked by another. This was 
supplemented by hand searching the reference lists for relevant articles.
Total-body head-down tilt of 5° to 60° was used as a definition for the Trendelenburg position 
and straight passive elevation of both legs of 10° to 90° in a supine position for PLR. Full text 
copies were obtained for all studies that were selected after reading title and abstract. 
Disputed articles or abstracts were included after arbitration by a third reviewer.
For all included studies the degree of tilt or elevation, number of patients, demographics, 
population pathology, CO or CI values, the CO measurement techniques and trends for 
mean arterial pressure (MAP), central venous pressure (CVP), heart rate (HR), systemic 
vascular resistance (SVR), pulmonary artery pressure (PAP) and pulmonary artery occlusion 
pressure (PAOP) were tabulated. 
Studies were excluded when fluid administration exceeded urinary loss or baseline 
measurement of CO or CI were missing. Other exclusion criteria were the presence of 
pregnancy, pneumoperitoneum, and epidural or spinal anaesthesia. 
Statistical analysis into the effect of the different manoeuvres on cardiac output was 
performed. For all other hemodynamic data descriptive statistics were used. To enable 
comparative analysis cardiac output was calculated from cardiac index using a body surface 
area of 1.8 m2 as an average converting factor. Mean change and standard deviation (SD) of CO 
after PLR and Trendelenburg was described in only a few studies. Also P-value of changes in 
CO or correlations with the baseline CO were scarcely reported. Therefore the standard error 
of the change from baseline was not available for the majority of the groups. Consequently a 
meta-analysis using traditional statistical techniques was not possible. Therefore we decided to 
perform an unweighted random effects meta-analysis. Under the usual random effects 
meta-analysis this is a valid approach, although not statistically optimal [8]. A paired t-test was 
used to calculate the overall mean changes and associated standard errors for both 
manoeuvres from baseline, up to one minute and between two and ten minutes. Due to the 
absence of most standard errors, forest and funnel plots could not be made, and random effect 
variance could not be determined. SPSS 17.0 was used for the analyses. All values are given as 
mean (SD). A p value < 0.05 was considered statistically significant.
Results
In total 624 articles were found after the first query in the three databases. For the 
Trendelenburg 500 hits were found after the first query and 47 were selected based on their 
abstract. Thirteen articles met the inclusion criteria and were included into the review. Three 
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articles were reviewed by arbitrage. 124 articles were found for PLR. 37 articles were selected 
after reading the abstract of which 21 remained after reading the full articles. An overview of 
all included studies and their characteristics are shown in Table 1 and 2.
Table 1 Characteristics of “Trendelenburg”-studies.
Authors Population N Age Hypo-
volaemia
Tilt
van Lieshout, et al. [28] Healthy 9 29 No 20°
Terai, et al. [5] Healthy 8 19-26 No 10°
Reuter, et al. [29] Cardiothoracic surgery 12 - Yes 30°
Terai, et al. [30] Healthy 10 21 No 20°
Ostrow, et al. [31] Cardiothoracic surgery 18 55 No 10°
Sing, et al. [22] Cardiothoracic surgery 8 60 Yes 15°
Dirschedl, et al. [32] Coronary artery disease 10 - No 6°
Reich, et al. [33] Cardiothoracic surgery, EF >40% 18 62 No 20°
Gentili, et al. [34] Mixed surgical 22 68 No 12°
Pricolo, et al. [35] Cardiothoracic surgery, EF>50% 5 - No 10°
Pricolo, et al. [35] Cardiothoracic surgery, EF>50% 8 - No 10°
Jennings, et al. [36] Healthy 8 26 No 10°
Jennings, et al. [36] Healthy 8 26 No 30°
Jennings, et al. [36] Healthy 8 26 No 60°
Jennings, et al. [36] Healthy 8 26 No 90°
Sibbald, et al. [9] Mixed ICU 61 - No 15-20°
Hong, et al. [37] Gynaecological surgery 25 44 No 15°
Trendelenburg position
Thirteen studies were included that assessed the effects of the Trendelenburg position on 
cardiac output. In these studies 246 patients were studied (n ranged between 5 – 61 with an 
average of 14 subjects per study with an age of 40 ± 18 years). Sixty percent of the studied 
populations was male.
Overall, Trendelenburg position increased MAP and PAOP. CVP increased in three studies 
and did not change in four studies. Heart rate remained unchanged in the majority of 
studies during head-down tilt. Sibbald and Taylor looked into the difference in hemodynamic 
reactions between normo- and hypovolaemic subjects after Trendelenburg position [9,10]. This 
was defined either by kissing papillary muscles on echography or a PAOP smaller than 6 
mmHg. Sibbald described a marked increase in CVP, MAP and PAP in normovolaemics [9]. 
In the hypovolaemic subjects there was no change in these parameters. However, the 
number of subjects in normovolaemic groups was three times larger than in the 
hypovolaemic groups (15 vs. 51 subjects). 
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Table 2 Characteristics of “passive leg raising” studies.
Authors Population N Age Hypo-
volaemia
Tilt
Boulain, et al. [6] Circulatory failure 15 65 Yes 45°
Tempe, et al. [38] Cardiothoracic surgery, LVEF>50 10 57 No 45°
Tempe, et al. [38] Cardiothoracic surgery, LVEF<35 10 52 No 45°
Reich, et al. [33] Cardiothoracic surgery 18 62 No 60°
Reich, et al. [33] Cardiothoracic surgery 20 36 No -
Nelson, et al. [39] Coronary artery disease 22 56 No 45°
Nelson, et al. [39] Coronary artery disease 22 56 No 45°
Gaffney, et al. [40] Healthy 10 30 No 60°
Paelinck, et al. [41] Healthy 24 41 No 45°
Terai, et al. [5] Healthy 8 19-26 No 60°
Bertolissi, et al. [42] Cardiothoracic surgery, RVEF>45 10 56 No 60°
Bertolissi, et al. [42] Cardiothoracic surgery, RVEF<40 6 67 No 60°
Schrijen, et al. [43] Emphysema 16 53 No 30°
Schrijen, et al. [43] Emphysema 13 56 No 30°
Carrère-Debat, et al. [44] Respiratory failure 10 60 - -
Schreuder, et al. [45] Cardiothoracic surgery 6 - No 45°
Schreuder, et al. [45] Cardiothoracic surgery 6 - No 45°
Dirschedl, et al. [32] Coronary artery disease 10 - No 45°
Ostrow, et al. [31] Cardiothoracic surgery 18 55 No 30°
Lafanechere, et al. [12] Circulatory failure 10 69 Yes 45°
Lafanechere, et al. [12] Circulatory failure 10 69 Yes 45°
Albert, et al. [46] Emphysema 30 52 No 35°
Maizel, et al. [11] Circulatory failure 17 64 Yes 30°
Maizel, et al. [11] Circulatory failure 17 58 Yes 30°
Jörgenson, et al. [47] Emphysema 10 67 No 60-90°
Jörgenson, et al. [47] Lung carcinoma 10 64 No 60-90°
de Wilde, et al. [48] Cardiothoracic surgery 13 - No 30°
de Wilde, et al. [49] Cardiothoracic surgery 15 66 No 30°
Jabot, et al. [13] General ICU 35 63 Yes 45°
Cardiac output showed a significant change in the overall population. Within one minute 
after head-down tilt: 9% or 0.35 L∙min-1. The increase in CO declined to 4% or 0.14 L∙min-1 
after two to ten minutes of Trendelenburg application (see Table 3). The same trend was seen 
in the normo- and hypovolaemic subpopulations. However, only two studies focused on 
hypovolaemic patients. The degree of head tilt-down does not influence the occurrence of a 
significant change in CO except for a transient increase after one minute of 10° tilt-down. 
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Table 3  Meta-analysis of changes in cardiac output (CO) after Trendelenburg (after 1 and after 2-10 








Change in CO 
L∙min-1 (%)
P-value
Trendelenburg, at 1 min  
[5,29,30,36]
4 (46) 2.81 ± 1.59 3.17 ± 1.97 0.35 ± 0.38 (9%) 0.111
Trendelenburg, at 2-10 mins  
[5,9,22,28-35]
11 (181) 3.04 ± 0.97 3.18 ± 1.04 0.14 ± 0.12 (4%) 0.004
PLR, at 1 min  
[6,32,33,38,40,42,43,45]
9 (140) 2.86 ± 0.39 3.05 ± 0.55 0.19 ± 0.23 (6%) 0.017
PLR, at 2-10 mins 
[5,11,12,31,33,38-41, 43,44,46,47,50,51]
15 (347) 2.91 ± 0.90 3.08 ± 1.01 0.17 ± 0.23 (6%) 0.005
CO is cardiac output; PLR is passive leg raising; p < 0.05 for change from baseline is considered significant
Passive leg raising
Twenty one studies were included that evaluated the hemodynamic effects of passive leg 
raising. In total 431 patients were studied with an average of 14 patients per study. In 
general, volume status was not clearly defined; four studies used hypovolaemic patients in 
their assessment. In these studies hypovolaemia was defined either as systolic pressure <90 
mmHg, a drop in systolic blood pressure >50 mmHg, an increase in CO >12% after volume 
therapy [6,11-13]. The legs were raised with an average of 46° (ranging between 30° and 75°).
Passive leg raising did not provide a general or unambiguous change in heart rate. Mean 
arterial pressure increased in 9 of 20 studies. CVP and PAP increased in all studies (n=8). 
Degree of PLR, volume status or pathological characteristics of the studied subjects did not 
influence the changes in either HR, MAP, CVP or PAP as a result of leg elevation. 
CO increased significantly one minute after application of PLR with 6% or 0.19 L∙min-1. (see 
Table 3). In hypovolaemic populations CO is raised after one minute of leg elevation by 11% or 
0.6 L∙min-1. This effect persists between two and ten minutes of application; 6% or 0.17 L∙min-1. 
Table 4  Effects of PLR and Trendelenburg on cardiac output (CO in L∙min-1) in directly comparing studies. 
 
Trendelenburg Passive leg raising












Terai, et al. [5] 8 10° 3.0 ± 0.2 3.4 ± 0.3 * 3.1 ± 0.3 60° 2.8 ± 0.2 3.2 ± 0.2 * 3.1 ± 0.3
Ostrow, et al. [31] 18 10° 3.33 ± 0.77 3.63 ± 0.73 45° 2.6 ± 0.7 2.9 ± 0.9
Dirschedl, et al. [32] 10 6° 2.6 ± 0.7 2.7 ± 0.7 30° 3.33 ± 0.77 3.61 ± 0.81
Reich, et al. [33] 18 20° 2.36 ± 0.79 2.52 ± 0.93 * 60° 2.36 ± 0.79 2.37 ± 0.73
PLR is passive leg raising. All subjects are reported to be normovolaemic. * p < 0.05 for change from baseline
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Direct comparison
Four studies directly compared the hemodynamic effects of Trendelenburg and PLR. Results 
of these studies are shown in Table 4. Although CO increases after both PLR and 
Trendelenburg within one minute after application with approximately 10% little can be said 
about the effect after 10 minutes. PLR seems to sustain this effect. However the amount of 
studies is low and the population sizes are small. More direct comparing studies are needed.
Discussion
The objective of this review was to compare the hemodynamic effects of the Trendelenburg 
position versus passive leg raising. We found that the Trendelenburg position and PLR 
increased cardiac output up to almost 10%. However, after several minutes Trendelenburg 
did not seem able to sustain this effect where PLR was still successful to maintain an 
increased CO. The reviewed studies nearly unanimously support the mechanism of 
autotransfusion as a way passive leg raising and Trendelenburg alters haemodynamics. 
Through elevation of the lower part of the body blood is translocated to the central 
circulation increasing cardiac output. The hypothesis of autotransfusion is supported by a 
nearly integral increase in reported central venous pressure and pulmonary artery occlusion 
pressure. 
Trendelenburg vs. PLR
Cardiac output seems likely to be redirected to central parts of the circulation away from 
parts with increased resistance. Blood volume is shifted from the legs to the more central 
part of the circulation. The effect of PLR can be readily explained by auto-transfusion. 
Morgan and co-workers estimated that PLR of a single leg (30° angle) transfuses 
approximately 150 ml of blood to the central circulation [14]. This is confirmed by Boulain and 
colleagues who calculated, based on the results of radio-isotopic scans by Rutlen and 
co-workers, that PLR of both legs shifted 300 ml of blood from the legs toward the central 
compartment and subsequently confirmed this by showing no difference between changes 
in stroke volume after PLR and rapid fluid loading with 300 ml [6,15]. 
However, there is a discrepancy in the duration of this effect between PLR and the 
Trendelenburg manoeuvre. A first explanation can be found in the lower position of the 
baroreceptors in reference to the heart [10,16,17]. In the Trendelenburg position the 
baroreceptors are located below the level of the heart. The extra gravitational force or 
hydrostatic pressure is expected to cause a decrease in the baro-activity, leading to general 
vasodilatation, decreased heart rate and heart contractility. This is counterproductive to the 
desired effect. However, in the majority of studies heart rate did not change. Gravity and 
suppression of the baroreflex (or Bainbridge effect) during the Trendelenburg position will 
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cause blood to dam in the veins, atria and pulmonary circulation which will decrease venous 
return and cardiac output subsequently [18-21]. This is supported by Sibbald and co-workers 
who reported a rise in central venous pressure [9]. Additionally, Sing and co-workers found 
that the Trendelenburg position did not improve systemic tissue oxygenation in 
hypovolaemic subjects [22]. This can be explained by the cephalad movement of abdominal 
organs against the diaphragm, resulting in a higher thoracic pressure and central venous 
pressure thus decreasing venous return [19-21]. 
Considerations
Several issues need to be taken into consideration. The standard error of the mean change is 
underreported in PLR and Trendelenburg literature. Also the standard errors could not be 
indirectly extracted from other data given in the articles, such as P-values or correlations. 
Henceforth, the data was not suited for traditional meta-analysis. Therefore we did a 
straightforward unweighted meta-analysis, which is statistically valid but some power is lost. 
The quality of the results of this meta-analysis would improve if more data was available and 
direct comparison was performed in the same groups.
We have to realize that hemodynamic parameters were monitored with different techniques. 
For instance, arterial blood pressure was measured with the Riva-Rocci method in some 
studies or with invasive techniques in either aorta or radial artery. Cardiac output was 
measured with variety of techniques with accuracies between 8 and 15% [23,24]. 
Thermodilution is the most often used technique and can be considered the “gold standard”. 
Only the techniques that show a high correlation or good agreement with the gold standard 
allowing to combine and to compare the results of the different studies [25]. The amplitude of 
the effect of CO with both maneouvers is well accepted in fluid loading responsiveness 
research and considered clinically significant [24,26].
The results of this review do not show a difference between normovolaemic and 
hypovolaemic patients in their response in CO after PLR or Trendelenburg. The amount of 
autotransfusion is likely to be less in a hypovolaemic state. However, this difference is likely 
compensated by the relative larger increase to a volume challenge in hypovolaemia 
compared to normovolaemia, i.e. when one is on a steeper slope of the Frank-Starling curve. 
A fluid loading challenge does not have to increase CO only in hypovolaemic patients but 
this will also occur during normovolaemia. In hypervolaemia, however, this is less likely 
since the heart will function on the flat part of the Frank Starling curve.
In this review differences exist between the studies such as mechanical ventilation or 
spontaneous breathing, level of sedation, beta blockade (i.e. cardiac surgery patients) and 
types of surgery. All these factors can influence the endogenous adrenergic response to 
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positional change and the magnitude of the effect on CO. Identification and consequent 
analysis of the influence of these confounders would be very complex and not in the scope of 
the present review.
We also have to consider the practical applicability of both manoeuvres. Trendelenburg can 
be performed in nearly every situation in a medical setting. Although PLR can be easy to 
perform it can be impossible during certain types of surgery. Trendelenburg will be relatively 
contraindicated in most head-trauma patients.
Finally, in hypovolaemia guarantee of sufficient cerebral blood flow is vital. Shenkin and 
co-workers observed cerebral flow velocity to decrease in normal humans during 
Trendelenburg position although carotid blood flow increased [27]. We cannot rule out that 
Trendelenburg position changes perfusion of the vital organs with or without coinciding 
changes in cardiac output. The absence of studies into the effects on regional blood flow or 
local oxygen delivery by these manoeuvres is a major limitation to hemodynamic assessment 
in clinical studies as a whole.
Conclusions
We compared the hemodynamic effects of the Trendelenburg and passive leg raising and 
found that both manoeuvres increased cardiac output by 6-9% within one minute. However, 
after several minutes PLR seemed more able to sustain this effect than Trendelenburg. This 
is possibly explained by the position of the baroreceptors and a cephalad movement of 
abdominal organs during Trendelenburg. Since fluid resuscitation during hypovolaemia is 
not achieved within minutes, we advocate the use of autotransfusion with PLR in the initial 
treatment of hypovolaemia if possible.
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Chapter 7 
Partitioning the resistances along the vascular tree: effects of dobutamine and 
hypovolemia in piglets with an intact circulation
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The hemodynamic effects of therapeutic interventions have been extensively studied on 
isolated arterial, venous or heart models either in vitro or in vivo. Although, intact circulation 
models have been used before, they are often limited to only one study characteristic; i.e. 
heart function, venous capacitance, (un)stressed volume, vascular compliance, mean 
systemic filling pressure or venous resistance [1]. None of these models is applicable in ICU 
patients and none was used to determine the coherent characteristics of the venous and 
arterial vasculature and heart function. Since arteries, veins and heart operate in concert, we 
developed an integrated in vivo model, applicable in patients, based on Guytonian 
physiology. 
We modelled the systemic circulation with one resistor upstream (Ra) and one resistor 
downstream (Rv) of mean systemic filling pressure (Pmsf) (Figure 1). At the site where the 
pressure is equal to Pmsf the large blood volume is indicated by a capacitor [2-4]. This site 
contains about 70% of total blood volume and has been reported to correspond with the 
location of the capillaries and post-capillary venules [5]. Resistance over the total systemic 
circulation (Rsys) and over the venous system (Rv) can be calculated from aortic pressure 
(Pao), central venous pressure (Pcv) and cardiac output (CO) values as (Pao-Pcv)/CO and Rv 
by (Pmsf-Pcv)/CO, respectively (Figure 1). Rsys reflects both arterial and venous resistance: 
Rsys = Ra +Rv. So, Ra = Rsys - Rv.
Figure 1  The circulation model to compute the resistances up-streams (Ra) and down-streams (Rv) of 
mean systemic filling pressure (Psf). The sum of Ra and Rv is equal to total systemic resistance 
(Rsys). Aortic pressure (Pao) and central venous pressure (Pcv) are measured. Mean systemic 
filling pressure is determined with inspiratory hold maneouvers. 
In this study we used a hemodynamic condition of hypovolemia as well as dobutamine as a 
known cardiovascular stimulant to test our model in an intact anesthetized piglet model. In 
the vasculature, Ruffolo and colleagues [6] presumed that with dobutamine, the β2 mediated 
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effects are counterbalanced by the α1 activity leading a decreased total peripheral vascular 
resistance by a reduction of sympathetic tone and arterial vasodilatation. However, since 
local vascular effects may differ owning to local differences in receptor expression which 
varies in arteries and vein, one may see either local vasodilatation or vasoconstriction. 
Presently, no intact-circulation model exists to study differences in systemic arterial and 
venous resistance. Since we recently validated a bedside technique to estimate mean 
circulatory filling pressure (Pmsf) [7], we are now able to determine the venous resistance in 
patients. Thus, examining both total blood flow and the ratio of the systemic to venous 
resistance one can quantify the effect of different hemodynamic conditions and vasoactive 
agents on total systemic vascular resistance and venous resistance.
The aim of our study was to determine the reproducibility of Pmsf, Rsys and Rv in our intact 
in vivo piglet model and, secondly, we tested our model during dobutamine and 
hypovolemia. We hypothesize that dobutamine would increase CO by the combined actions 
of increasing inotropy, arterial vasodilation, with less evident venodilation. Furthermore, we 
expected both hypovolemia and dobutamine to decrease Pmsf and hypovolemia to not 
change in the site of Pmsf, i.e. the ratio Rv/Rsys to be constant. 
Methods
All experiments were performed according to the ‘‘Guide for Care and Use of Laboratory 
Animals’’ published by the US National Institutes of Health and were approved by the local 
Animal Care Committee. 
Surgery 
Ten Yorkshire piglets were anesthetized with 30 mg∙kg-1 sodium pentobarbital intra-
peritoneal, followed by a continuous infusion of 9.0 mg∙kg-1∙h-1. After tracheostomy, the 
animals were ventilated at a rate of 10 breaths per minute at an I:E-ratio of 2.4:3.6 and with a 
tidal volume adjusted to maintain arterial PCO2 of approximately 40 mmHg, while a positive 
end-expiratory pressure of 2 cmH2O was applied. PCO2, airway pressure and airflow were 
measured in the tracheal cannula. The animals were placed in a supine position on a 
thermo-controlled operating table (38° C). A catheter was inserted through the right 
common carotid artery into the aortic arch to measure Pao and to sample arterial blood. Two 
other catheters were inserted through the right external jugular vein. A pulmonary artery 
catheter was inserted to measure pulmonary artery pressure, to measure thermodilution 
cardiac output (COtd) and to sample mixed venous blood. A quadruple-lumen catheter was 
inserted into the superior vena cava to measure Pcv and to infuse sodium pentobarbital and 
pancuronium bromide (Organon N.V., Boxtel, the Netherlands). The catheters for vascular 
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pressure measurements were kept patent by an infusion of saline with 2.5 IE Heparin ml-1 at 
3 ml∙ h-1. The bladder was cannulated trans-abdominally to check urine loss in order to 
maintain water balance. After an intercostal thoracotomy in the second left intercostal space, 
an electromagnetic flow probe (type transflow 601, model 400, Skalar, Delft, The 
Netherlands) was placed within the pericardium around the ascendant part of the aortic arch 
to measure aortic blood flow. Two suction catheters, one dorsal and one ventral, were 
inserted into the left pleural space. The thorax was closed airtight and both air and fluids 
were evacuated for 1-2 minutes with -10 cmH2O suction while applying a PEEP of 10 
cmH2O. After surgery and while on continuous pentobarbital infusion, the animals were 
paralyzed with an intravenous infusion of pancuronium bromide (0.3 mg∙kg-1∙h-1), after a 
loading dose of 0.1 mg∙kg-1 in 3 minutes. 
Measurements 
The electrocardiogram (ECG), Pao, pulmonary artery pressure (Ppa), Pcv, flow probe signal 
and ventilatory pressure (Pvent) flow were simultaneously recorded. Zero level of blood 
pressures was chosen at the level of the tricuspid valves, indicated by the pulmonary artery 
catheter during lateral-to-lateral radiography. The airway pressure transducer was balanced at 
zero level against ambient air. During the observation periods, ECG, blood flow and pressure 
signals were sampled in real time for 30-s periods at 250 Hz. The mean of four 
thermodilution cardiac output measurements equally distributed of the ventilatory cycle was 
used to obtain the value of COtd [8,9]. Areas under the aortic blood flow curves were analyzed 
online and calibrated by COtd to estimate beat-to-beat cardiac output (COem). After the 
surgical procedure the animals were ventilated at a rate of 10 min-1 with an inflation time of 
2.4 s and an expiration time of 3.6 s. Tidal volume was readjusted to an end-expiratory PCO2 
of approximately 5.33 kPa (40 mmHg), usually corresponding with a slightly higher arterial 
PCO2. The ventilatory settings were kept constant during the observation periods. 
We determined Pmsf using inspiratory pause procedures as previously described [5,10,11]. 
Briefly, during inflation of the lungs venous capacitance is loaded due to an increase in Pcv, 
which leads to a transient reduction in venous return, in right ventricular output and 
consequently in left ventricular output (Figure 2). To avoid transiently effects on the 
relationship between venous return and Pcv, we measured Pcv and (CO) during short 
periods of end-inspiratory steady state following these initial non-steady state conditions. CO 
and Pcv are determined over the final 5 seconds for a set of seven 12-sec inspiratory hold 
procedures at seven randomly applied tidal volumes between 25 and 300 ml. The inspiratory 
hold manoeuvres are separated by 5-minute intervals to re-establish the initial hemodynamic 
steady state. From the steady state values of Pcv and CO measured by an electromagnetic 
flow probe (COem) during the seven inspiratory pause periods a venous return curve was 
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constructed by fitting a linear regression line according to the method of least square means 
through these data points (Figure 3). Pmsf is defined as the extrapolation of this linear 
regression to zero flow [5,10,11].
Figure 2  Effects of an inspiratory hold mane0uver on aortic pressure (Pao), central venous pressure (Pcv), 
airway pressure (Pt) and beat to beat cardiac output (COem). Preceding the hold maneouver the 
effects of a normal ventilatory cycle are plotted. 
122)
Figure 3  Venous return curve for an individual animal. The relationship between venous return (COem) 
and central venous pressure (Pcv) is plotted. Mean system filling pressure (Pmsf) is indicated by 
extrapolating the curve to COem=zero.
Protocol 
To eliminate the effects of surgery, opening of the pericardium, and applying mechanical 
ventilation on the hemodynamic measurements, the piglets were allowed to stabilize for 60 to 
120 minutes after surgery. Data collection started once heart rate (HR), mean Pao and Pcv 
were stable for at least 15 minutes. After stabilization, baseline-1 measurements were 
performed. Next, continuous dobutamine infusion was started with 6 μg∙kg-1∙min-1 and 
hemodynamic measurements were performed after 30 minutes. The dobutamine infusion 
was stopped and after 30 minutes baseline-2 measurements were obtained. The observations 
were continued 15 minutes after bleeding the animals with 10 ml∙kg-1. The observations ended 
with baseline-3 measurements 15 minutes after giving back the withdrawn 10 ml∙kg-1 blood. 
Data analysis and statistics 
We fitted the set of seven data points of Pcv and COem by linear regression for each 
condition to define the venous return curve. We defined Pmsf as the extrapolation of this 
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linear regression to zero flow (Figure 3), assuming that airway pressure does not affects 
Pmsf. We have previously validated this extrapolation in piglets [5,10,11]. Total systemic vascular 
resistance (Rsys) was calculated as the ratio of the pressure difference between mean Pa and 
mean Pcv and COtd (Rsys = (Pa - Pcv)/COtd). The resistance downstream of Pmsf was taken 
to reflect the resistance to venous return (Rv) and was calculated as the ratio of the pressure 
difference between Pcv and Pmsf and COtd (Rv = (Pmsf-Pcv)/COtd). Systemic arterial 
resistance (Ra) was taken to be the difference between systemic and venous resistance. The 
ratio of Rv and Rsys describes the location within the circulation where Pmsf exists. A 
higher ratio implies a more upstream Pmsf location. After confirming a normal distribution 
of data with the Kolmogorov-Smirnov test, differences in parameters during baseline and 
interventions were analyzed using paired t-tests. Repeatability was calculated from the three 
baseline conditions using Bland-Altman analysis. Hereto, for each animal the mean and 
difference of the values of baseline-1 and 2 and of baseline-2 and 3 was determined. The 
upper and lower limits of agreement were calculated as bias ± 2SD. The coefficient of 
variation (COV) was calculated as 100% x (SD/mean). Effects of time on our data set were 
calculated by comparing baseline values. Changes induced by the interventions with 
dobutamine and hypovolemia were compared to the mean of the baseline values before and 
after the interventions to illuminate time effect. All values are given as mean ± SD. A p value 
< 0.05 was considered statistically significant.
Results
Ten 8–10 week old piglets (all females) bodyweight of 10.3 ± 0.7 kg were studied. Pooled data 
are shown in Table 1. A Kolmogorov-Smirnov test indicated normal distribution of all data. 
In 10 animals baseline-1, dobutamine, and baseline-2 data was obtained, in only 8 animals 
we were able to study the effects of bleeding by 10 ml∙kg-1.
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Table 1  Pooled results for 10 piglets at start (Baseline-1), 30 minutes after the start of 
6 μg∙kg-1∙min-1 IV dobutamine infusion (Dobutamine), 30 minutes after stopping the dobutamine 
infusion (Baseline-2), 15 minutes after bleeding 10 ml∙kg-1 (hypovolemia) and 15 minutes after 
reestablishing normovolemia (Baseline-3).
Baseline-1 Dobutamine Baseline-2 Hypovolemia Baseline-3
Pao (mmHg) 88.10 ± 17.24 87.51 ± 9.37 82.56 ± 17.02 83.05 ± 14.46 86.83 ± 18.30
Ppa (mmHg) 15.52 ± 3.51 19.77 ± 6.99 19.74 ± 7.39 17.10 ± 6.51 18.96 ± 5.97
Pcv (mmHg) 4.09 ± 1.33 4.10 ± 1.03 4.62 ± 1.38 3.75 ± 1.71 † 4.69 ± 1.47
HR (min-1) 146 ± 42 215 ± 33 ‡ 152 ± 42 175 ± 47 ‡ 150 ± 45
COtd (ml∙sec-1) 24.15 ± 3.70 33.64 ± 3.94 ‡ 24.53 ± 5.38 22.69 ± 3.87 † 24.57 ± 4.64
Pmsf (mmHg) 13.59 ± 1.04 12.02 ± 1.27 † 14.10 ± 1.37 10.94 ± 1.81 ‡ 14.85 ± 1.28
Pvr (mmHg) 10.71 ± 1.21 7.88 ± 1.12 * 9.50 ± 1.72 7.19 ± 1.66 ‡ 10.15 ± 1.75
Rv (mmHg∙sec∙ml-1) 0.401 ± 0.095 0.237 ± 0.037 ‡ 0.406 ± 0.126 0.327 ± 0.104 † 0.465 ± 0.085
Rsys (mmHg∙sec∙ml-1) 3.474 ± 0.424 2.507 ± 0.271 ‡ 3.379 ± 0.322 3.496 ± 0.352 3.359 ± 0.455
Rv / Rsys 0.117 ± 0.031 0.096 ± 0.019 † 0.127 ± 0.037 0.095 ± 0.035 † 0.129 ± 0.039
Hb (g∙dL-1) 9.56 ± 1.02 10.34 ± 1.22 † 9.73 ± 0.99 9.67 ± 0.89 9.71 ± 1.05
Aorta pressure (Pao), pulmonary artery pressure (Ppa), central venous pressure (Pcv), heart rate (HR), cardiac output with 
thermodilution (COtd), mean systemic filling pressure (Pmsf), pressure gradient for venous return (Pvr), venous flow 
resistance (Rv), systemic flow resistance (Rsys), location of Pmsf (Rv/Rsys), and hemoglobin (Hb).  
* p < 0.05, † p < 0.01 and ‡ p < 0.001 to the average of the baseline value before and after the intervention.
Repeatability 
Bland-Altman analyses for repeated measurements of the main derived variables Pmsf, Pvr, 
Rsys, Rv and Rv/Rsys are given in Table 2. A remarkable low percentage coefficient of 
variation of 3.8% was found for Pmsf. The percentage coefficient of variation increases with 
the number of variables incorporated in the calculation and was highest for Rv/Rsys. 
Table 2  Bland-Alman results for repeated measurements of mean systemic filling pressure (Pmsf), 
gradient for venous return (Pvr), systemic vascular resistance (Psys), the resistance for venous 
return (Rv) from Pmsf to central venous pressure and the quotient Rv/Rsys as a location of Pmsf 
in the circulation. Data of baseline-1, baseline-2 and baseline-3 are used (n=18).
Mean Bias SD COV limits of agreement
% lower upper
Pmsf (mmHg) 14.17 -0.55 0.54 3.8 -1.63 0.53
Pvr (mmHg) 9.64 -0.18 0.78 8.1 -1.74 1.38
Rsys (mmHg∙sec∙ml-1) 3.422 0.078 0.348 10.0 -0.618 0.774
Rv (mmHg∙sec∙ml-1) 0.415 -0.023 0.059 14.2 -0.141 0.095
Rv/Rsys 0.12 0.01 0.02 16.7 -0.03 0.05
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Interventions 
The infusion of 6 μg∙kg-1∙min-1 dobutamine increased HR and COtd and decreased Pmsf, 
Pvr, Rv, Rsys and Rv/Rsys ratio. Whereas Pao, Ppa and Pcv did not change during the study. 
The decrease of Rv during dobutamine was larger than the decrease in Rsys, 52% and 28% 
respectively. Recovery baseline condition after dobutamine (baseline-2) did not show any 
significant changes from the initial baseline values (baseline-1), except for HR which 
decreased after dobutamine infusion was stopped but still was elevated compared to 
baseline-1. Bleeding the animals with 10 ml∙kg-1 showed a decrease in Pcv, Pmsf, Pvr , Rv 
and Rv/Rsys. Recovery to baseline condition after bleeding (baseline-3) did not show any 
significant changes from baseline values before bleeding (baseline-2). Surprisingly, 
hemoglobin (Hb) increased during continuous dobutamine infusion and returned to 
baseline-1 values 30 minutes after the infusion was stopped. Hemoglobin did not changed by 
bleeding.
Discussion
Our data supports the feasibility to estimate Pmsf, Rsys and Rv. The discrimination between 
arterial and venous resistance is possible because we can estimate Pmsf accurately. Our data 
on vascular resistance clearly shows that although both arterial and venous components of 
vascular resistance decrease, the primary peripheral vascular effects of dobutamine in the 
healthy animal model was to induce more venodilation than arterial dilation. Bleeding the 
animals showed Pmsf, Pcv, COtd and surprisingly Rv to decrease and Pao and Rsys to be 
constant. Evidently, there is some compensation for the loss of venous return by adaptation 
of Rv.
Repeatability
Comparison of baseline-1, -2 and -3 showed no differences, except for the observation of 
heart rate HR during baseline-2. Therefore, we conclude for a stable observation periods in 
our animals. We determined the precision of the main derived variables, i.e. Pmsf, Pvr, Rsys 
and Rv, by Bland-Altman analysis of repeated measurements (Table 2). Although, Pmsf is 
determined by extrapolation of the venous return curve to COem is equal to zero (Figure 3), 
the coefficient of variation appeared to be surprisingly low (3.8%). With the low coefficient of 
variation for Pmsf, Rv and Rsys changes by the intervention with dobutamine and 
hypovolemia can be monitored with precision. Therefore, we consider the data as presented 
in Table 1 as reliable.
Our estimated Pmsf values (11-15 mmHg) are in agreement with those described in highly 
instrumented animals, which are in dogs 7-12.5 mmHg [12-17], rats 7-9 mmHg [18,19], pigs 10-12 
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mmHg [5,10,11], and as high as 20-30 mmHg in conscious calves implanted with an artificial 
heart [20]. Furthermore, we report a baseline Pmsf value of 19 mmHg in cardiovascular 
surgical patients [7]. 
How can our data be explained? In a non-controlled circulation a decrease in effective blood 
volume (i.e. a change from stressed to unstressed volume) will be reflected by a decrease in 
Pmsf [21]. If dobutamine caused arterial vasodilation such that the number of perfused 
capillaries increased, then unstressed volume should also increase, decreasing Pmsf for a 
constant blood volume. The greater number of draining venous conduits would also 
decrease the resistance to venous return. We found that dobutamine decreased without 
altering Pcv, decreasing the pressure gradient for venous return. Despite this decrease in 
pressure gradient, cardiac output was increased. Thus, the decrease in Rv was more than 
inversely proportional to the increase in cardiac output or cardiac output would have 
remained constant. A decrease in Rv may be caused by four mechanisms; (1) a decrease of 
the length of the vascular bed between the sites were the pressure is equal to Pmsf and right 
atrium, (2) an increase in cross section of the vascular bed, (3) decrease blood viscosity of 
blood or (4) a combination of the three mechanisms. As we measure an increase in Hb 
during dobutamine infusion a decrease in viscosity is very unlikely. Thus, the observed 
decrease in Pmsf combined with the increased COtd requires that Rv decrease due to an 
increase in the venous flow cross-sectional area, presumably due to dobutamine-induced 
increased parallel vascular blood flow.
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Figure 4  Conceptual model of the systemic circulation. Horizontally, the linear projection of vascular flow 
resistance (Rsys) between aortic valves (at the right) and right atrium (at the left) is plotted. In 
this linear projection the aorta takes about 2% , the arterioles about 55%, the remaining arterial 
system about 15% and the rest is distributed between capillaries and the venous system. The 
resistance (Rv) down-streams mean systemic filling pressure (Psf) and central venous pressure 
(Pcv) is indicated. Vertically, aortic pressure (Pao), central venous pressure (Pcv) and mean 
systemic filling pressure for baseline condition and during infusion of dobutamine are plotted. 
The values of Table 2 are used to construct the model. Further explanation is given in the text.
The changes in Pao, Pcv, COtd, Rsys and Rv are illustrated schematically in Figure 4, in which 
flow resistance is projected on the x-axis. We have used this graphical model to analyze two 
different stationary conditions in circulation, i.e. baseline condition and during infusion of 
dobutamine. The numeric data for this model are taken from Table 1, columns baseline-1 and 
dobutamine. The lines between Pao and Pcv represent the pressure gradient (Psys) over Rsys 
and between Pmsf and Pcv; the pressure gradient (Pvr) for venous return over Rv. The slope of 
the lines represent blood flow, i.e. COtd=Psys/Rsys=Pv/Rv. During dobutamine infusion the 
Pao-Pcv difference was equal to baseline. However, COtd increased and both Rsys and Rv 
decreased significantly. The fall in Rv due to dobutamine was larger than the fall in Rsys, 52% 
and 28% respectively. From this difference in response to dobutamine we conclude that the 
primary peripheral vascular effect of dobutamine is on the venous side of the circulation as 
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shown in Figure 4. The larger decrease on the venous side can be explained mainly by the 
decrease in Pmsf due to dobutamine. If we had observed no change in Pao, Pcv or Pmsf 
despite an increase in COtd, then Rv must have changed proportional to Rsys, which is 
described by the intersection of dashed Pao-Pcv dobutamine line and solid Pmsf line. 
Importantly, our method to determine Pmsf has recently also been validated in mechanically 
ventilated patients [7], thus this approach can now to applied to humans as well. In addition, we 
confirmed the well-known positive inotropic effect of dobutamine as manifest by the increase 
in HR and stroke volume despite an unchanged Pcv and Pao. It is unclear from our data which 
factor plays a greater role in increasing COtd, increasing inotropy or decreasing Rv.
In our animals hypovolemia caused/produced Pmsf, Pcv, COtd and surprisingly Rv to 
decrease and Pao and Rsys to be constant. The gradient for venous return, Pvr=Pmsf-Pcv, 
decreased with 27%, so with a constant resistance for venous return, Rv, we expected a 
decrease in CO of the same order (CO=Pvr/Rv). However, Rv decreased by 16% leading to a 
decrease in COtd with only 9%. Thus, there appears to be compensation for the loss of 
venous return by adaptation of Rv, manifested by the significant increase in heart rate. 
Potentially, this occurred by shifting blood away from the splanchnic circulation with its 
higher Rv ro other systemic vascular circuits, as we have previously shown [22], but our study 
does not allow us to confirm this speculation. However, since we observed that the location at 
which Pmsf exist (Rs/Rsys) shifted more into the direction of the venous site of the 
circulation, suggests that such a redistribution of blood flow did occur. 
Limitations 
Some limitations apply to our model. The technical set-up with a flow probe around the 
aorta is not general applicable in humans. A reliable less invasive beat-to-beat determination 
of cardiac output by trans-oesophageal ultrasound or arterial pulse contour allow similar 
studies to be done in humans [7]. 
We measured only Pao and Pcv and calculated Pmsf. Pmsf is a lumped variable of all the 
vascular beds. Thus, it is not clear, which specific or general vascular beds were affected by 
dobutamine infusion or hypovolemia. The difference in local adrenergic receptor (subtype) 
expression and overall expression of the receptors vary between different vascular beds and 
between species. Although the circulation of the pig bares macroscopic resemblance to the 
human physiology, a direct extrapolation of the results is precarious. This, however, also 
applies for previous studies [1,6]. Clearly, future human studies using less invasive means will 




The use of our in-vivo animal model to assess the hemodynamic effects on Pmsf, Rsys, Rv 
and Rv/Rsys of a cardiovascular drug and of hypovolemia was successfully tested. The 
discrimination between arterial and venous resistance is possible because we can estimate 
Pmsf accurately. The higher cardiac output seen during dobutamine infusion was attributed 
to the combined increased cardiac function and decreased venous flow resistance despite a 
decrease in Pmsf. Hypovolemia decrease as expected Pmsf but this decrease was partly 
compensated for by a decrease in Rv to preserve venous return and thus cardiac output.
130)
References
 1.  Pang CC. Autonomic control of the venous system in health and disease: effects of drugs. Pharmacol Ther 
2001; 90: 179-230.
 2.  Gelman S. Venous function and central venous pressure: a physiologic story. Anesthesiology 2008; 108: 735-748.
 3.  Magder S, De Varennes B. Clinical death and the measurement of stressed vascular volume. Crit Care Med 
1998; 26: 1061-1064.
 4.  Peters J, Mack GW, Lister G. The importance of the peripheral circulation in critical illnesses. Intensive Care 
Med 2001; 27: 1446-1458.
 5.  Versprille A, Jansen JR. Mean systemic filling pressure as a characteristic pressure for venous return. 
Pflugers Arch 1985; 405: 226-233.
 6.  Ruffolo RR, Jr. The pharmacology of dobutamine. Am J Med Sci 1987; 294: 244-248.
 7.  Maas JJ, Geerts BF, van den Berg PC, Pinsky MR, Jansen JR. Assessment of venous return curve and mean 
systemic filling pressure in postoperative cardiac surgery patients. Crit Care Med 2009; 37: 912-918.
 8.  Jansen JR, Schreuder JJ, Bogaard JM, van Rooyen W, Versprille A. Thermodilution technique for 
measurement of cardiac output during artificial ventilation. J Appl Physiol 1981; 51: 584-591.
 9.  Jansen JR, Schreuder JJ, Settels JJ, Kloek JJ, Versprille A. An adequate strategy for the thermodilution 
technique in patients during mechanical ventilation. Intensive Care Med 1990; 16: 422-425.
 10.  Den Hartog EA, Versprille A, Jansen JR. Systemic filling pressure in intact circulation determined on basis 
of aortic vs. central venous pressure relationships. Am J Physiol 1994; 267: H2255-H2258.
 11.  Hiesmayr M, Jansen JR, Versprille A. Effects of endotoxin infusion on mean systemic filling pressure and 
flow resistance to venous return. Pflugers Arch 1996; 431: 741-747.
 12.  Guyton AC. Determination of cardiac output by equating venous return curves with cardiac response curves. 
Physiol Rev 1955; 35: 123-129.
 13.  Guyton AC, Lindsey AW, Abernaty B, Richardson T. Venous return at various right atrial pressures and the 
normal venous return curve. Am J Physiol 1957; 189: 609-615.
 14.  Pinsky MR. Instantaneous venous return curves in an intact canine preparation. J Appl Physiol 1984; 56: 
765-771.
 15.  Greene AS, Shoukas AA. Changes in canine cardiac function and venous return curves by the carotid 
baroreflex. Am J Physiol 1986; 251: H288-H296.
 16.  Lee RW, Lancaster LD, Gay RG, Paquin M, Goldman S. Use of acetylcholine to measure total vascular 
pressure-volume relationship in dogs. Am J Physiol 1988; 254: H115-H119.
 17.  Fessler HE, Brower RG, Wise RA, Permutt S. Effects of positive end-expiratory pressure on the canine 
venous return curve. Am Rev Respir Dis 1992; 146: 4-10.
 18.  Samar RE, Coleman TG. Mean circulatory pressure and vascular compliances in the spontaneously 
hypertensive rat. Am J Physiol 1979; 237: H584-H589.
 19.  Yamamoto J, Trippodo NC, Ishise S, Frohlich ED. Total vascular pressure-volume relationship in the 
conscious rat. Am J Physiol 1980; 238: H823-H828.
 20.  Honda T, Fuqua JM, Edmonds CH, Hibbs CW, Akutsu T. Applications of total artificial heart for studies of 
circulatory physiology; measurement of resistance to venous return in postoperative awake calves. 
Preliminary report. Ann Biomed Eng 1976; 4: 271-279.
 21.  Prather JW, Taylor AE, Guyton AC. Effect of blood volume, mean circulatory pressure, and stress relaxation 
on cardiac output. Am J Physiol 1969; 216: 467-472.
 22.  Schlichtig R, Klions HA, Kramer DJ, Nemoto EM. Hepatic dysoxia commences during O2 supply 





Assessment of venous return curve and mean systemic filling pressure in 
postoperative cardiac surgery patients
Jacinta Maas, Bart Geerts, Paul van den Berg, Micheal Pinsky and Jos Jansen
Critical Care Medicine 2009; 37(3): 912-8
 
134)
The cardiovascular system is a closed circuit with varying blood flow out of the heart into the 
arterial system (cardiac output) and flow back to the heart from the venous system (venous 
return) that may not be equal at any point in time owing to ventilation-induced changes in 
venous return, but which over time must be equal [1,2]. Thus, under steady state apnoeic 
conditions cardiac output (CO) and venous return (VR) equal. Guyton et al. [3,4] showed that 
the relationship between stepwise changes in right atrial pressure (Pra) and the resulting 
changes in venous return describes a venous return curve, which itself is a function of the 
circulating blood volume, vasomotor tone and blood flow distribution. Importantly, right 
atrial pressure at the extrapolated zero flow pressure-intercept reflects mean systemic filling 
pressure (Pmsf) and the slope of this relation describes the resistance for venous return 
(Rvr) [3,5]. This relationship between right atrial pressure and VR was well described in 
animal models with an artificial circulation [4], in patients during stop flow conditions [6] and 
in animals with an intact circulation using invasive hemodynamic monitoring [7-10]. However, 
it has never been evaluated in humans with an intact circulation. If such venous return 
curves could be easily calculated at the bedside, then complex cardiovascular analysis would 
be feasible thereby augmenting greatly our understanding of the dynamic determinants of 
circulatory insufficiency states and their responses to therapies. Intravascular blood volume 
can be divided in unstressed volume (the blood volume necessary to fill the blood vessels 
without generating an intravascular pressure), and stressed volume (the blood volume which 
generates the intravascular pressure, which is mean systemic filling pressure in no flow 
conditions).
Previously, Pinsky [7] constructed instantaneous venous return curves based on the beat to 
beat changes in Pra and simultaneously measured right ventricular output during a single 
mechanical breath, neglecting possible transient effects of increasing Pra on venous return 
[1,2]. Versprille and Jansen [8] prevented these transient changes by measuring Pra and right 
ventricular output during steady state conditions generated by ventilator applied inspiratory 
pause periods at different inflation volumes. Unfortunately, it is difficult to measure 
pulmonary blood flow on a beat to beat basis at the bedside. We hypothesized that if 
inspiratory hold manoeuvres that increase right atrial pressure create a new steady state then 
venous return and cardiac output would again be equal and direct measures of left-sided 
cardiac output could be used to estimate steady state venous return.
Thus, we studied the effect of 12-second inspiratory hold manoeuvres on the relation 
between central venous pressure (Pcv), as a surrogate for right atrial pressure, and arterial 
pulse contour-derived cardiac output (COmf), as a surrogate for venous return, as Pcv was 
varied by inspiratory hold manoeuvres and intravascular volume status altered by a head-up 




Twelve post-operative patients after elective coronary artery bypass surgery or aortic valve 
replacement were included into the study after approval by the university medical ethics 
committee and patient’s informed consent was obtained. All patients had symptomatic 
coronary artery disease without previous myocardial infarction and were on beta adrenergic 
blocking medication. Patients with congestive heart failure (NYHA class 4), aortic aneurysm, 
extensive peripheral arterial occlusive disease, or postoperative valvular insufficiency, were 
not considered for this study. Patients with postoperative arrhythmia or the necessity for 
artificial pacing or use of a cardiac assist device were also excluded.
Anaesthesia during surgery was maintained with sufentanil and propofol and patients were 
ventilated in synchronized intermittent mandatory surgery was maintained with propofol 
and ventilation (SIMV) mode (Evita4 servo ventilator Draeger, Lubeck, Germany) adjusted to 
achieve normocapnia (arterial PCO2 between 40 and 45 mmHg) with tidal volumes of 6-8 
ml∙kg-1 and a respiratory rate of 12-14 breaths∙min-1. Fraction of inspired oxygen (FiO2) was 
0.4 and a positive end-expiratory pressure (PEEP) of 5 cmH2O was applied. A hemodynamic 
stability was achieved using fluids and catecholamines. During the study interval all subjects 
were haemodynamically stable and no changes were made in their vasoactive drug therapy. 
Every patient experienced full recovery from anaesthesia within 8 hours following surgery 
and was discharged from intensive care unit on the first post-operative day. 
 
Measurements
Arterial blood pressure (Pa) was monitored via a 20 Gauge, 3.8 cm long radial arterial 
catheter inserted by Seldinger technique and connected to a pressure transducer (PX600F, 
Edwards Lifesciences). Pcv was measured with a central venous catheter inserted through 
the right internal jugular vein (MultiCath 3 venous catheter, Vigon GmbH & Co, Aachen, 
Germany) and connected to a pressure transducer (PX600F, Edwards Lifesciences). Both Pa 
and Pcv transducers were referenced to the intersection of the anterior axillary line and the 
5th intercostal space. Airway pressure (Pvent) was measured at the entrance of the 
endotracheal tube. Pvent was balanced at zero level against ambient air. Standard ECG leads 
were used to monitor heart rate (HR). Beat to beat cardiac output was obtained by modelflow 
(COmf) pulse contour analysis as previously described by us [11-13]. We calibrated the pulse 
contour cardiac output measurements with 3 thermodilution cardiac output measurements 
equally spread over the ventilatory cycle [12].
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Experimental protocol
Before starting the protocol the mechanical ventilation mode was switched to airway 
pressure release ventilation (APRV) with the same rate, FiO2, and PEEP level. Inspiration 
pressure was adapted to have the same gas exchange as in SIMV mode. This change in 
ventilation mode allowed external control of the ventilatory process. We developed a 
computer program to drive the ventilator. During the observation period ventilator settings, 
sedation and vasoactive medications remained unchanged. No spontaneous breathing 
movements were observed during the study. Pa, Pcv and Pvent were recorded on computer 
disk for offline data analysis at a sample frequency of 100 Hz and 0.2 mmHg resolution. 
We constructed venous return curves by measuring steady state Pa, Pcv and COmf over the 
final 3 seconds for a set of four 12-second inspiratory hold manoeuvres at Pvent plateau 
pressures of 5, 15, 25, 35 cmH2O. The inspiratory hold manoeuvres were separated by 
1-minute intervals to re-establish the initial hemodynamic steady state. An example of the 
hemodynamic changes during an inspiratory hold is presented in Figure 1. 
Figure 1  Effects of an inspiratory hold manoeuvre on arterial pressure (Pa), central venous pressure (Pcv), 
airway pressure (Pvent) and beat to beat cardiac output (COmf). Preceding the hold manoeuvre 
the effects of a normal ventilatory cycle are plotted. 
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When Pvent increases, Pcv increases concomitantly, while COmf and Pa decrease with a 
delay of 3-4 beats, reaching a steady state between 7 and 12 seconds after start of inflation. 
From the steady state values of Pcv and COmf during the four inspiratory pause periods a 
venous return curve was constructed by fitting a linear regression line through these data 
points (Figure 2).
Figure 2  Relationship between venous return (COmf) and central venous pressure (Pcv) for an individual 
patient. Venous return curves are plotted for three conditions, baseline (a), hypovolemia (b) and 
hypervolaemia (c). 
The four inspiratory hold manoeuvres were performed under three sequential volumetric 
conditions: initial baseline conditions (Baseline) with the subject lying supine, relative 
hypovolemia by rotating the bed to a 30o head-up (anti-Trendelenburg) position (Hypo), and 
after administration of 500 ml HydroxyethylStarch (HES 130/0.4) in supine position 
(Hyper). Measurements were done 2 minutes after head-up tilt and 2-5 minutes after the 
fluid bolus, which was given in 15-20 minutes. 
Data analysis and statistics
We fitted the set of 4 data points of Pcv and COmf by linear regression for each volume state 
to define the venous return curve. We defined Pmsf as the extrapolation of this linear 
regression to zero flow (Figure 2), assuming that airway pressure does not affects Pmsf. We 
have previously validated this extrapolation in piglets [8-10]. 
Total systemic vascular resistance (Rsys) was calculated as the ratio of the pressure difference 
between mean Pa and mean Pcv and COmf (Rsys = (Pa - Pcv)/COmf). The resistance 
downstream of Pmsf was taken to reflect the resistance to venous return (Rvr) and was 
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calculated as the ratio of the pressure difference between Pcv and Pmsf and COmf (Rvr = 
(Pmsf-Pcv)/COmf). Systemic arterial resistance (Ra) was taken to be the difference between 
systemic and venous resistance. The ratio of Rvr and Rsys describes the location within the 
circulation where Pmsf exists. A higher ratio implies a more upstream Pmsf location.
Systemic compliance (Csys) was calculated by dividing the amount of fluid (Vload) 
administrated to induce the Hyper state by the Pmsf difference between Baseline and Hyper 
(Csys = Vload /(PmsfHyper –PmsfBaseline). We assume systemic compliance to be constant for 
the three volaemic conditions studied. Stressed vascular volume (Vs) was calculated as the 
product of Csys and Pmsf. We calculated Vs for all three relative volume conditions. 
Data are presented as mean ± SD. Linear regressions were fitted using a least-squares 
method. The changes between the three conditions were tested by a paired t-test, with 
differences corresponding to a P < 0.05 considered significant. We compared Baseline to 
both Hypo and Hyper. 
Results
Sixteen patients were recruited into the study but 4 were excluded from analysis because they 
could not receive an additional volume challenge. We report in Table 1 the patient characteristics 
and in Table 2 the pooled data of the 12 subjects who completed all three steps of the protocol. 

























1 M 60 80 172 85 8.2 4.6 72 36.8 CABG - 300 15
2 M 57 78 169 119 9.9 5.7 73 36.9 CABG Dobu 2 300 15
3 M 79 78 174 86 7.5 6.3 88 36.9 AVR Dobu 5 200 10
4 M 50 90 190 93 7.4 3.2 138 36.3 AVR NPN 0.25 300 15
5 M 80 90 172 99 8.0 6.1 80 36.7 CABG Nor 0.01 200 10
6 F 64 83 167 76 7.1 5.8 88 37.4 CABG Nor 0.04, 
Dobu 3
200 10
7 M 50 112 183 83 4.0 5.7 85 37.0 CABG Nor 0.06 500 15
8 M 57 91 177 63 4.9 6.4 78 35.1 CABG - 300 10
9 M 71 73 179 93 8.0 8.8 91 37.1 CABG Nor 0.09, 
Dobu 4
120 5
10 M 66 88 178 69 3.0 7.4 71 35.8 CABG Nor 0.02 200 10
11 M 75 95 173 77 9.0 4.4 130 36.5 CABG - 300 10
12 F 60 74 158 89 3.7 5.3 86 36.6 CABG Nor 0.04, 
Enox 2
150 5
mean 64 86 174 86 6.7 5.8 90 36.6 256 11
sd 10 11 8 15 2.3 1.4 22 0.6 101 4
HR, heart rate; Pcv, central venous pressure; CO, cardiac output; MAP, mean arterial pressure; Temp, body temperature; CABG,  
coronary artery bypass grafting; AVR, aortic valve replacement; Dobu, dobutamine; NPN, nitroprusside sodium; Nor, 
norepinephrine; Enox, enoximone
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Venous return curve analysis
Pcv and COmf decreased during Hypo and increased during Hyper. Similarly, Pmsf 
decreased during Hypo and increased during Hyper, whereas the slope of the venous return 
(conductance) was not significantly different for the three conditions of Baseline, Hypo and 
Hyper. The pressure gradient for venous return did not change with Hypo but increased 
with Hyper such that Rvr was unchanged by Hypo but increased with Hyper. Importantly, 
Rsys, did not change. Thus, the estimated location of Pmsf was unchanged by Hypo but 
migrated upstream with Hyper. 




mean SD p1 
Hyper 
mean SD p2
Pa (mmHg) 89.9 21.6 75.7 17.3 0.001 96.5 14.9 0.17
Pcv (mmHg) 6.72 2.26 4.02 2.12 0.001 9.67 2.63 0.007
COmf (L∙min-1) 5.82 1.44 4.76 1.3 0.001 6.83 1.36 0.002
HR (min-1) 86 14.7 85.7 15.1 0.456 84.3 10.7 0.401
Slope (L∙min-1∙mmHg-1) -0.465 0.151 -0.429 0.16 0.388 -0.389 0.135 0.134
Pmsf (mmHg) 18.76 4.53 14.54 2.99 0.005 29.07 5.23 0.001
Pvr (mmHg) 12.04 3.70 10.52 2.27 0.106 19.40 6.88 0.003
Rvr (mmHg∙min∙L-1) 2.18 0.86 2.41 1.14 0.184 2.91 1.10 0.037
Rsys (mmHg∙min∙L-1) 15.89 9.00 16.95 10.27 0.379 13.52 5.60 0.122
Rvr/ Rsys (%) 14.94 5.00 14.84 2.37 0.931 22.62 8.07 0.006
Values are means ± SD; n=12 patients. Pa, arterial pressure; Pcv, central venous pressure; COmf, cardiac 
output; HR, heart rate; Slope, slope of venous return curve; Pmsf, mean systemic filling pressure; Pvr, 
pressure difference between Pmsf and Pcv; Rvr, resistance for venous return; Rsys, resistance of the systemic 
circulation. Statistical comparison, p1, paired t-test between baseline and hypovolaemic condition (hypo) and 
p2, paired t-test between baseline and hypervolaemic condition (hyper)
Systemic compliance and stressed volume
The change in stressed volume versus Pmsf is shown in Figure 3. Assuming a constant 
compliance the loss of stressed volume due to Hypo is approximately 200 ml. On average 
systemic compliance was 80 ± 62 ml∙mmHg-1 (0.98 ± 0.82 ml∙mmHg-1∙kg-1 body weight) 
and stressed volume during Baseline was 1677 ± 1643 ml (12.5 ± 12.1 ml∙kg-1 body weight). 
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Figure 3  Relationship between change in blood volume and mean systemic filling pressure (Pmsf) for 
three conditions, baseline (a), hypovolemia (b) and hypervolaemia (c). See text for discussion.
Discussion
Our study demonstrates that by using a simple inspiratory hold manoeuvre while 
simultaneously measuring Pcv and Pa one can generate venous return curves and derive their 
associated vascular parameters at the bedside. Our data suggest that volume altering 
manoeuvres (Hypo and Hyper) do not alter vascular conductance (slope of the venous return 
curve). These clinical data are concordant with the long-described experimental data 
introduced by Guyton and colleagues over 50 years ago [4,14]. Importantly, our novel approach 
to assessing venous return allows these analyses to be done at the bedside in patients after 
coronary artery bypass surgery or aortic valve replacement. Patients with congestive heart 
failure (NYHA class 4), aortic aneurysm, extensive peripheral arterial occlusive disease, 
postoperative valvular insufficiency, postoperative arrhythmia or the necessity for artificial 
pacing or use of a cardiac assist device were excluded from this study. It will be interesting to 
see how these vascular parameters change in different disease states, such as septic shock and 
heart failure, and how treatments alter them further because these analyses allow for the 
repetitive estimation of circulatory vascular compliance and effective circulatory blood volume. 
Methodological issues
During an inspiratory pause period a new steady state was attained, which can be concluded 
from the plateau phase in the COmf, Pa and Pcv (Figure 1). In this example the time needed 
to reach the plateau was approximately 7 seconds. This duration is too short to be associated 
with changes in autonomic tone which would otherwise occur owing to the decrease in 
Pa-induced baroreceptor-mediated increase in sympathetic tone. Samar and Coleman [15] 
showed in rats that a total circulatory stop, by pulmonary occlusion, caused a simultaneous 
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decrease of arterial pressure and a rise in central pressure to an equal plateau pressure 
within 4 to 5 seconds. This was followed by a second rise in Pcv after 10-12 seconds of 
circulatory arrest in rats [15,16] and after 12-15 seconds in dogs [17]. The second rise was seen in 
unanaesthetized rats and during methoxyflurane anaesthesia, however, seldom seen with 
pentobarbital and inhibited by hexamethonium or spinal-cord transaction [18]. Thus, any 
secondary increase in HR or Pcv was due to sympathetic reflex activation. We did not 
observe an increase in Pcv or HR during the last phase of our inspiratory pause, not even 
during pause pressures of 35 cmH2O. Furthermore, all Pa values rapidly reached steady state 
conditions within 7 seconds, making our analysis relatively free of the confounding effects of 
varying autonomic tone. However, our subjects were also receiving neuro-suppressive agents 
(propofol and sufentanil) during the study interval, thus sympathetic responsiveness may 
have been blunted. Propofol depresses the baroreflex responses to hypotension and inhibits 
sympathetic nerve activity in healthy volunteers [19,20], whereas sufentanil might depress 
baroreceptor reflexes [21]. Thus, these studies will need to be repeated in non-anesthetized 
subjects to validate their usefulness in that population. Still, in the setting of general 
anaesthesia, these findings appear valid.  
During inflation venous capacitance is loaded due to an increase in central venous pressure, 
which leads to a transient reduction in venous return, in right ventricular output and 
consequently in left ventricular output [1,2]. To avoid this effect on the relationship between 
venous return and Pcv we measured Pcv and COmf during short periods of steady state 
following these initial non-steady state conditions (Figure 1). Our Pmsf estimation method 
by extrapolating the values of four pairs of Pcv and COmf obtained from four levels of 
inspiratory plateau pressures has several advantages. First, it allows the construction of 
Guyton-type venous return curves with an intact circulation, an opportunity not presently 
available. Second, Pmsf can be determined without creating stop flow conditions, such as 
stopping the heart by electrical fibrillation or injection of acetylcholine or by blocking the 
circulation. And thirdly, mean systemic filling pressure is not influenced by changes in lung 
or thorax compliance. Lung or thorax compliance effects the transfer of the applied airway 
pressures to intra-thoracic pressures. Thus, during an inspiratory hold the resulting Pcv 
depends on these compliances. But, indeed, the measured Pcv and CO will always be on the 
same line in the venous return plot. For instance, in a patient with stiffer lungs, during an 
inspiratory hold the transfer from airway pressure to intra-thoracic pressure will be less, 
resulting in a smaller increase in Pcv and a smaller decrease in CO.
We assumed a linear relation between Pcv and COmf to extrapolate to the condition of 
COmf is zero (Figure 2). This assumption is based on the observation of linearity of the 
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venous return curves presented by Guyton and co-workers [4,14] and is expressed by the 
mathematical relation VR=CO=(Pmsf – Pcv)/Rvr. Furthermore, this linearity has been 
confirmed in the intact circulation in several animal studies [7-10,22,23]. Our venous return 
curves were best fitted with straight lines allowing extrapolating the venous return curve to 
flow zero. This linearity was neither affected by Hypo or Hyper.
Our estimated Pmsf values are higher than those described in highly instrumented 
animals, which are in dogs 7-12.5 mmHg [4,7,14,17,24,25], rats 7-9 mmHg [15,16], pigs 10-12 
mmHg [8-10], and as high as 20-30 mmHg in conscious calves implanted with an artificial 
heart [26]. We report Baseline Pmsf values of 18.8 mmHg in our cardiovascular surgical 
patients. A primary difference between the prior animal studies and our patient 
observations is the difference in baseline Pcv. In the animals studies this value is close to 
zero whereas Pcv in our patient population is on average 6.7 mmHg. If one assumes a 
similar Rvr, this Pcv pressure difference would extrapolate to a Pmsf of 12 mmHg for our 
subjects if their Pcv were zero (see Table 2). Thus, our Pmsf values are coupled with  
the increased Pcv. 
Our present data seem to be in conflict with those of our previous study, wherein we 
demonstrated that inspiratory hold manoeuvres did not decrease blood flow, as estimated by 
thermodilution pulmonary artery flow [27] despite an increase in Pcv. There were no 
differences between the two studies in terms of Pa (75 ± 15 versus 88 ± 18 mmHg), Pcv (9 ± 
4 versus 8 ± 2 mmHg) and cardiac output (5.7 ± 1.52 versus 5.6 ± 1.6 L∙min-1, previous to 
present mean pooled data, respectively). However, two major differences in the protocols 
exist. First, the inspiratory hold manoeuvre used by van den Berg et al. [27] had a temporarily 
higher inflation pressure at the beginning of the manoeuvre which was decreased to the 
steady state plateau value, and second the bolus thermodilution method was applied during 
the inspiratory pause in the first study whereas we used the modelflow pulse contour cardiac 
output method to measure instantaneous flow in the present one. Re-examination of the 
data of van den Berg et al.[27] suggests that the thermodilution injections might have been 
performed before the plateau in blood flow had been reached. If this were the case, then the 
thermodilution cardiac output values would over-estimate steady state values, resulting in an 
underestimation of the slope of the venous return curve. Furthermore, in their study [27] 
plateau pressures from 0 up to 19 cmH2O were used whereas we used plateau pressures 
from 5 up to 35 cmH2O, which are comparable to those used by Versprille and Jansen 
[8] in 
their animal experiments. The limited range of applied plateau pressures in the van den 
Berg study [27] might have hampered the construction of proper venous return curves. 
Jellinek et al. [28] estimated in 10 patients during episodes of apnoea and ventricular 
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fibrillation, induced for defibrillator testing, and found a mean Pmsf value of 10.2 mmHg 
and Schipke et al. [6] estimated a mean Pmsf value of 12 mmHg in a similar group of 85 
patients. However, both studies were done on highly anesthetized non-volume resuscitated 
subjects. Our method of estimation of Pmsf differs considerably from stopping flow by 
defibrillation of the heart and our method allows an estimation of Pmsf with intact 
circulation, applicable in the intensive care unit. Still, until paired comparisons of Pmsf are 
made using the two techniques (i.e. stop flow and our method) in the same subjects direct 
comparisons and interpretation of the data can not be made.
Using these manoeuvres to assess cardiovascular status
Moving patients from supine into a head up tilt position shifts blood from the central 
compartment to the legs, creating a relative hypovolaemic state as manifest by a decreasing 
Pmsf, Pcv and cardiac output. Potentially, other conflicting processes could also be occurring 
simultaneously. As the blood volume shifted to the legs increase femoral venous pressure, 
venous vascular diameter will increase decreasing vascular resistance from the legs. The 
impact of the intra-abdominal volume shift off the diaphragm is less clear but may increase 
hepatic resistance if chest wall movement compresses the sub-diaphragmatic liver. The results 
of these effects lead to no change in Rvr and a decrease in COmf, Pa, Pcv and Pmsf (Table 2). 
Volume loading creates relative hypervolaemia which results in an increase of Pmsf, Pcv, CO 
and Pa. The higher CO can only be generated by a higher filling of the right atrium reflected 
in an increase of Pcv. Because the pressure gradient for venous return is increased more 
than Rvr, CO increases (Table 2). 
Pmsf is the pressure at the mid-point of the vascular pressure drop from the aorta to the 
right atrium. In practice, it is usually locate in the venules and is less than arteriolar pressure 
and more than Pcv but close to capillary-venule tissue pressure [8,18]. The localization of Pmsf 
within the circulation is a conceptual model at best, since it reflects a lumped parameter of 
all the vascular beds. However, its position in the pooled vascular beds will shift depending 
on changes in arterial and venous resistances as was pointed out by Versprille and Jansen [8]. 
Our data suggests that the vascular site for Pmsf exists in the range of the capillary-venule 
pressures, i.e. Rvr/Rsys= 15% (Table 2). And, indeed, this site shifted upstream (Rvr/
Rsys=23%) with Hyper, whereas Hypo had no effect on the site of Pmsf  
(Rvr/Rsys=15%). These data suggest that in the immediate post-operative period increased 
sympathetic tone keeps Pmsf in the venular side but with volume loading and a presumed 
reduction of vasomotor tone, this point shifts retrograde toward the arterial system. It will be 
interesting to see how this location changes with the use of vasoactive drug therapy and in 
patients with either sepsis or heart failure. We also saw that Rvr increased during 
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hypervolaemic conditions whereas conductance (conductance = 1 / Rvr) was constant. We 
are not sure why this would be the case, because anatomically and physiologically speaking, 
the same factors affect both resistance and conductance. Potentially, our technique 
systematically overestimated Pmsf, and thus pressure gradient for venous return under 
hypervolaemic conditions due to squeezing of blood volume out of the lung; or the 
associated increase in Pcv decreased the flow through the more dependent venous conduits. 
Our study design does not allow us to speculate further on these Rvr changes.
Whole body vascular compliance is calculated as the ratio of the change of volume to the 
change in estimated Pmsf (∆V/∆P). Using our inspiratory hold technique we found a 
vascular compliance, Csys, of 0.98 ml∙mmHg-1∙kg-1 body weight. Because the 
administration of 500 ml of colloid can expand plasma volume with more than 500 ml, 
because of fluid recruitment of the extravascular space and because of fluid loss (urine and 
blood loss), the amount of 500 ml is an approximation of the actual volume expansion. 
Previous studies in instrumented anesthetized animals have reported a linear relation 
between Pmsf and blood volume over a Pmsf of 5 to 20 mmHg [18]. Thus, vascular 
compliance over this Pmsf range may be considered constant. From this constant total 
systemic vascular compliance and the change in Pmsf from Baseline to Hypo we calculated 
an effective volume loss to be about 200 ml. This loss is due to a shift of blood from stressed 
to unstressed blood volume. 
The stressed volume can be estimated from the compliance and Pmsf. In normovolemic 
patients in supine position we estimated an averaged stressed volume of 1677 ml or  
19.5 ml∙kg-1. To our surprise this calculated stressed volume is close to the stressed volume 
of 20.2 ml∙kg-1 reported by Magder and De Varennes [29] in patients undergoing hypothermic 
circulatory arrest for surgery on major vessels. They measured stressed volume as the 
volume that drained from the patient into the reservoir of the pump when the pump was 
turned off. 
Previously reported values for Csys ranged from 1.4 to 2.6 ml∙mmHg-1∙kg-1 in dogs [17,30-33] 
and from 1.5 to 2.4 ml∙mmHg-1∙kg-1 in rats [15,16,34]. The lower compliance (0.98 ml∙mmHg-
1∙kg-1) observed in our patients may reflect species differences or differences in methodology 
used. The main difference in methodology is related to the time between volume loading 
and the determination of Pmsf. In animal studies the Pmsf measurement is performed  
30 seconds after volume loading, whereas we finished our measurements after more than 
20 minutes following volume loading. According to Rothe [18] it is virtually impossible to 
measure the vascular capacitance characteristics, and thus passive V/P curves and stressed 
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volume of the total body in reflex-intact animals and humans. This limitation is because one 
cannot change blood volume and measure Pmsf in less than 7-10 seconds, which is the 
maximal delay before reflex venoconstriction normally becomes evident, unless these 
reflexes are blocked. In our patients the use of propofol and sufentanil might have blocked 
these reflexes [19-21] and might be the explanation for the corresponding stressed volume 
results of our study and the study of Magder and De Varennes [29]. 
Conclusions
Mean systemic filling pressure can be determined in intensive care patients with an intact 
circulation with use of inspiratory pause procedures, making estimations of circulatory 
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Fluid therapy is an important tool in hemodynamic management of patients with 
suboptimal tissue perfusion. Excessive fluid resuscitation, however, can result in general and 
pulmonary oedema; increasing hospital stay and even mortality [1]. In ventilated patients with 
regular heart rhythm, stroke volume variation (SVV) and pulse pressure variation (PPV) 
perform well as predictors of a clinically significant increase in cardiac output (CO) after 
fluid administration (i.e. fluid loading responsiveness or FLR) [2,3]. In vasoplegic patients 
both indicators failed [4,5]. Furthermore, SVV and PPV have never been shown to perform as 
a measure of volume status. Therefore the search for a measure of volume status and a 
predictor of fluid loading responsiveness which can be used independent of respiratory 
settings and heart rhythm continues [6]. 
A physiological measure of effective volume status is mean systemic filling pressure 
(MSFP); the equilibrium pressure anywhere in the circulation under circulatory arrest. The 
pressure gradient between static filling pressure and central venous pressure is the driving 
force for venous return and thus for cardiac output. Consequently, increasing MSFP and 
thereby the pressure gradient for venous return by fluid expansion should improve cardiac 
output, assuming a constant resistance to venous return and adequate myocardial function. 
In pharmacology research, upper arm occlusion pressure (Parm) has been used to determine 
(the effects of drugs on) venous capacitance and arterial resistance [7]. We hypothesize that 
Parm might function as an indicator of filling pressure and volume status. MSFP has never 
been studied as a predictor of fluid responsiveness. We determined Parm by measuring 
arterial pressure 30 seconds after stop-flow induced by inflating a cuff around the upper 
arm. The aim of this study was to explore the value of Parm as a predictor of fluid loading 
responsiveness. This approach is attractive, as it would provide the clinician with a simple, 
readily available and robust measure that can be obtained at the bedside. This method would 
be independent of sedation, arrhythmias and mechanical ventilation.
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Methods
Twenty-four patients undergoing elective-cardiac surgery were included after approval of the 
institutional ethics committee (P06.149, chairmen Prof. Dr. F.C. Breedveld, approval date 5 
december 2006) and personal informed consent was obtained. All patients had symptomatic 
coronary artery or valvular disease with preserved ventricular function. Patients with aortic 
aneurysm, extensive peripheral arterial occlusive disease, postoperative severe arrhythmia, 
postoperative valvular insufficiency or the necessity for artificial pacing or use of a cardiac 
assist device were excluded. 
Prior to surgery, each patient received a pulmonary artery catheter (Intellicath; Edwards 
Lifesciences; Irvine, CA, USA) to measure thermodilution COtd and CVP and a 20 G radial 
artery catheter (Prad). Patient’s anaesthesia was continued with propofol (2.5 mg∙kg-1∙h-1) and 
sufentanil (0.06-0.20 μg∙kg-1∙h-1). The lungs were mechanically ventilated (Evita 4, Draeger, 
Lubeck, Germany) in a volume-control mode with standard settings (12 breaths∙min-1, tidal 
volume 8-10 ml∙kg-1∙min-1, FiO2 0.4, PEEP 5 cmH2O). Airway pressure (Paw) was measured at 
the proximal end of the endotracheal tube. During the observation period the patients 
maintained the supine position. Use of sedative and vascular medication remained unchanged. 
No fluids were administered during the observation period outside the study protocol.
An upper arm blood stop-flow was created with a rapid cuff inflator (Hokanson E20, 
Bellevue, Washington) and matching upper arm cuff. Duration of stop-flow was 35 seconds 
with a cuff pressure 50 mmHg above the patients’ systolic blood pressure. Arm occlusion 
pressure (Parm) was calculated as the average arterial pressure during one second at 30 
seconds after arm occlusion.
The arterial pressure Prad was analysed with the modelflow program (CO, FMS, 
Amsterdam, the Netherlands) to provide beat-to-beat values of CO. We calibrated the pulse 
contour cardiac output measurements with three thermodilution COtd measurements 
equally spread over the ventilatory cycle [8]. From these beat-to-beat cardiac output values, 
stroke volume variation (SVV) and pulse pressure variation (PPV) were determined. SVV 
and PPV were calculated for 5 ventilatory cycles and their values averaged.
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Measurements of Parm, CVP, MAP, CO, SVV and PPV were done during baseline in supine 
position and 2-5 minutes after rapid fluid loading with 500 ml hydroxyethyl starch solution 
(Voluven®, Fresenius Kabi, Bad Homburg, Germany). 
Statistical methods
A formal power analysis was not performed since relevant data was not available from 
literature. However, study sample size is similar to other fluid loading responsiveness 
studies. We used a Kolomogorov-Smirnov test and a paired t-test. Fluid responsiveness was 
defined as a >10% increment of modelflow cardiac output after volume expansion. The 10% 
cut-off corresponds with more than twice the reported precision of the Modelflow method 
(i.e. twice the SD for repeated measurements) [14,15]. Hence, responders will experience 
clinically significant changes in CO. Prediction of fluid responsiveness for Parm, CVP, PVR, 
SVV and PPV was tested by calculating the area under the receiver operating characteristic 
(ROC) curve. All values are given as mean ± SD. A p value < 0.05 was considered statistically 
significant.
Results
Twenty-four patients (19 males) of 64 ± 10 years with a BSA of 2.0 ± 0.2 m2 started and 
finished the study protocol. Seventeen received straightforward coronary artery by-pass 
grafting, seven (also) had single or two valve repair. Data was distributed normally. Pooled 
results of hemodynamic variables at baseline and after 500 ml fluid administration are 
shown in Table 1. After 500 ml fluid loading CO, Parm, MAP and CVP increased. HR did 
not change. PPV and SVV decreased. 
Table 1  Changes in hemodynamic parameters from baseline to after 500 ml fluid loading for all patients, 
responders and non-responders. 
All patients (n=24) Responders (n=17) Non-responders (n=7)
Parameters Baseline 500 ml P value Baseline 500 ml P value Baseline 500 ml P value
CO (L∙min-1) 5.2 ± 1.3 6.0 ± 1.4 < 0.001 5.1 ± 1.3 6.2 ± 1.4 < 0.001 5.5 ± 1.3  5.7 ± 1.3 0.148
Parm (mmHg) 18.6 ± 7.7 24.3 ± 8.7 < 0.001 16.2 ± 6.3 22.0 ± 7.6 < 0.001 24.3 ± 8.2  29.9 ± 9.1 < 0.001
MAP (mmHg) 82.3 ± 15.6 90.7 ± 16.1 < 0.001 78.9 ± 9.9 88.9 ± 11.2 < 0.001 90.4 ± 23.6 94.8 ± 25.2 0.056
CVP (mmHg) 9.0 ± 2.6 11.5 ± 2.9 < 0.001 8.6 ± 2.6 10.9 ± 2.5 < 0.001 9.9 ± 2.5  13.0 ± 3.4 0.004
PPV (%) 13.8 ± 9.0 8.0 ± 7.5 < 0.001 14.8 ± 7.8 8.1 ± 6.6 0.001 11.1 ± 11.5  7.7 ± 10.0 0.011
SVV (%) 15.5 ± 10.5 9.3 ± 9.3 0.001 16.5 ± 10.9 8.5 ± 6.5 < 0.001 13.0 ± 9.9  11.2 ± 14.6 0.627
HR (min-1) 83 ± 16 83 ± 14 0.908 83 ± 18 83 ± 16 1.000 81 ± 10  82 ± 11 0.860
CO is cardiac output, Parm is arm occlusion pressure, CVP is central venous pressure, MAP is mean arterial pressure and 
HR is heart rate
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The population was divided into FLR responders (n=17) with an increase of at least 10% in 
COm after 500 ml fluid loading and non-responders (n=7). In the responder group CO, 
MAP, CVP increased and SVV and PPV decreased. Parm increased from 16 to 22 mmHg. In 
the non-responder group, Parm increased from 24 to 30 mmHg. CVP also increased. PPV 
decreased. CO, MAP, SVV and HR did not change significantly.
Receiver operating characteristic curves were used to qualify the prediction of fluid 
responsiveness for each parameter. The area under the curve (AUC) for prediction of fluid 
responsiveness for Parm was 0.786 (95% CI: 0.567 to 1.000). At a cut-off of 21.9 mmHg 
sensitivity is 71% and specificity 88% to predict FLR. The results for CO, Parm, MAP, CVP, 
PPV and SVV are in Table 2.
Table 2  Area under the receiver operating characteristics curve to predict fluid loading responsiveness 
from baseline values.
Area 95% confidence interval
Lower Upper
Cardiac output (L∙min-1) 0.588 0.355 0.821
Arm occlusion pressure (mmHg) 0.786 0.567 1.000
Mean arterial pressure (mmHg) 0.588 0.399 0.853
Central venous pressure (mmHg) 0.353 0.105 0.601
Pulse pressure variation (%) 0.853 0.693 1.000
Stroke volume variation (%) 0.761 0.531 0.990
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Discussion
Our study demonstrates that Parm was significantly lower in the responder group. Parm is a 
good predictor of fluid responsiveness in our studied group. We used Parm for the first time 
to study fluid loading responsiveness.
Both SVV and PPV have been reported to perform better as predictors of fluid 
responsiveness than static pressures (CVP and pulmonary artery occlusion pressure) [3,9-12]. 
However, SVV or PPV are influenced by ventilator settings as tidal volume [9,13], respiratory 
rate [14] and also to cardiac function. In patients with reduced cardiac function SVV is 
expected to be smaller, because stroke volume is obviously limited and consequently 
ventilator induced changes in stroke volume will be reduced [3,10] Reuter and co-workers 
showed that SVV could still perform as a predictor of fluid loading responsiveness in 
patients with reduced cardiac function, although SVV was indeed smaller in patients with 
impaired cardiac function [13]. Furthermore, for the determination of SVV and PPV it is 
essential that patients are fully dependent on mechanical ventilation, and a regular heart rate 
is obligatory. In spontaneous breathing patients [4,5] and in mechanically ventilated patients 
with tidal volumes smaller than 8 ml∙kg-1 SVV and PPV failed to predict FLR accurately [9] In 
our study patients, all after cardiac surgery, were mechanically ventilated with an averaged 
tidal volume of 9.1 ml∙kg-1 (7-12 ml∙kg-1) predicted body weight. Thus, for some of our 
patients SVV and PPV may be less reliable. The Parm technique does not require specific 
tidal volume or respiratory rate. To measure Parm with the arm occlusion method only a 
peripheral arterial catheter is required. These requirements allow measurement in almost all 
operating rooms and intensive care patients. Its application is not limited to sedated and 
ventilated patients with a regular heart rhythm. In our study, Parm was a good predictor of 
fluid loading responsiveness, at least equal to SVV or PPV. However, our study patients were 
a relatively homogenous group.
Definition of fluid loading responsiveness
There is no consensus on the amount of fluid or use of parameter to assess fluid loading 
responsiveness. Fluid amounts between 250-1000 ml are reported [3-5,15,16]. The outcome 
measures used were CO [4,5,16] and SV [15] or SV index [3]. A positive response was defined as a 
change in outcome parameter of more than 10%-25% [3,4,16]. We chose 10% change in pulse 
contour CO as cut-off level after fluid loading with 500 ml. The 10% increase in CO was 
chosen because this increase can be measured accurately with the modified Modelflow pulse 
contour method [17-20]. This value corresponds with the boundaries used in other studies 
where a 10% cut-off was used for 500 ml fluid loading responsiveness [4,21-23]. 
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Considerations
The number of patients (n=24) included in our study is relatively low and the distribution of 
(non)reponders is unequal. Still with this low number of patients we were able to find highly 
significant results. Prediction of fluid loading responsiveness with baseline Parm was with a 
high sensitivity (71%) and specificity (88%). We theorise that these results can be explained 
by the similarity between Parm and mean systemic filling pressure. MSFP is the equilibrium 
pressure anywhere in the circulation under circulatory arrest, whereas Parm might be seen 
as the equilibrium pressure of the arm. We hypothesize that MSFP may be largely equal for 
different vascular compartments of the body because their venous outflow pressures and 
arterial input pressures are relatively similar. MSFP is a physiological measure of effective 
volume status [24,25]. The pressure gradient between MSFP and CVP is the driving force for 
venous return and thus for cardiac output. Increasing MSFP and thereby the pressure 
gradient for venous return by fluid expansion should improve cardiac output, assuming a 
constant resistance to venous return. If there is hypervolemia or a cardiac limitation, i.e. the 
heart operates on the flat part of the Frank-Starling curve, fluid loading will increase CVP 
along with MSFP, and venous return will not increase. It is important to stress that we 
excluded patients with previous myocardial infarction and patients with congestive heart 
failure (NYHA class 4). Therefore we must be careful to extrapolate to patients with heart 
failure. In our patients a low Parm (< 22 mmHg) could indicate fluid loading 
responsiveness. In the case of cardiac failure or tamponade, CVP will rise along with Parm 
during volume administration. This will result in an unchanged pressure gradient for 
venous return and thus will fail to induce an improvement in cardiac output. Therefore, we 
expect our results applicable to patients with uncompromised cardiac function. Rapid 
increments of CVP can than be seen as a warning of right ventricular limitation.
Conclusions
Arm occlusion pressure can be measured at the bedside. Unlike SVV, the measurement of 
Parm is relatively independent of heart rhythm, mechanical or spontaneous breathing or 
sedation. Parm seems to be a good predictor of fluid loading responsiveness, at least in 
cardiac surgery patients without severe heart failure. 
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Section 4  
Challenges and fluid loading responsiveness
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Chapter 10 
Predicting cardiac output responses to passive leg raising by a PEEP-induced 
increase in central venous pressure, in cardiac surgery patients
Bart Geerts, Leon Aarts, Johan Groeneveld and Jos Jansen 
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Changes in central venous pressure (CVP) are probably more useful in guiding fluid 
treatment of mechanically ventilated hypovolaemic patients than absolute pressure values 
which are confounded by concomitant positive end-expiratory pressure (PEEP) [1-3]. 
Furthermore, assessment of a reliable predictor prior to fluid loading would allow the 
physician to prevent harmful overloading. Ventilator-induced stroke volume variations (SVV) 
are commonly used to predict fluid responsiveness, i.e. an increase in cardiac output by fluid 
loading or passive leg raising (PLR). However, SVV is only applicable in mechanically-
ventilated patients without spontaneous breathing efforts and with a regular heart rhythm. 
Furthermore, SVV depends on respiratory rates and tidal volumes [4-8]. Passive leg raising 
can be used as a reversible, endogenous fluid challenge of about 250-300 ml and, if correctly 
performed, the cardiac output response correlates well to that upon exogenous fluid 
administration in predicting fluid responsiveness [4,9-20]. However, repeated PLR is not 
practicable in all patients and all settings. Another manoeuvre to predict fluid 
responsiveness is an end-expiratory hold which produces an increase in pulse pressure and 
cardiac output. The magnitude of the change may be assessed by comparatively non-invasive 
pulse contour methods [19]. However, it is likely that the change depends on inspiratory 
pressure and thus on tidal volume and the resultant impediment in venous return. Taken 
together, current dynamic methods to predict fluid responsiveness have limitations and may 
not prevent harmful fluid overloading in mechanically ventilated, critically ill patients.
We hypothesized that the change in CVP produced by a change in PEEP of short duration can 
be used to predict the response of cardiac output to fluid loading, since an increase in PEEP is 
associated with an increase in CVP and a decrease in cardiac output, dependent on volume 
status [1,21-23]. To test this hypothesis, we measured the changes in CVP due to an increase in 
PEEP of 10 cmH2O and defined fluid responsiveness by the response in cardiac output to 
subsequent PLR. We compared the predictive value of the change in CVP with those of 
absolute CVP and SVV.
Methods
The study was approved by the Medical Ethics Committee of the Leiden University Medical 
Centre and written informed consent was obtained prior to surgery. Twenty consecutive 
patients undergoing elective cardiac surgery were enrolled into the study. During surgery, 
before admission to the ICU, each patient underwent pulmonary artery catheter insertion 
(Intellicath; Edwards Lifesciences; Irvine, CA, USA) to measure thermodilution cardiac output 
(CO) and CVP. A radial artery catheter was used to measure radial arterial pressure in all 
patients. In the ICU, anaesthesia was continued with propofol target control infusion (1.0 
μg∙ml-1) and sufentanil according to institutional standards. The lungs were mechanically 
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ventilated in a volume-control mode with standard settings to achieve normocapnia with a 
tidal volume of 8-10 ml∙kg-1 and a respiratory frequency of 12-14 breaths∙min-1. The FiO2 was 
0.4 and baseline PEEP 5 cmH2O. None of the patients suffered significant blood loss (> 50 
ml∙h-1) during the data collection period.
Protocol and measurements
Blood pressure transducers were referenced to the level of the intersection of the anterior 
axillary line and the 5th intercostal space. CVP, mean arterial pressure (MAP) and heart rate 
(HR) were averaged over 30 second intervals. Bolus thermodilution CO was obtained, within 3 
minutes with an automated system under computer control, by the mean of triplicate 
measurements equally spread over the ventilatory cycle [24]. SVV was determined from 
beat-to-beat CO values measured over 20 second intervals using the LiDCO (LiDCO Ltd, 
Cambridge, UK) radial artery pulse contour system. The system was calibrated by entering the 
mean value of the first series of 3 thermodilution measurements at the start of our protocol. 
All measurements were carried out following stabilization and within two hours of arrival on 
the ICU. During the observation period the patients remined supine and doses of sedative and 
vasoactive agents were unaltered. Measurements of CVP, SVV, CO, MAP and HR were made 
under five experimental conditions: 
1) baseline 1; 
2) PEEP increased with 10 cmH2O (to a level of 15 cmH2O); 
3) baseline 2; 
4) passive leg raising; 
5) baseline 3; 
Each condition was maintained for a five minute period and measurements were performed 
in the final three minutes of each period. Passive leg raising was performed by maintaining 
the patient supine position and raising the legs 30 degrees by using the facility to raise the 
lower end of the bed. The thorax and head (i.e. the heart and baroreceptors) were maintained 
at the same through all of the study periods and the pressure transducers did not have to be 
re-referenced. 
Statistical analysis
Usually, fluid responsiveness is characterized by an increase of 10-15% in CO after rapid fluid 
loading with 500 ml [2]. Recently, Jabot and colleagues showed that PLR from the supine position 
induces lower increase in CO than PLR from the semi-recumbent position [17]. Based on their 
results and those of Lafanachere and colleagues [15] we reasoned that in responders PLR from the 
supine position should result in an increase of CO >7%. Our thermodilution technique with 
automated triplicate measurements equally spread over the respiratory cycle has a precision of 
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3.5% [24]. Therefore, this technique should detect changes in CO induced by PLR larger than 7% 
accurately, thereby allowing identification of responders. All data were normally distributed 
(Kolmogorov-Smirnov test P>0.05). The effects of PEEP and PLR were evaluated by subtracting 
the mean of the baseline value before and after the challenge from the value found during the 
challenge. Comparisons of different experimental conditions were performed using the paired 
t-test. The Pearson correlation coefficient was used to relate baseline variables to increases in CO 
upon PLR. Receiver operating characteristic (ROC) curves and 95% confidence intervals (95%CI) 
for the area under the curve (AUC) were computed. A p-value for the difference between the AUC 
and the reference value of 0.5 (i.e. prediction of responders and non-responders by chance) is 
calculated. From the ROC curves the optimum cut-off value with the greatest combined sensitivity 
and specificity were computed, using baseline SVV, absolute values and changes in CVP [25]. 
AUC’s of the ROC curves (AUROC) of baseline SVV and PEEP induced change in CVP were 
compared. Data are summarized by mean and standard deviation (SD). A P<0.05 was considered 
statistically significant. Statistical calculations were performed by using SPSS for windows (V12; 
SPSS Institute, Chicago, IL, USA and MedCalc V9, Mariakerke, Belgium). 
Results
Twenty patients were included in the study; patient characteristics are tabulated in Table 1. 
Twelve patients underwent coronary artery by-pass surgery (CABG) and, eight received either 
a single valve replacement or a combination of CABG and valvular repair surgery. Table 2 
shows that, compared to baseline, an increase with 10 cmH2O PEEP decreased CO increased 
CVP and SVV, but had little effect on MAP and HR. Passive leg raising increased CO, CVP 
and MAP but decreased SVV. All variables returned to baseline after the PEEP and PLR 
challenges. Whereas baseline CVP and baseline SVV related to the percentage change in CO 
due to PLR (Figure 1), the change in CVP due to PEEP correlated best to the change in CO due 
to PLR (Figure 1). Changes in CO upon PEEP moderately correlated to changes in CO by PLR 
(r=-0.47, P=0.036).
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Table 1 Patient characteristics (n=20).
Age 61 [range 35-80] years
Sex m/f 16 [80%]/ 4 [20%]
Body surface area 2.00 (0.21) m2 
Type of surgery 
  - coronary artery bypas grafting 11 [55%] 
  - valvular repair 9 [45%]
Dobutamine or dopamine 3 [15%]
Norepinephrine 2 [10%]
Tidal volume 752 (127) ml
Mean airway pressure 9 ± 1 cmH2O
Positive end-expiratory pressure, 5 ± 0 cmH2O 
FiO2 0.4
PaO2 13.03 ± 0.13 kPa
PaO2/FIO2 ratio 31.0 ± 1.1
Data collected postoperative immediately before the study was performed. Data, except in the case 
of age, are shown as mean ± standard deviation






Change P Baseline PLR PLR Change P
CVP (mmHg) 9.2 ± 3.6 11.5 ± 3.2 2.4 ± 1.8 <0.001 9.2 ± 3.6 11.6 ± 3.6 2.3 ± 1.3 <0.001
SVV (%) 6.2 ± 3.8 10.6 ± 6.5 4.7 ± 3.7 <0.001 5.8 ± 3.5 3.9 ± 2.7 -1.9 ± 1.8 <0.001
CO (L∙min-1) 5.2 ± 1.3 4.6 ± 1.2 -0.6 ± 0.5 <0.001 5.5 ± 1.5 5.9 ± 1.7 0.4 ± 0.3 <0.001
MAP (mmHg) 83 ± 13 80 ± 14 -3 ± 10 0.054 84 ± 16 92 ± 14 8 ± 10 0.003
HR (min-1) 79 ± 13 78 ± 12 -1 ± 1 0.400 79 ± 12 77 ± 12 -2 ± 3 0.259
PLR is passive leg raising; CVP is central venous pressure; SVV is stroke volume variation; CO is cardiac output by 
thermodilution; MAP is mean arterial blood pressure; HR is heart rate. Baseline PEEP is the group average of the values 
before and after the PEEP-challenge; baseline PLR the group averaged value before and after PLR. The results are shown 
as mean (SD).
There were 10 PLR responders and 10 non-responders. Cardiac output values before and after 
the PEEP challenge were 5.1 ± 1.2 and 5.3 ± 1.5 L∙min-1, in responders and non-responders (ns), 
respectively. Cardiac output values around PLR were 5.5 ± 1.6 and 5.5 ± 1.5 L∙min-1 in responders 
and non-responders (ns), respectively. Baseline CVP values before and after the PEEP challenge 
were 7.1 ± 2.8 and 11.3 ± 3.1 mmHg in responders and non-responders, respectively (P=0.003). 
Baseline SVV values around the PEEP challenge were 8.7 ± 3.2 and 3.5 ± 2.1% in PLR 
responders and non-responders, respectively (P=0.001), but the PEEP-induced change in SVV 
did not differ. The PEEP-induced increase in CVP was less in non-responders to PLR than in 
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responders: 1.1 ± 0.4 and 3.6 ± 1.8 mmHg or 9 ± 7 and 62 ± 42% (P=0.001). Baseline values of 
CVP for responders and non-responders were 11.3 ± 3.1 and 7.1 ± 2.8 mmHg (P=0.006), 
respectively. Also, the decrease in CO upon the application of PEEP was less in PLR non-
responders than responders (6 ± 7% versus 16 ± 10%, P=0.014). 
Figure 1  In the first graph (i), the relationship between baseline central venous pressure (Baseline CVP) 
and change in thermodilution cardiac output (CO) by passive leg raising (dCO, PLR) is shown 
(r=-0.63, P=0.003); in the second graph (ii), the relationship between baseline stroke volume 
variation (Baseline SVV) and dCO, PLR (r=0.67, P=0.002). In the third graph (iii), relationship 
between the positive end-expiratory pressure (PEEP)-induced change in CVP (dCVP, PEEP) and 
dCO, PLR is depicted (r=0.77, P<0.001). Baseline values of CVP and SVV were the averaged 
results of baseline measurements before and after the PEEP-challenge. dCVP is the change in 
CVP due to PEEP compared to the averaged baseline value. The horizontal dashed line in the 
graphs indicate the cut-off between responders and non-responders. Closed symbols refer to 
responders. 
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The results of ROC curves analyses are shown in Figure 2. For baseline CVP, the AUC was 
0.85 (95%CI 0.68 and 1.00, P=0.008) and the optimum cut-off value of 9.8 mmHg had a 
sensitivity of 80% and a specificity of 80% to predict PLR responsiveness. The AUC for 
baseline SVV was 0.90 (95%CI 0.76 and 1.00, P=0.003), and a baseline SVV cut-off of 7.3% 
had a sensitivity of 70% and a specificity of 100% to predict PLR responsiveness. For the 
predictive value of the CVP response (change) to PEEP, the AUC was 0.99 (95%CI 0.94 and 
1.00, P<0.001) and a cut-off value of an increase of 1.5 mmHg had a sensitivity of 100% and a 
specificity of 90% for PLR responsiveness. The AUC of baseline SVV was not significantly 
different from the AUC for CVP response to PEEP (P=0.299), indicating that baseline SVV 
and the CVP response to PEEP can be used equally to predict responders and non-responders 
to fluid loading.
Figure 2  Receiver operating characteristics (ROC) curve of baseline CVP (dotted line), baseline stroke 
volume variation (dashed line) and change in central venous pressure (straight line) upon a 
PEEP challenge to predict responsiveness to passive leg raising. The area under the curve is 0.85 
(with a 95% CI of 0.68 and 1.00) for baseline CVP, 0.99 (with a 95% CI 0.94 and 1.00) for 
changes in CVP and 0.90 (with a 95% CI 0.76 and 1.00) for baseline SVV.  
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Discussion
Our study shows that with higher baseline SVV values, lower baseline CVP values and greater 
rises in CVP upon a PEEP challenge the response of CO on an endogenous fluid loading by 
PLR can be predicted. Of these predictors, the rise in CVP with PEEP seems most robust to 
predict fluid responsiveness with least risk for confounding by ventilatory conditions.
Figure 3  A simplified model of the interaction of the heart function curve and venous return curve. On the 
left (A) the effects of positive end-expiratory pressure (PEEP) and on the right (B) the effects of fluid 
loading by passive leg raising (PRL) on central venous pressure (CVP) and cardiac output (CO) are 
indicated. From hypovolaemia (hypo) to normovolaemia (normo) the venous return curve (straight 
line) moves up and the intersection with the cardiac function curve (curved line) rises to a higher 
CO and CVP level. Left panel, addition of PEEP shifts the heart function curve to the right (dashed 
line) altering the intersection with the venous return curve to a lower CO and a higher CVP. With 
the application of PEEP the change in CVP (dCVP) and the change in CO (dCO) are larger during 
hypovolaemia (dCVP1 and dCO1) than during normovolaemia (dCVP2 and dCO2). Which suggest 
that the value of dCVP is an is an indicator for fluid loading responsiveness. Right panel, addition 
of PLR, dashed lines) results in an increase in CVP and CO. With fluid loading by PLR during 
normovolaemia a greater dCVP (dCVP2) and a smaller dCO (dCO2) is observable than during 
hypovolaemia (dCVP1 and dCO1). dCO with PLR have been shown to be an indicator of fluid 
loading responsiveness. For further explanation see text.
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We based our study on the simplified Guytonian model of the circulation (Figure 3). We 
consider the effects of PEEP and of PLR in the hypo- and normovolaemic state. Many authors 
demonstrated that the venous return curve, i.e. the relationship between CO and CVP, moves 
up in parallel with increased blood volumes (Figure 3, lines hypo- and normovolaemia) [26-29]. 
We have previously constructed venous return curves using prolonged inspiratory hold 
manoeuvres in cardiac surgical patients and showed that the slopes were equal in hypo-, 
normo-, and hypervolaemic conditions [29]. Magder has shown that application of PEEP shifts 
the cardiac function curve to the right, altering the intersection with the venous return curve to 
a lower CO and a higher CVP (see Figure 3A, change from point A to point B) [1]. In patients 
with hypovolaemia, the increase in CVP and decrease in CO (dCVP1 and dCO1) is larger than 
in patients with normovolaemia (dCVP2 and dCO2), in line with experimental data [21]. Thus, 
the PEEP-induced change in CVP as well as the change in CO describes in which part of its 
function curve the heart operates. Fluid loading by PLR will move up the venous return curve 
(Figure 3B, dashed lines). In patients with hypovolaemia and in those with normovolaemia the 
intersection with the cardiac function curve will move towards its plateau [30]. Fluid loading in 
these two volaemic conditions results in an increasing change in CVP (see Figure 3B, from 
dCVP1 to dCVP2) and a decreasing effect on CO (see Figure 3B, from dCO1 to dCO2). Thus, 
with PEEP, dCVP and dCO should change inversely but proportionally, depending on the 
volume status whereas with fluid loading reverse effects of dCVP and dCO are predicted. We 
used PLR as a surrogate for fluid infusion since it well correlates with responsiveness to 
exogenous fluids [4,9-20]. Moreover, the use of PLR obviates unnecessary and potentially 
harmful fluid loading in non-responders. 
We found, as predicted by the model, that the increase in CVP by PEEP directly relates to the 
increase in CO by PLR and thus may be of value to predict fluid responsiveness (Figure 1); 
second, that PEEP increases CVP and decreases CO, but that the increase in CVP as well as 
the decrease in CO is less in non-responders than in responders (normo- versus 
hypovolaemia). Our results imply that the predominant mechanism of the decrease in CO 
with PEEP is diminished venous return and a decrease in right ventricular preload, that in 
turn may limit the rise in CVP [1,21,22] We cannot judge from our data the effect of abnormal 
lungs and altered airway pressure transmission on the circulatory response to PEEP [22,23] 
Another limitation of the model is that it does not take circulatory control mechanisms into 
account. Therefore, we measured the effects of PEEP between 2 and 5 minutes after its 
application. Changes in myocardial contractility may change the position and shape of the 
heart function curve. Therefore, a deterioration of cardiac function may lead to a decrease in 
SVV and a decrease of in the change in CVP produced by PEEP as well as a less fluid-
responsive patient. This was not examined in this study The fact that baseline CVP was also 
associated with changes in cardiac output can be explained by the relatively low PEEP we used 
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in our patients, but changes in filling pressures to guide fluid treatment are less confounded 
by PEEP than absolute levels [3,22]. The observation that the CO response to PEEP was of less 
predictive value than the CVP response for the CO increase upon PLR can be explained by a 
lesser decrease in CO for a given PEEP-induced rise in CVP in hypo- than in normovolaemic 
conditions, as shown in animal experiments [21]. We should also keep in mind that the PEEP 
challenge moves the work-point of the cardiac function and venous return curves downwards 
to the steep part of the curve (larger change in CO), whereas PLR moves the work point 
upwards into the flat part of curve (smaller change in CO, Figure 3). This may help explain 
why the PLR response of CO was of less predictive value for the PEEP-induced fall in CO than 
vice versa (data not shown). The decrease in CO with PEEP may lead to an unacceptably too 
low CO for several minutes. Thus, when there areclear signs of hypovolaemia the use of the 
PEEP-challenge may not be appropriate. 
Our proposed challenge resembles the end-expiratory occlusion test [19] to predict fluid 
responsiveness but carries the relative advantage, of being independent of ventilatory 
conditions provided that PEEP can be increased by 10 cmH2O. Since the PEEP challenge is 
easy to apply and CVP is measured routinely in the ICU, the PEEP-induced change in CVP 
may provide the physician with a robust and easy-to-use tool to assess fluid responsiveness. 
The drawback of the PEEP challenge is its dependence on maintenance of a steady state 
during the challenge and potential worsening of hypotension. A SVV of about 10% or above, 
derived from non-invasive arterial pulse contour algorithms, has been used to predict an 
increase of 10% to 15% in CO in response to 500 ml fluid loading [4-8]. Our patients were 
subjected to a smaller preload challenge and the optimal cut-off to define responsiveness was 
somewhat lower. The SVV requires a regular heart rate and full mechanical ventilatory 
support, with predictive values dependent on respiratory rates and tidal volumes [7,8] Again, 
we may speculate that our PEEP challenge is less dependent on these prerequisites. Even 
though SVV had a similar predictive to the PEEP challenge, the latter may thus be 
preferable, particularly in case of arrhythmias. One might also argue that performing a PLR 
and looking at the CO response would render our PEEP challenge redundant. However, PLR 
is not always feasible and necessitates some CO measurement, while our PEEP challenge 
does not. (In contrast the PLR challenge does not require mechanical ventilation [14,18]. 
Finally, the relatively small changes in CVP evoked by PEEP can only be discerned at the 
bedside when accurately measured.
Conclusions
Our data suggest that brief PEEP-induced increases in CVP predict fluid responsiveness at 
least as well as absolute values of CVP and SVV, after cardiac surgery, and are less likely to be 
confounded by ventilatory conditions.
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Vincent and Weil’s fluid challenge: revisited and revised
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Fluid overload and hypovolaemia can still not be accurately identified Hamilton recently 
concluded in an editorial [1]. Traditional filling pressures like central venous pressure (CVP) 
often fail as a predictor [2-4]. This complicates hemodynamic management since unnecessary 
fluid loading can lead to pulmonary and general oedema [5]. Therefore, new methods are 
being developed to prevent fluid over-loading by an accurate prediction of the response to 
fluid loading. 
In 2006, Vincent and Weil (V&W) revisited the “fluid challenge”. This protocol (see Figure 
1) is largely based on their clinical experience and assessment of relevant publications [6]. It 
provides objectives for fluid management. In their approach, 500 ml of fluid is administered 
over 30 minutes and every 10 minutes the effect is evaluated. When a mean arterial pressure 
(MAP) of 75 mmHg is reached fluid administration is stopped. When a CVP of 15 mmHg is 
reached before this target is reached fluid administration is discontinued and the use of 
catecholamines may be considered. 
Since flow-guided fluid therapy improves outcome in the ICU [1], we investigated the impact 
of adding pulse contour cardiac output to V&W’s protocol to introduce a more sophisticated 
protocol to reduce the amount of unnecessary administered fluids (see Figure 1). We also 
compared the effects on unnecessary fluid loading and change in cardiac output (CO) of the 
original, and the altered, protocol of V&W with a straightforward fluid loading 
responsiveness protocol.  In this third protocol (see Figure 1), we assessed the ability of 
changes in pulse contour cardiac output after 50 ml and 100 ml fluid loading to predict fluid 
loading responsiveness.




Twenty-one patients undergoing elective coronary artery bypass grafting (CABG) or single 
valve repair were included into the study after approval of the institutional ethics committee 
and personal informed consent was obtained. All patients had symptomatic coronary artery 
disease without previous myocardial infarction and were on beta-adrenergic blocking 
medication. Patients with congestive heart failure (NYHA class 4), aortic aneurysm, 
extensive peripheral arterial occlusive disease, or postoperative valvular insufficiency, were 
not considered for this study. Patients with the necessity for artificial pacing or use of a 
cardiac assist device were also excluded.
Before ICU admission, each patient had received a pulmonary artery catheter (Intellicath, 
Edwards Lifesciences; Irvine CA, USA) inserted into the pulmonary artery via the right 
jugular vein to measure CVP and thermodilution cardiac output (CO). In addition, all 
patients had received a 20 G radial artery catheter to measure arterial pressure (Prad). In the 
ICU, patient’s anesthesia was continued with propofol-target-control infusion and sufentanil 
according to institutional standard. The lungs were mechanically ventilated in a volume-
control mode with standard settings to achieve normocapnia (arterial PCO2 between 40 and 
45 mmHg) with tidal volumes of 8-10 ml∙kg-1 and a respiratory frequency of 12-14 
breaths∙min-1. Fraction of inspired oxygen was 0.4 and a positive end expiratory pressure 
(PEEP) of 5 cmH2O was applied. During the study interval ventilator settings, sedation and 
vasoactive medication continued unchanged. No significant bleeding (<50 ml∙h-1) occurred 
during the study period.
Hemodynamic measurements 
Both Prad and CVP pressure transducers were referenced to the level of the tricuspid valve and 
zeroed to atmospheric pressure. Prad and CVP data were continuously recorded with a 
resolution of 0.125 mmHg at a sample frequency of 200 Hertz and stored a personal computer 
for analysis and documentation. From Prad we calculated heart rate (HR), MAP, CO, pulse 
pressure variation (PPV), and stroke volume variation (SVV) over 30 second intervals using two 
different pulse contour methods; modified Modelflow (COm, FMS, Amsterdam, the 
Netherlands) and PulseCO (COli, LiDCO, LiDCO Ltd., London, UK). Both methods are 
extensively described elsewhere [7]. We calibrated both pulse contour devices with the same 
averaged value of three thermodilution measurements performed equally spread over the 
ventilatory cycle [8,9]. Over the same 30 seconds interval HR, CVP and MAP were calculated. 
Study protocol
All measurements were carried out within two hours after arrival in the ICU. During the 
observation period patients maintained a supine position. At baseline, measurements of 
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MAP, HR, CVP, COm, COli, PPV, and SVV were performed. Following baseline 
measurements, a first out of ten 50 ml fluid loading boluses with a hydroxyethyl starch 
solution (Voluven®, Fresenius Kabi, Bad Homburg, Germany) was performed manually in 
30 seconds and measurements were repeated one minute after fluid administration. 
Subsequently, two minutes after the start of the first fluid load, a second 50 ml fluid loading 
was performed. In 20 minutes a total of 500 ml of colloid was administered in 10 steps. 
After each 50 ml step measurements were repeated.
Statistical analysis
Statistical analyses were performed by a Kolmogorov-Smirnov test, paired t-test and linear 
regression analysis. A formal prospective power analysis was not performed since relevant 
data was not available from literature. However, study sample size is similar to other fluid 
loading responsiveness studies.
A 10% change in Modelflow cardiac output after 500 ml fluid loading was used to divide 
responders and non-responders [10-13]. The 10% cut-off corresponds with more than twice the 
reported precision of the Modelflow method (i.e. twice the SD for repeated measurements) 
[14,15]. Hence, responders will experience clinically significant changes in CO. The reliability 
to predict responders (preload dependence) was analyzed by computing the area under the 
receiver operating characteristics (ROC) curve. Subsequently we used the optimal cut-off 
value for pulse contour CO after 100 ml fluid administration (to predict FLR after 500 ml of 
colloids) as a new step in our revised protocol. Both protocols were applied to all patients to 
analyse the total amount of fluid that would have been administered before goals were met 
(see Figure 1). All values are given as mean ± SD. A p value < 0.05 was considered 
statistically significant.
Results
Twenty-one patients (16 males) of 64 ± 11 years with a BSA of 1.99 ± 0.20 m2 started and 
finished the study protocol. Fourteen received straightforward CABG, seven had single or 
two valve repair. 
Kolmogorov-Smirnov analysis indicated normal distribution of all data. Pooled results of 
hemodynamic variables at baseline and after 50, 100 and 500 ml fluid administration are 
shown in Table 1. After 500 ml fluid loading COm, COli, MAP and CVP are increased. HR 
did not change. SVV and PPV of 8 patients could not be used because of heart beat 
irregularities and these variables were therefore not included for further analysis. An 
example of such irregularity is given in Figure 2. 
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Figure 2  An example of an irregular heart rhythm (patient 3) which causes variation in stroke volume 
variation (SVV) and PPV measurements over 5 sequential respiratory cycles. Prad is radial artery 
pressure and SV is stroke volume. The dots in the lower part of the graph show the variation in SV. 
 
 
Table 1 Pooled data of hemodynamic variables before and after fluid loading.
Variable Baseline 50 ml p 100 ml p 500 ml p
MAP (mmHg) 81.8 ± 17.5 82.4 ± 18.0 0.207 83.9 ± 19.0 0.006 91.4 ± 17.4 <0.001
CVP (mmHg) 8.5 ± 2.7 8.7 ± 2.7 0.291 8.7 ± 2.8 0.446 11.5 ± 3.0 <0.001
HR (min-1) 82.9 ± 16.2 82.7 ± 15.6 0.420 82.9 ± 15.6 0.995 83.5 ± 14.6 0.490
COm (L∙min-1) 5.2 ± 1.3 5.3 ± 1.2 0.014 5.4 ± 1.3 0.034 6.0 ± 1.4 <0.001
COli (L∙min-1) 4.9 ± 1.3 5.1 ± 1.3 <0.001 5.2 ± 1.3 < 0.001 5.7 ± 1.3 <0.001
MAP, mean arterial pressure; CVP, central venous pressure; HR, heart rate; COm, Modelflow cardiac output; 
COli, LiDCO cardiac output; p, p-value compared to baseline
The population was divided into responders (n=15) with an increase of at least 10% in COm 
after 500 ml fluid loading and non-responders (n=6). The average increase in COm after 
500 ml was 18% in the responder group and <2% in the non-responder group. When 
V&W’s original protocol would have been used approximately 200 ml fluid would have been 
administered in the responder group (14 of 15 responders reached a MAP of 75 mmHg and 
1 of 15 a CVP of 15 mmHg). The average change in CO at this point was 7% compared to 
baseline. Around 100 ml fluid would have been administered in the non-responder group 
with an average change in CO of <1%. 
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Table 2  Area under ROC curves.
 
 Area 95% confidence interval
Lower Upper
CVP, baseline 0.183 0.000 0.369
COm, baseline 0.478 0.234 0.721
∆COm, 50 ml 0.711 0.462 0.960
∆COm, 100 ml 0.856 0.647 1.000
COli, baseline 0.494 0.251 0.738
∆COli, 50 ml 0.456 0.193 0.718
∆COli, 100 ml 0.717 0.494 0.939
MAP, baseline 0.344 0.074 0.615
∆MAP, 50 ml 0.278 0.025 0.530
∆MAP, 100 ml 0.400 0.139 0.661
HR, baseline 0.467 0.214 0.720
dCVP is change in central venous pressure; dCOm and dCOli are change in cardiac 
output by Modelflow and LiDCO; dMAP is change in mean arterial pressure; HR is 
heart rate.
The area under the Receiver Operating Characteristics (ROC) curves for changes in CVP, 
MAP, HR, COm, COli after 50 and 100 ml are given in Table 2 and Figure 3. In general, the 
results of a fluid loading of 100 ml have a better chance to predict responders than results 
after a fluid loading with 50 ml. Best results are observed for changes in COm after 100 ml 
fluid loading (area under the ROC 0.86, 95% confidence interval between 0.65 and 1.00). A 
change in Modelflow CO of at least 4.3% has a sensitivity of 67% and a specificity of 100% 
after 100 ml of fluid loading. Sensitivity is 60% and specificity 83% for a similar cut-off in 
CO measured with the LiDCO device after 100 ml fluid loading. In our patient population, 
baseline CVP, MAP and COli did not predict responsiveness with more accuracy than 
mathematical chance.
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Figure 3  Receiver Operating Curves (ROC) of changes in pulse contour cardiac output (COm 100 ml, 
dashed black line, COm 50 ml, thin gray line and COli 100 ml, dotted black line) in 15 cardiac 
surgery patients to predict a 10% increase in pulse contour cardiac output after 500 ml fluid 
loading. Both COm and COli have identical responders after 500 ml fluid administration.  
 
When V&W’s original protocol would have been used CO would have increased 7%. 
Addition of COm to the protocol would have lead to a mean administration of 100 instead of 
200 ml fluid administration to non-responders and an increase of 18% in CO in responders 
(instead of 7%). Moreover, the use of pulse contour CO in the protocol would have prevented 
extra fluid loading in two (of 21) patients when a MAP of 75 mmHg was not yet reached. 
Discussion
The objective of this study was to further refine Vincent and Weil’s fluid-challenge protocol 
[5,6] by adding pulse contour CO and using smaller fluid-challenge steps. The use of changes 
in pulse contour CO (COm and COli) after 50 and 100 ml of fluid administration were 
assessed to predict the effects on CO after a fluid loading of 500 ml. 
We found that changes in COm accurately predict fluid loading responsiveness even after a 
test administration of 50 ml. Accuracy is further improved after 100 ml of fluid loading. 
These findings concur with a previous report by de Wilde et al. [16] who showed in a 
comparative study of three pulse contour methods that COm had optimal correlation and 
highest Bland-Altman agreement with COtd. We also found that the addition of pulse 
contour CO to the strategy formulated by V&W would have led to less fluid being 
administered unnecessarily in non-responders. A fluid loading responsiveness protocol 
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which uses with changes in pulse contour CO after a fluid challenge would have reduced 
unnecessary fluid loading and increased cardiac output further.
In general, reduced filling pressures, like CVP, are more likely to characterize hypovolaemia 
whereas high filling pressures are more likely in hypervolaemia or heart failure. Therefore 
absolute filling pressures are not reliable in predicting the effects of volume loading [17]. 
Volume deficit with low SV are commonly compensated for by an increase in HR to maintain 
CO (on a normal level). This compensatory mechanism may be absent in patients with 
intrinsic heart disease, and during treatments with anti-arrhythmic drugs or during deep 
sedation. Stress, fever, pain, anaemia or vaso-active drugs produce endogenous adrenergic 
stimulation with compensating increases in HR and vasoconstriction, limiting the value of 
HR and blood pressures for assessing the severity of hypovolaemia [18]. A protocol-based 
strategy is thus possible in sedated ICU patients, applicability in spontaneous breathing 
patients needs further evaluation. We, therefore, would like to advocate the use of CO to 
monitor hemodynamic improvements and use of CVP for safety limits.
Responders and non-responders
The 10% increase in CO was chosen because this increase can be measured accurately with 
the modified Modelflow pulse contour method [9,19]. This value corresponds with the 
boundaries used in other studies where a 10% cut-off was used for 500 ml fluid 
responsiveness [10-13].
Changes in COm due to the fluid challenge in responders and non-responders are different. 
COm increased 0.2 ± 0.1 L.min-1 (p<0.001) after 50 ml, 0.3 ± 0.2 L.min-1 (p<0.001) at 100 ml 
and 1.0 ± 0.3 L.min-1 (p<0.001) after 500 ml fluid administration in the responder group. In 
contrast, COm did not change significantly in the non-responder group (-0.1 ± 0.1 L.min-1 
with p=0.110, 0.0 ± 0.2 L.min-1 with p=0.704 and -0.3 ± 0.2 L.min-1 with p=0.054, 
respectively). Also, pooled results for COli did show significant changes after 50, 100 and 
500 ml fluid administration in responders. 
Depending on the patient’s condition the fluid challenge will achieve a significant increase 
in cardiac output. Fluid loading will shift the working point on the heart function curve to 
the right into the more flat part of the curve. We used changes in cardiac output due to a 
fluid challenge with 50 to 100 ml to predict the response to 500 ml fluid loading. This is 
shown graphically in Figure 4. 
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Figure 4  The cardiac function curve: a fluid challenge of 50 ml in a non-responder and a responder to 
predict a 500 ml fluid administration. On the vertical axis cardiac output (CO) is shown and on 
the horizontal axis preload by transmural central venous pressure (CVP,tm). In the left panel, the 
administration of 50 ml shifts the heart function curve of this non-responder to the right 
resulting in a small increase in CO and a relatively larger increase in CVP,tm. The increase in 
CO after adding 500 ml fluid is still small. For responder, right panel, the increase in CO is 
significant after 50 ml fluid loading and continues to increase after 500 ml.  
 
Limitations of the technique
The use of small volumes to test fluid loading responsiveness could be valuable to decrease 
the chance of overloading the circulation to occur and at the same time correction of a 
suboptimal blood flow is initiated [5,6]. The findings of this study can provide a first step in 
the development of an adapted fluid-loading protocol. A larger randomized study is needed 
to test the effects of this protocol on morbidity and mortality.
The use of traditional parameters [2,4,20-23], dynamic parameters like SVV and PPV, have been 
studied extensively for their predictive value of fluid loading responsiveness. Other 
challenges, like the respiratory systolic variation test or passive leg raising, require either 
special techniques or depend on the method of execution for their quality (re-referencing of 
pressure transducers and bed-tilting for instance). The use of a test fluid administration is 
straightforward and can be used in everyday critical care.
Limitations of the study
Several limitations apply to this study. First, this is a proof of concept study. We studied 21 
cardio-surgical patients. Although relations between the hemodynamic parameters and ROC 
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curves showed significance, a larger number of patients is needed to allow extrapolation of 
these results to a general ICU population. 
Second, patients were sedated and lungs were mechanically ventilated. We agree with 
Vincent and Weil [6] that the fluid challenge is likely to be applicable to awake and 
spontaneous breathing patients. However, the predictive value of administering a test fluid 
and measurements of its response on pressures and CO has to be shown in spontaneous 
breathing patients.  
Third, baseline SVV and PPV was not possible in 8 of our patients due to heart rhythm 
irregularities (see Figure 2). Hence, we were not able to study the value of SVV and PPV to 
predict FLR in this study or its possible value for the V&W’s protocol. Several studies have 
reported on the effects of arrhythmias on SVV measurements [24]. Since changes in COli did 
not and COm did allow accurate prediction of FLR, we hypothesize that the heart rhythm 
irregularities also influenced the accuracy and precision of COli measurements. 
Nonetheless, COm measurements averaged over 30 second intervals remained reliable 
throughout this study. Because minor cardiac arrhythmias occur frequently (8 of 21 in this 
study alone) in the ICU and in cardiac surgery patients, this enhances the applicability and 
robustness of the pulse contour method strategy. 
Conclusions
Vincent and Weil’s original fluid-challenge protocol reduces fluid loading in non-responders 
and leads to an increase in CO in responders. The addition of pulse contour cardiac output 
to the protocol can further reduce unnecessary fluid loading and enhances the improvement 
of CO in responders. When COm is increased by 4.3% after a 100 ml trial administration, a 
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Chapter 12 
Pulse contour cardiac output and passive leg raising to assess fluid loading 
responsiveness in cardiac-surgery patients
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The selection of patients that will benefit from fluid loading is important since unnecessary 
fluid loading in a non-responsive subject may potentially cause pulmonary and general 
oedema. Passive leg raising (PLR) is a routinely-applied bedside method that accurately 
predicts volume responsiveness [1-6]. However, its clinical application requires dynamic 
assessment of cardiac output (CO). Transient increases in transthoracic and oesophageal 
Doppler CO and left ventricular stroke area by ultrasound during PLR predict preload 
responsiveness. However, ultrasound measurements are neither routinely performed, 
consistent among operators nor easy to perform continuously [7]. Furthermore, the 
HemoSonic ultrasound device most frequently used in PLR research [1-6] is currently 
withdrawn from the market. Recently, DeBacker and Pinsky hypothesized that other CO 
measurement techniques such as pulse power or pulse contour analysis could provide 
similar results and supplant Doppler ultrasound monitoring [8]. This approach is attractive, 
as it would provide the clinician with a simple, readily available and robust measure that can 
be obtained at the bedside. 
The aim of our study is to evaluate the applicability of two different radial artery pulse 
contour CO devices, one using pulse power (COli, LiDCO, London, UK) and the other using 
Modelflow arterial pulse contour analysis (COm, FMS, Amsterdam, the Netherlands) in 
prediction fluid loading responsiveness by tracking CO changes due to a PLR manoeuvre. 
The changes in cardiac output by these two methods are compared to changes in CO by 
thermodilution (COtd). 
Methods
Twenty patients undergoing elective coronary artery bypass (CABG) and, or valvular 
reconstruction surgery were included into the study after approval of the University Medical 
Ethics Committee of the University of Leiden. All patients signed informed consent to be 
part of this study. Subjects were included in the study during their initial post-operative 
period once hemodynamically stable with a mean arterial pressure (MAP) > 70 mmHg, 
central venous pressure (CVP) between 5-10 mmHg and a cardiac index > 2.5 L∙min-1. 
Exclusion criteria included severe arrhythmias, advanced congestive heart failure (ejection 
fraction <20%), intra-cardiac shunts, symptomatic peripheral vascular disease, symptomatic 
pulmonary disease, aortic aneurysm and significant valvular regurgitation after surgery.
Anaesthesia during surgery was with propofol and sufentanil infusions according to 
institutional standards. Upon arrival in the ICU sedation was continued. The lungs were 
mechanically ventilated in a volume-control mode with settings aimed to achieve 
normocapnia with a tidal volume of 8-12 ml∙kg-1 and a respiratory frequency of 12-14 
breaths∙min-1. Fraction of inspired oxygen was 0.4 and PEEP 5 cmH2O. During the 
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observation period, ventilator settings, sedation and vasoactive medication, when used, were 
continued unchanged.
All subjects had a pulmonary artery catheter (Intellicath; Edwards Lifesciences; Irvine, CA, 
USA) inserted into the right jugular vein and a radial arterial catheter (20 G) inserted prior 
to ICU admission. COtd measurement was performed with an automated system under 
computer control. COtd was measured in triplicate (with 10 ml saline solution at room 
temperature) in two minutes, with the measurements equally spread over the ventilatory 
cycle. The three individual COtd measurements were averaged [9]. Blood pressure 
transducers were referenced to the level of the tricuspid valve and zeroed to atmospheric 
pressure. Arterial pressure, heart rate (HR) and CVP data were continuously recorded with a 
sample frequency of 100 Hertz and stored on a personal computer for documentation and 
offline analysis. MAP, systolic arterial pressure (SP), pulse pressure (PP) and pulse pressure 
variation (PPV) were calculated from arterial pressure. Stroke volume variation (SVV) and 
CO was averaged over 30 second intervals using pulse power (SVVli and COli) and 
Modelflow (COm). The LiDCO system was calibrated. The Modelflow was used uncalibrated. 
A detailed description of the two methods can be found elsewhere [10-12].
Measurements were carried out within two hours after arrival in the ICU following MAP 
stabilization (85.0 ± 12.0 mmHg) and restoration of central body temperature (36.6 ± 0.7 
°C). Characteristics and treatment data of each patient were collected. Passive leg raising was 
performed from the supine position by lifting both legs at a 30° angle and holding them 
there for 5 minutes. Measurements of HR, MAP, PP, SP, CVP, COtd, COm, COli, PPV and 
SVV were performed 5 minutes before, 2 minutes after initial elevation of the legs with legs 
still elevated, and 5 minutes after return from passive leg raising. 
We used a Kolmogorov-Smirnov test, paired t-test and linear regression analysis. The 
reliability to track changes in CO was analyzed by computing the area under the receiver 
operating characteristics (ROC) curve, with responders related to 7% COtd increase during 
PLR [13]. Usually, responders are characterized by an increase of 10-15% in CO after rapid 
fluid loading with 500 ml [14]. Lafanechere et al. [3] showed that the effect of PLR on CO of 
patients in supine position was equal to 250 ml fluid loading. We reasoned that in the same 
group of responders a PLR-induced auto-transfusion of 250 ml should result in an increase 
of CO of 5 to 7.5%. Our thermodilution technique with automated triplicate measurements 
equally spread over the respiratory cycle has shown a precision of 3.5% [9,11]. Therefore, this 
technique should detect changes in CO induced by PLR larger then 7% (2SD precision) 
accurately and identifying responders by a >7% increase in CO by PLR reliable. All values 




Twenty patients met the inclusion criteria and were enrolled in the study. All finished the 
study. Clinical patient data is shown in Table 1. An example of the effects of PLR on 
haemodynamics in one patient is given in Figure 1. Beat-to-beat systolic, mean and diastolic 
blood pressures increase and modulation of the variables by mechanical ventilation decrease 
during PLR, associated with no change in HR, an increase in SV and decrease in SVV.
Table 1 Demographic data of the patients.










1 m AVR 52 80 160 250 0.25 nitroprusside
2 m AVR 79 82 178 140
3 m AVR 61 73 186 150
4,0 dobutamin, 0,02 
norepinephrine
4 m CABG 72 97 178 200
5 f AVR 35 86 169 350
6 m CABG 65 69 170 220
7 m CABG 78 103 182 200
8 m CABG 56 118 178 250
9 m AVR 58 88 178 150
10 f CABG 69 73 158 200 3 dopamine
11 m CABG 53 95 178 300
12 m CABG 67 83 175 200 2 dobutamine
13 m CABG 75 88 178 250
14 m CABG, MVP, TVP 54 100 187 200 0.75 nitroprusside
15 f CABG, AVR 59 59 158 150
16 m CABG 80 74 172 200 0.3 norepinephrine
17 m CABG 66 72 183 200
18 m CABG 63 66 160 220
19 m AVR 62 106 176 250 0.25 nitroprusside
20 m CABG, MVP, TVP 73 71 175 200 0.5 enoximone
Mean ± 
SD 64 ± 11 84 ± 15 174 ± 9 214 ± 52
Abbreviations: CABG is coronary artery by-pass grafting; AVR is aortic valve replacement, TVP is tricuspid valve 
replacement; MVP; mitral valve replacement.
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Figure 1  Beat-to-beat changes in hemodynamic variables by passive leg raising (PLR). Syst, MAP and Dias are 
systolic, mean and diastolic arterial blood pressure respectively; HR, heart rate; SV stroke volume 
A Kolmogorov-Smirnov test indicated normal distributions of all hemodynamic data. 
Compared to baseline (Table 2), PLR increased COtd, COm, COli, MAP, PP, SP and CVP, 
decreased SVV and PPV, and had no effect on HR. All 20 subjects behaved in a qualitatively 
similar fashion to the one subject’s example, Figure 1. Although COtd increased in all 
patients, COm increased in 19 of 20, COli increased in 15 of 20. Furthermore, MAP 
increased in 19 of 20, SP in 19 of 20, PP in 18 of 20, CVP in 18 of 20, HR increased in 5 and 
decreased in 7 out of 20 subjects. SVVm and SVVli decreased in 16 and 17 out of 20, 
respectively whereas PPV decreased in 18 out of 20.
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Table 2  Haemodynamic variables at baseline and after 30° passive leg raising (PLR) in all 20 patients.
Parameters Baseline PLR P-value
COtd (L∙min-1) 5.62 ± 1.66 5.91 ± 1.67 < 0.001
COm (L∙min-1) 6.17 ± 1.75 6.28 ± 1.76   0.002
COli (L∙min-1) 5.61 ± 1.39 5.85 ± 1.38 < 0.001
HR (min-1)* 79.1 ± 12.4 78.4 ± 13.2   0.256
CVP (mmHg) 9.2 ± 3.6 11.5 ± 4.0 < 0.001
PAP (mmHg) 19.9 ± 5.7 22.4 ± 5.8 < 0.001
MAP (mmHg) 84.7 ± 11.5 90.7 ± 13.4 < 0.001
PP (mmHg) 59.0 ± 10.3 65.2 ± 10.3 < 0.001
SP (mmHg) 124.8 ± 13.6 135.1 ± 17.2 < 0.001
SVVm (%) 5.8 ± 3.5 3.9 ± 2.7 < 0.001
SVVli (%) 7.3 ± 3.5 7,0 ± 2,1 < 0.001
PPV (%) 6.0 ± 4.2 4.3 ± 3.8   0.001
Rsys (dyne∙sec∙cm-5) 1115 ± 341 1140 ± 325   0.296
Abbreviations: Thermodilution cardiac output (COtd), radial artery pulse contour cardiac output (uncalibrated Modelflow, 
COm and LiDCO, COli), heart rate (HR), central venous pressure (CVP), pulmonary artery pressure (PAP), mean arterial 
pressure (MAP), systolic pressure (SP), pulse pressure (PP), stroke volume variation (SVVm and SVVli), pulse pressure 
variation (PPV) and systemic vascular resistance (Rsys).
Results of linear regression for all 20 patients are summarized in Table 3. A significant 
relationship between the change in COtd and the change in MAP, PP, SP, COm and COli 
was found. Noticeably, also baseline SVV and PPV related relatively well with the change in 
cardiac output due to passive leg raising.
Table 3  Slope of linear regression hemodynamic variables versus changes in thermodilution cardiac 
output due to PLR.
Slope 95% Confidence Interval P-value
Lower Upper
∆COm 0.875 0.547 1.203 <0.001
∆COli 0.810 0.488 1.131 <0.001
∆HR -0.585 -1.318 0.147 0.109
∆MAP 0.428 0.074 0.782 0.020
∆SP 0.276 0.047 0.506 0.021
∆PP 0.190 0.028 0.352 0.024
∆CVP 0.060 -0.036 0.157 0.207
SVVm baseline 0.738 0.249 1.228 0.005
SVVli baseline 0.660 0.138 1,181 0.016
PPV baseline 0.656 0.238 1.074 0.004
Abbreviations: Uncalibrated Modelflow cardiac output (COm), LiDCO cardiac output (COli), heart rate (HR), 
mean arterial pressure (MAP), systolic pressure (SP), pulse pressure (PP), central venous pressure (CVP), 
stroke volume variation (SVV) and pulse pressure variation (PPV)
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To construct Receiver Operating Characteristics (ROC) curves the population was divided 
into responders (n=10) and non-responders (n=10) based on an increase of at least 7% in 
COtd during PLR in responders. When COm increased by ≥2.5%, a concomitant increase of 
≥5% COtd was predicted with 89% sensitivity and 100% specificity. The optimal cut-off for a 
change in MAP is 5.5% increase. The (area under the) ROC curves for ∆COm, ∆COli, 
∆MAP, ∆PP, ∆SP and baseline SVV and PPV are given in Table 4 and Figure 2.
Table 4 Area under the ROC curves.
Area 95% Confidence Interval
Lower Upper
∆COm 0.968 0.890 1.000
∆COli 0.841 0.643 1.000
∆MAP 0.873 0.694 1.000
∆PP 0.714 0.434 0.995
∆SP 0.778 0.535 1.000
PPV baseline 0.808 0.615 1.000
SVVm baseline 0.825 0.617 1.000
SVVli baseline 0.873 0.665 1.000
Responders are defined by an increase in thermodilution cardiac output of at least 7% as a result of PLR.
Abbreviations: Change in radial artery pulse contour cardiac output (uncalibrated Modelflow, ∆COm and LiDCO, ∆COli), 
change in mean arterial pressure (∆MAP), ), pulse pressure (∆PP), change in systolic pressure (∆SP),  pulse pressure 
variation (PPV) and stroke volume variation (SVVm and SVVli)
Figure 2  Receiver operating characteristics curves comparing the ability of passive leg raising induced 
changes. In A: ∆COm (thin line), ∆COli (dashed line), baseline SVVm (dotted line), baseline 
SVVli (bold line). In B: ∆MAP (thin line), ∆PP (dotted line), ∆SP (bold line) and baseline PPV 




We showed that PLR with 30° of both legs produced a rapid increase of COtd associated with 
a proportional increase in COm, COli, MAP, PP and SP (Table 2). Furthermore, we found 
significant relationships between the change in COtd and the change in COm, COli, MAP, 
PP and SP. Our PP results confirm and extend the results of Boulain et al. and support their 
conclusion that PLR induced changes in PP predict the response to fluid loading [1]. Our 
results also support the hypothesis of DeBacker and Pinsky  that changes in pulse contour 
derived cardiac output due to PLR can be used to assess preload in cardiothoracic surgery 
patients [8]. Changes in COm tend to a slightly better predictive value than changes in MAP 
and COli, or baseline SVV and PPV, these differences are not statistically significant. 
Our findings concur with data previously reported by de Wilde et al. [10]. who showed that 
Modelflow pulse contour has lower limits of agreement and a better correlation coefficient 
for the regression of changes in CO with changes in thermodilution CO compared to the 
LiDCO’s technique. Furthermore, in another report de Wilde et al.[15] showed superior results 
of uncalibrated Modelflow compared to auto-calibrated FloTrac-Vigileo and HemoSonic in 
tracking changes in cardiac output. 
Continuous measurements of COm are more feasible than oesophageal Doppler CO and left 
ventricular stroke area since these methods are not routinely performed and the quality of 
measurement is dependant on the expertise of the observer. Also passive raising of the legs 
may interfere with the echocardiographic image.
To compare the effects of PLR on MAP, PP, SP, COm, COli and baseline SVVm, SVVli and 
PPV we separated responders from non-responders by setting the cut-off level for COtd 
change to 7%, considering the described effect of PLR from supine position [3] and the 
precision of our thermodilution method. Next, the reliability to predict preload dependency 
by changes in COm, COli, MAP, PP, SP due to PLR and baseline SVV and PPV was 
evaluated by calculating the area under the ROC curves. No statistical differences between 
the the AUC of the ROC curves for COm, COli, PPV and SVV were found. This uniformity 
might be explained by the fact that all predictors have the same radial arterial pressure 
source. However, the COm and COli techniques use different algorithms, therefore, some of 
the agreement must reflect similar accuracy of the two techniques.
In a large two-center study Monnet and co-authors [2] included 71 general ICU patients of 
which 31 had spontaneous breathing activity and/or arrhythmias. In the group of ventilator 
dependent patients they showed, by using the HemoSonic ultrasound system, that a PLR 
induced increase of aortic blood flow ≥ 10% predicted the effect of a 500 ml fluid load 
responsiveness with a 97% sensitivity and 94% specificity. Whereas a PLR induced increase 
in PP ≥ 12% had a 60% sensitivity and 85% specificity. In the patients with spontaneous 
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breathing activity the sensitivity and specificity were 88% and 93% for the aortic blood flow 
and as poor as 75% and 46% for PP. Other studies [3,5,6] confirmed that PLR predicts fluid 
responsiveness. Essential to the use of the PLR procedure to assess preload responsiveness 
is the need of a fast responding cardiac output method during the manoeuvre (Figure 1). The 
studies mentioned above used Doppler ultrasound techniques, however, these techniques 
may not be routinely performed or widely available. In addition, the quality of measurement 
is dependant on the expertise of the observer. Our results with beat-to-beat pulse contour 
cardiac output in patients after cardiac surgery agree with the results of Monnet et al. 
obtained with HemoSonic Doppler aortic blood flow (ABF) [2]. Therefore, measurement of 
pulse contour CO seems interchangeable with ultrasound ABF and may supplant it as was 
hypothesized by DeBacker and Pinsky [8]. 
We showed that various hemodynamic changes in response to PLR, such as COli, PP, MAP, 
COm can predict a positive CO response to PLR. The response to PLR can probably, in most 
circumstances, be used as a surrogate for response to fluid loading, because of its high 
sensitivity and specificity. We expected PLR to mimic a reversible fluid loading of 
approximately 250-300 ml. However, it is unsure whether the volemic status of a patient will 
change the volume of autotransfusion by PLR. We did not follow our initial measures with 
volume challenges because all the patients were deemed to be haemodynamically stable, and 
thus not needed further fluid resuscitation. 
Our study confirms that baseline SVV and change in COm and COli by PLR can be used to 
predict preload dependence in patients receiving mechanical ventilation. Since COm and 
COli can also be measured in normal breathing patients, we expect that COm and COli are 
more appropriate candidates to predict preload dependence during PLR in these patients. 
However, further study is needed into the reliability in spontaneous breathing patients. 
Differences exist in the implementation of the PLR procedure between studies [2,3,6]. These 
differences could interfere with a direct comparison of our results with beat-to-beat pulse 
contour and Doppler ultrasound cardiac output measurements. In our study, patients 
remain in a supine position throughout the protocol and only the legs are raised. The heart 
and baroreceptors are in-level and do not change, thus, blood pressure transducers do not 
have to be re-referenced resulting in a constant quality for pulse contour cardiac 
measurement. In half of the Doppler ultrasound studies [2,5,6], the patient moved from a 
semi-recumbent position (45o) to a position with the lower limbs raised to 45o while the 
patient’s trunk was lowered to supine position. This approach was probably chosen to keep 
the ultrasound probe in position but it changes the position of the baroreceptors in relation 
to the heart. Since heart rate was unchanged, this change in position may be considered as 
unimportant. Although, these differences may influence the comparability between studies 
we did not observed large differences. 
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Conclusions
In stable CABG patients under mechanical ventilation after cardiac surgery a correlation was 
observed between changes in method of the arterial pulse contour and thermodilution 
techniques. Preload reserve or responsiveness could therefore be determined. Further 
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The Respiratory Systolic Variation Test to predict fluid loading responsiveness
Bart Geerts, Rob de Wilde, Leon Aarts and Jos Jansen
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Especially in cardiac surgery patients, unnecessary fluid loading can lead to general and 
pulmonary oedema, and prolong hospitalization [1]. Several traditional and dynamic 
parameters have been studied for the predictive value to fluid loading responsiveness (FLR, 
i.e. an increase in CO) but no gold standard exists.
Preisman and colleagues studied a Respiratory Systolic Variation Test (RSVT) in 18 
mechanically-ventilated patients undergoing cardiac surgery to predict FLR with a increase 
in CO of at least 15% after 250 ml fluid loading [2]. The RSVT consists of three successive 
incremental-pressure-controlled inspiratory breaths (10, 20 and 30 cmH2O) of 1.5 seconds 
[2]. 
The lowest systolic blood pressure for each breath is plotted against their respective airway 
pressure, Figure 1. The slope of this plot is the RSVT-value, and is suggested to increase with 
hypovolaemia and decrease with fluid loading [2,3]. RSVT is reported to predict FLR with high 
sensitivity and specificity [2]. However, the RSVT were applied manually and no control group 
was used. We developed a semi-automated RSVT procedure and tested transferability of the 
RSVT with a threshold of 0.51 mmHg∙cmH2O
-1 in independent group of patients to predict 
FLR.
Methods 
Fourteen patients undergoing elective-cardiac surgery were included after approval of the 
institutional ethics committee and personal informed consent was obtained. Prior to surgery, 
each patient received a pulmonary artery catheter (Intellicath; Edwards Lifesciences; Irvine, 
CA, USA) to measure CO and CVP, and a 20 G radial artery catheter to measure arterial 
pressure (Prad).
Patient’s anaesthesia was continued with propofol-target-control infusion and sufentanil in 
the ICU. The lungs were mechanically ventilated (Draeger, Evita 4, Lubeck, Germany) in a 
pressure-control mode with standard settings (12 breaths∙min-1, tidal volume 8-10 ml∙kg-
1∙min-1, FiO2 40%, PEEP 5 cmH2O). To perform the RSVT semi-automatic we putted the 
ventilator under computer control. Airway pressure (Paw) was measured at the proximal end 
of the endotracheal tube. 
The radial artery pressure (Prad) was analysed with the Modelflow program (FMS, 
Amsterdam, the Netherlands) to provide beat-to-beat values of systolic blood pressure (Psys),  
MAP, HR and to determine pulse pressure variation (PPV) over 30 second intervals [4]. 
Thermodilution cardiac output (COtd) was obtained as averaged value of three 
thermodilution measurements performed equally spread over the ventilatory cycle [5].
During the observation period the patients maintained the supine position. Use of sedative 
and vascular medication remained unchanged. No fluids were administered during the 
observation period outside the study protocol.
The 1.5 second RSVT procedure and COtd, MAP, Psys, PPV, HR and CVP measurements 
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were semi-automatically performed before and five minutes after a 500 ml administration of 
colloid in 15 minutes. Responders were characterized by a ≥10% increase in COtd with 500 
ml fluid loading five minutes after fluid was administered.
Statistical analyses were performed with a Kolmogorov-Smirnov test and (un)paired t-test. 
Reliability to predict fluid loading responsiveness was assessed using the threshold of 0.51 
for RSVT from the report of Preisman and co-workers [2]. Study size was similar to the study 
of Preisman and co-workers. The accuracy of the test is unknown hence no power analysis 
was performed.
Figure 1  An example of the Respiratory Systolic Variation Test (RSVT). Upper graph; three successive 1.5 
seconds incremental-pressure-controlled inspiratory breaths of 10, 20 and 30 cmH2O are applied 
with a PEEP of 5 cmH2O (Pvent is airway pressure). Second graph; a linear transfer of Pvent to 
central venous pressure (CVP) can be observed. Third graph; radial artery pressure (Prad) is 
plotted and lowest systolic blood pressure (Psys) for each RSVT breath is indicated. Lower graph; 




Fourteen patients (10 male) of 63 ± 10 years, 86 ± 15 kg and 175 ± 9 cm were included. 
Eleven patients received straightforward CABG and three received single valve repair with or 
without CABG. 
Data was normally distributed. CO, CVP and MAP increased due to fluid administration. HR 
did not change and PPV and RSVT-values decreased (Table 1). CO increased with 34% in 
responders (n=9) and did not change in non-responders (n=5). An RSVT with a threshold of 
0.51 predicted responders and non-responders correctly in 78% of the patients (sensitivity 
78%, specificity 60%, positive predictive value 78%, and negative predictive value 60%). A 
PPV of 10% (conform Preisman’s 9.4%) would have missed one responder; sensitivity 90%, 
specificity 100%, positive predictive value 100% and negative predictive value 80%.
Table 1  Changes in hemodynamic parameters from baseline to after 500 ml fluid loading for all patients, 
responders and non-responders.
Parameters All patients Responders Non-responders
Baseline 500 ml P value Baseline 500 ml P value Baseline 500 ml P value
COtd (L∙min-1) 5.6 ± 1.5 6.8 ± 1.6 0.002 5.3 ± 1.1 7.0 ± 1.4 0.001 6.3 ± 1.9 6.4 ± 2.1 0.384
MAP (mmHg) 84.1 ± 22.3 94.3 ± 18.1 0.021 86.0 ± 27.0 97.3 ± 21.1 0.074 80.7 ± 11.7 89.0 ± 10.6 0.187
HR (min-1) 81 ± 16 78 ± 14 0.075 86 ± 16 82 ± 12 0.120 72 ± 14 71 ± 15 0.313
CVP (mmHg) 9.2 ± 3.2 11.4 ± 2.8 0.001 9.6 ± 1.8 11.6 ± 1.6 0.007 8.4 ± 5.0 11.0 ± 4.4 0.107
RSVT 
(mmHg∙cmH2O
-1) 0.96 ± 1.02 0.57 ± 0.80 0.003 0.86 ± 0.47 0.41 ± 0.33 0.007 1.15 ± 1.69 0.86 ± 1.30 0.229
PPV (%) 14.8 ± 9.2 7.2 ± 4.9 0.004 17.4 ± 8.5 7.0 ± 3.4 0.007 10.0 ± 9.3 7.6 ± 7.4 0.136
Thermodilution cardiac output (COtd), mean arterial pressure (MAP), heart rate (HR), central venous pressure (CVP), 
Respiratory Systolic Variation Test (RSVT) and pulse pressure variation (PPV).
Discussion 
In response to earlier publications of Preisman and co-workers [2], we evaluated the RSVT in 
an independent group of post cardiac surgery patients and found RSVT with a threshold of 
0.51 reliable in predicting responders and non-responders. To perform semi-automated 
RSVT manoeuvres we put the ventilator under computer control. Preisman and colleague’s 
characterized responders by a ≥15% change in CO after 250 ml of fluid loading [2]. We used 
500 ml since this is more broadly used in FLR research [6-9]. Apparently, this difference in 
characterizing responders has no impact on the RSVT threshold of 0.51. 
Several considerations have to be mentioned. First, RSVTs can only be measured in patients 
on mechanical ventilation with an arterial catheter and without arrhythmias [10]. Second, it is 
not unimaginable that pathologic states of the lung like COPD or ARDS influence the 
reliability of the test because the change in lung compliance may have an impact on the 
(199
transmission of alveolar to intra-thoracic pressure [11]. Third, changes in vasomotor tone 
during progression of sepsis, brain injury and peripheral vascular disease could influence 
clinical use of the RSVT as a hemodynamic monitoring tool. Fourth, one can imagine that 
during very low cardiac output states application of an RSVT can cause a brief reduction in 
venous return and hence further reduce CO. Fifth, only a small number of patients have 
been studied. The RSVT technique has to be further evaluated in other subgroups. 
Conclusions
We showed that the RSVT procedure is transferable and feasible to predict fluid loading 
responsiveness. The advantage of the RSVT is that it is not affected by tidal volume and 
breathing frequency like PVV.
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Chapter 14 
Discussion; fluid loading responsiveness and how can we use it?
Bart Geerts, Johan Groeneveld, Leon Aarts and Jos Jansen
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A wide array of variables is available to the ICU and OR physician to assess the 
hemodynamic state of a patient. Urinary output, skin colour, capillary refill, mean arterial 
pressure, central venous pressure, heart rate, mixed venous oxygen saturation and pulse 
pressure are just a few of these variables and their number keeps rising [1,2]. However, it is 
still not possible to accurately detect hypovolaemia or hypervolaemia [3]. Overzealous fluid 
administration can increase the incidence of infections, anastomosal leakage, general and 
pulmonary oedema. This complicates hemodynamic management since unnecessary fluid 
loading can increase hospital stay and even mortality [4,5] Several strategies exist to decrease 
the likelihood of hypervolaemia and at the same time select patients that may require fluid 
loading, pharmacological support or both.
Fluid loading responsiveness
No gold standard exists to guide hemodynamic management. Fluid loading responsiveness 
(FLR) is a relatively novel strategy and has received wide attention. In general, fluid loading 
responsiveness can be described as the response of cardiac output (CO) on an intra-vascular 
administration of a certain amount of fluid. Responders are defined as those patients that 
increase their cardiac output above a threshold value after this volume loading [6]. It is 
assumed that increasing cardiac output will lead to an increase in flow and oxygen transport 
to vital organs consequently. Thus, FLR aims to optimize perfusion and oxygen delivery to 
vital organs like brain, heart and kidneys. FLR does not specifically lead to the diagnosis of 
strict hypovolaemia or normovolaemia. Fluid loading responsiveness is more likely to signal 
that a patient is functioning on or near the flat part of the Frank Starling curve. Identifying a 
responder with FLR indicates that fluid will likely cause an improvement of the 
hemodynamics of the patient with less chance of overfilling. 
The working point of the circulation of an ICU patient can be described by the intersection 
of both the venous return curve and the Frank Starling curve. The venous return curve of a 
patient shifts upward during hypervolaemia and shifts parallel downwards during 
hypovolaemia. Whereas, the Frank Starling curve is influenced by neurological and humoral 
control mechanisms, vascular and cardiac function. Hence, the working point of the 
circulation changes continuously due to changes in the administration of parenteral fluids, 
airway pressure and changing renal, cardiac and vascular function [7]. This stresses the need 
for a continuous or repeated determination of fluid-requirements. 
However, a practical consensus over the definition of fluid loading responsiveness is missing 
and therefore the definition of FLR differs widely in the available literature. Even more 
important is the ability to predict FLR, i.e. responders and non-responders without the 
administration of fluids. The idea behind predicting FLR is that overall fluid administration 
will decrease. To our knowledge no study exists to date that studies the impact of FLR or 
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prediction of FLR on outcome. Thus, more elaborate research is needed. But first we have to 
develop a uniform definition of FLR to be able to compare the results of FLR research. 
Second, we will need to come up with a workable algorithm to predict FLR and to guide fluid 
management in a patient followed by a study of its effect on outcome. In this manuscript we 
will discuss different dimensions to fluid loading responsiveness and its possible use in 
everyday practice.
Pitfalls in Determining Fluid Loading Responsiveness
No consensus exists how to assess FLR. The amount of fluid used to assess FLR varies 
between 7 ml∙kg-1 [8] and 20 ml∙kg-1 [9], or 250 ml [10] and 1000 ml [11]. It is easy to imagine 
that if instead of 250 ml 1000 ml is administered the change in CO can be expected to be 
larger. The amount of fluid administrated to determine FLR should be weight adjusted to 
allow for comparison of inter-individual and inter-study results. A 5 ml∙kg-1 bolus should 
illicit a significant change in CO in responders. For instance this would be a 500 ml bolus in 
a 100 kg man or a 250 ml in a 50 kg fragile elderly lady. 
Directly related to this, is the type of fluid that is used for administration. The composition 
of a fluid does not only determine the time that it will be present in the intravascular 
compartment but also the amount of fluid recruited from the extra-vascular compartment. 
Prather et al. [12] showed that colloids remain in the intravascular compartment for more than 
two hours and even attract fluids from the extravascular compartments where crystalloids 
tend to disappear within 80 minutes in dogs. Consequently, we have to point out the 
importance of the duration of the administration of fluid and timing of the measurement of 
CO. This directly influences the number of responders, i.e. the number of responders is 
expected to be larger if CO is measured directly after fluid bolus administration instead of 
60 minutes after a 60 minute infusion. This issue will be less relevant when fluids are 
administered within 5 minutes and CO is measured within several minutes.
Different parameters are used to define (non)responders; cardiac output, stroke volume, 
stroke volume index, left ventricular end-diastolic area index, cardiac index and aortic blood 
flow velocity. The effect of fluid loading can be described as a move of the working point to 
the right on the Frank-Starling curve. When the heart operates on the ascending part of the 
curve cardiac output will increase more in response to fluid loading (responder) than if the 
heart already operates near the flat part of the curve. We advocate the use of the change in 
cardiac output to determine (non)responders since it is one of few parameters likely to 
correlate to (vital) organ perfusion, it is a robust parameter, and CO is one of two factors to 
describe the Frank-Starling curve. The Frank Starling principle is based on the fiberlength-
contractility relationship within the ventricle. If ventricular end-diastolic volume (preload) is 
increased ventricular fiberlength is also increased, resulting in an increased ‘tension’ of the 
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muscle and an increased contraction length. 
Another factor directly influencing the number of responders is the cut-off value. The cut-off 
to discriminate between responders and non-responders after a fluid challenge varies 
between 5% and 25% change in CO [10,13]. Since the precision and accuracy of cardiac output 
measurement technique directly determines the clinical significance, we would like to relate 
the technique to measure CO to the cut-off value and the amount of administered fluid [14]. 
Previously, Critchley and Critchley [15] concluded that a new method was allowed to replace 
the gold standard when repeatability was within twice the standard deviation (2SD) of the 
gold standard method. Cecconi et al. discussed that the coefficient of variance (CV) was to be 
used [16]. They advised only to use a new CO method clinically when CV is below 10% (or 
clinically significant in their words). However, studies on the accuracy of different CO 
methods to determine changes (after an intervention) are scarce or lacking. Moreover, it is 
disputable that the assessment of agreement of CO methods as put forth by Critchley and 
Cecconi can be used for this purpose. Data by de Wilde and co-workers suggest that pulse 
contour methods (Modelflow and possibly LidCO) track changes in thermodilution cardiac 
output more accurately than suggested by earlier repeatability data [17]. We found that a 4.3% 
change in Modelflow CO after 100 ml fluid administration accurately predicts fluid loading 
responsiveness. 
Jansen et al. reported a precision of 3.5% for thermodilution cardiac output to determine 
(genuine) CO [18]. Henceforth, a cut-off for triplicate thermodilution CO would be between 
3.5% and 7%. Thus, our data indicates that lower cut-off values can be used (or more fluid 
has to be administered than with thermodilution) than the previously used 20%. We, 
therefore, advocate the use of different cut-off values based on the methods used to assess 
CO and their accuracy to track changes in cardiac output. We also advocate the use of a 
limited number of CO measurement techniques in FLR research. Only those measurement 
techniques that (have) prove(n) to be precise and accurate can be used.
Prediction of FLR
The aim of predicting FLR is to achieve the most adequate or optimal cardiac output with the 
least amount of fluids. In the prediction of FLR three major shortcomings are to be solved. 
First, an unambiguous definition of FLR is needed (see the discussion above). Second, errors 
related to the calculation and use of various predictors like LVEDA, SVV, PVV and changes 
on challenges like PLR and PEEP need to be quantified. Third, patient characteristics have to 
be taken into consideration to select a suitable parameter for FLR prediction. Forth, 
reliability of statistical analysis to compute the sensitivity, specificity and the threshold value 
to define responders and non-responders must be defined.
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Echographic and Dynamic Parameters to Predict FLR
In theory, echographically determined volume parameters of the heart are supposed to be 
highly reliable predictors of FLR. The volume changes within the heart or vena cava are 
directly linked to cardiac function; when wall movement is limited inotropic assistance is 
warranted. And when filling of the ventricles is not optimal, fluid administration is 
indicated. Study results are very promising [19]. Several factors may, however, frustrate these 
results. Operator-related factors, like level of experience, changes in probe position and 
intermittent application, greatly influence the reliability and robustness of echographic 
monitoring [20]. The predictive value for FLR of echographic parameters in patients receiving 
mechanical ventilation seems to outscore the results for these parameters in spontaneously-
breathing patients [21]. 
These operator- and patient-bound factors influence the accuracy to predict FLR. We 
highlight the results of the most studied parameters here; results for left ventricular 
end-diastolic area (LVEDA) [22-26] vary with sensitivity reported to be between 60 to 89%, 
specificity between 58 and 91% and the AUC of the ROC curve between 0.24 ± 0.11 and 0.78 
(95% CI between 0.59 and 0.97) [23,26]. For global end-diastolic volume index (GEDVI) [13,27-29] 
the AUC of the ROC curves is between 0.23 and 0.70 (0.46-0.94) [28,29].
In recent years, new variables based on heart-lung interaction, i.e. respiratory-induced stroke 
volume variation (SVV) and pulse pressure variation (PPV) have been introduced in the ICU. 
Pulse pressure (PP) is defined as the beat-to-beat difference between the systolic and the 
diastolic pressure. PPV is the amplitude of cyclic changes induced by mechanical ventilation. 
The variations in PP and stroke volume induced by mechanical ventilation have been linked to 
volume status [30]. PPV is thought to be directly proportional to stroke volume variation [31]. The 
reliability for SVV and PPV varies from lower sensitivity and specificity of 70% to over 90% to 
predict FLR. Although SVV is a direct measure of variation in cardiac output, results for SVV 
show a wider spread [13,32,33]. Even though PPV is used as an indirect measure for SVV, results 
for PPV seem superior which may be especially true in septic patients [34], where vasoplegia is 
less likely to cause a reliable SVV measurement result. We need to consider that the calculation 
of SVV requires beat-to-beat SV measurements using a pulse contour analysis algorithm 
whereas PPV is measured directly from the arterial waveform. SVV will require an ongoing 
validation in clinic conditions as algorithms are developing with time [35]. In that context it is 
noteworthy that more recent publications report lower area under the ROC curves than older 
publications. Whether this depends on publication bias, a decrease in the accuracy of newer 
pulse-contour methods to determine SVV or more frequent improper use remains uncertain. 
Several restrictions apply to the use of dynamic parameters. Cardiac arrhythmias 
significantly decrease the reliability of SVV and PPV [20]. The use of these dynamic 
parameters has been validated in sedated and mechanically ventilated patients without 
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spontaneous breathing activity. Third, SVV, and probably PPV, is not only influenced by 
intravascular volume but also by the depth of the tidal volume used in mechanical 
ventilation of the lungs [26].
Patient Characteristics, Challenges and FLR
When FLR is assessed patient (co)morbidity is of importance to select the most reliable 
parameter. For SVV, PPV and LVEDA determinations the limitations are reasonably well 
described (see above). For several disease states, however, we do not know yet how they 
influence the reliability of a parameter to predict FLR. For instance, we do not know what the 
influence of right ventricular dysfunction has on the accuracy of dynamic variables to predict 
FLR. In these cases, the use of a challenge could be helpfull. 
Reversible autotransfusion by passive leg raising (PLR) and a provocation method with the 
application of increased PEEP have also become the subject of intense interest. Particularly, 
the groups of Boulain, Monnet and Teboul studied the reliability of parameters during PLR 
to predict FLR [36,37]. The robustness and reliability of the “static parameters” during the 
challenge can be explained by the direct use of the Starling curve. The working point on the 
Frank Starling curve of each individual patient (with its own pathophysiological constitution) 
is determined and FLR can be assessed. The amplitude of the change in CO after the 
challenge can be used to predict FLR. These challenges are reversible, standardized and 
easily performed. 
Statistical Testing
Overall receiver operating characteristics (ROC) are used to describe the precision of the 
prediction of fluid loading responsiveness. Sensitivity and specificity and threshold values to 
identify responders and non-responders on fluid loading are determined for several variables 
in a specific population. However, the application of ROC curves also requires secondary 
testing in a control population with the earlier found cut-off values in order to determine 
reproducibility in similar and different sub-populations. Since reproducibility is only rarely 
assessed, straightforward extrapolation of study results is not possible. This also hinders 
formulation of a department protocol for bedside use.
A second issue related to statistical analysis in FLR research is related to the size of the study 
populations; population size varies between 8 [38] and 60 [39] in reports up to 2010. However, 
no study reports on power analysis. Moreover, rarely the significance of the found area under 
the ROC curve (AUROC) is reported. Hanley et al. demonstrated the value of statistical 
testing between ROC curves [40]. We advocate the use of this test to compare AUROC with 
mathematical chance (Test: AUROC ≠ 0.500) and to allow comparison of ROC curves for 
different parameters, especially when power analysis are absent.
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Conclusions
The restricted use of fluids in the intensive care and operating theatre reduces risk of 
complications like pulmonary edema. Targeted infusion strategies have shown to benefit 
patients. Fluid loading responsiveness is a novel strategy that aims to optimize perfusion 
and oxygen delivery to vital organs. This strategy is likely to signal that a patient is 
functioning on or near the flat part of the Frank Starling curve. Predicting fluid loading 
responsiveness is described as the use of a hemodynamic variable to predict the effect of a 
fluid bolus administration. 
FLR research has shown promising results but no consensus exists on the exact definition of 
FLR. The amount of fluid, type of fluid, the parameter used to define responders, timing of 
the measurement of CO after fluid loading, the cut-off value to define responders and the 
cardiac output measurement technique vary widely. Based on these pitfalls and current 
knowledge, we propose to define FLR is the use of (a set of) baseline hemodynamic variables 
(or a change in a variable after a challenge manoeuvre) to predict a clinically significant 
change in cardiac output within 5 minutes after a 5 ml∙kg-1 bolus of a crystalloid or colloid 
fluid is administered within 5 minutes. Moreover, the use of an accurate and precise cardiac 
output measurement technique to assess FLR is desirable. We advise a cut-off for triplicate 
thermodilution CO of 3,5% and for pulse contour CO around 5% change. Consequently, we 
can use this explicit classification to define responders and integrate results of different FLR 
studies. Until major morbidity and mortality studies have been performed into the LFR 
strategy, we advise the use of pulse pressure variation and challenges like passive leg raising 
to assess FLR in critically ill patients. Baseline PPV and changes in static filing pressure after 
PEEP and PLR challenges have repeatedly shown to predict FLR with high sensitivity and 
specificity in different patient populations. However, it remains important to recognize a 
patients specific pathophysiology to select the most reliable parameter to predict FLR.
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Patients in the intensive care unit (ICU) and in the peri-operative phase are dependent on 
physicians and nurses for their fluid intake. Volume status optimization is required to 
maximize oxygen delivery to vital organs. Unnecessary fluid administration can, however, 
lead to general and pulmonary oedema, cardiac failure, infections, prolonged hospitalization 
and death. Besides signs like skin turgor, diuresis and skin colour, hemodynamic 
measurements like central venous pressure (CVP) and mean arterial pressure (MAP) are 
most often used for hemodynamic management. These parameters, however, often fail to 
accurately predict the response of a patient to fluid loading. 
Cardiac output (CO) is the amount of blood pumped through the circulation by the heart per 
minute. The general conception is that an increase in cardiac output will improve perfusion 
of vital organs. Increased flow might also imply improved oxygen delivery to the tissues. This 
is the basis of the fluid loading responsiveness strategy (FLR). This strategy aims to prevent 
fluid overloading by an accurate prediction of the response in cardiac output to fluid loading. 
Arthur Guyton’s work provided an important step forward to the determination of volume 
status directly. Together with the shape of cardiac output function curve, dimensions of the 
vascular system, blood viscosity and mean systemic filling pressure (MSFP) can be 
considered as a primary determinant of venous return and thus cardiac output. Ultimately, 
MSFP can be used to calculate stressed volume and, hence, quantify effective volume status 
in a specific patient. 
In this thesis, we review literature on fluid loading responsiveness research, we try to assess the 
impact of literature on hemodynamic management in Dutch ICU’s, we discuss a novel method 
to assess mean systemic filling pressure and last we discuss studies performed to assess the 
reliability of several challenges to predict FLR; +10 cmH2O PEEP, the fluid challenge, passive 
leg raising, the respiratory ventilator manoeuvre and the measurement of baseline MSFP. The 
manoeuvres are aimed at determining the working point of the circulation on the Frank-
Starling curve. It is assumed that when the patient is on the ascending portion of the Frank-
Starling curve an (auto)transfusion will increase cardiac output. 
Chapter 1 
Many methods of cardiac output measurement have been developed, but the number of 
methods useful for human studies is limited. The “holy grail” for the measurement of 
cardiac output would be a method that is accurate, precise, operator independent, fast 
responding, non-invasive, continuous, easy to use, cheap and safe. This method does not 
exist today. In chapter one, we reviewed methods to measure cardiac output; the Fick 




We evaluated cardiac output using three new methods – the auto-calibrated FloTrac–Vigileo 
(COed), the non-calibrated Modelflow (COmf) pulse contour method and the ultra-sound 
HemoSonic system (COhs) – with thermodilution (COtd) as the reference. In 13 
postoperative cardiac surgical patients, 104 paired CO values were assessed before, during 
and after four interventions: (1) an increase of tidal volume by 50%; (2) a 10 cmH2O increase 
in positive end-expiratory pressure; (3) passive leg raising and (4) head up position. With the 
pooled data the difference (bias (2SD)) between COed and COtd, COmf and COtd and COhs 
and COtd was 0.33 (0.90), 0.30 (0.69) and 0.41 (1.11) L∙min-1, respectively. Thus, Modelflow 
had the lowest mean squared error, suggesting that it had the best performance. COed 
significantly overestimates changes in cardiac output while COmf and COhs values are not 
significantly different from those of COtd. Directional changes in cardiac output by 
thermodilution were detected with a high score by all three methods.
Chapter 3 
The aim of this study was to compare the accuracy of stroke volume variation (SVV) as 
measured by the LiDCOplus system (SVVli) and by the FloTrac-Vigileo system (SVVed). We 
measured SVVli and SVVed in 15 postoperative cardiac surgical patients following five study 
interventions; a 50% increase in tidal volume, an increase of PEEP by 10 cmH2O passive leg 
raising, a head-up tilt procedure and fluid loading. Between each intervention, baseline 
measurements were performed. 136 data pairs were obtained. SVVli ranged from 1.4% to 
26.8% (average 8.7% ± 4.6%); SVVed from 2.0% to 26.0% (average 10.2% ± 4.7%). The bias 
was found to be significantly different from zero at 1.5% ± 2.5%, p < 0.001, (95% confidence 
interval 1.1-1.9). The upper and lower limits of agreement were found to be 6.4% and 3.5% 
respectively. The coefficient of variation for the differences between SVVli and SVVed was 
26%. This results in a relative large range for the percentage limits of agreement of 52%. 
Analysis in repeated measures showed coefficients of variation of 21% for SVVli and 22% for 
SVVed. The LiDCOplus and FloTrac- Vigileo system are not interchangeable. Furthermore, 
the determination of SVVli and SVVed are too ambiguous, as can be concluded from the 
high values of the coefficient of variation for repeated measures. These findings underline 
Pinsky’s warning of caution in the clinical use of SVV by pulse contour techniques.
Chapter 4 
Selection of patients who will benefit from fluid loading is critical since unnecessary fluid 
administration can lead to parameters and challenges in daily practice in Dutch intensive 
care units. We sent 446 questionnaires to ICU physicians in the Netherlands. 39% of 
questionnaires were returned. In the initial assessment of pulmonary oedema and cardiac 
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failure. Filling pressures such as CVP, MAP, cardiac output and clinical signs have 
traditionally been at the centre of haemodynamic monitoring. We performed a survey to 
evaluate the impact of recently introduced volume status urine production and capillary refill 
were found most important. To estimate need for volume expansion; CVP was used by 70%, 
stroke volume variation (SVV) or pulse pressure variation (PPV) by 47%, and CO by 20%. 
Seventy-five percent used a fluid challenge to predict responsiveness. Changes in heart rate, 
MAP, CVP and CO were used most in characterizing responders and non-responders. The 
presence of guidelines to characterize hypo- or hypervolaemia was indicated by 25% and only 
half of these respondents indicated they used these guidelines. Many Dutch ICU physicians 
use the recently developed variables SVV and PPV as well as fluid challenges to predict the 
effects of fluid loading on CO, although, CVP is still used by the majority. 
Chapter 5 
Unnecessary fluid administration increases morbidity, mortality and intensive care stay. 
Fluid loading responsiveness (FLR) is a strategy used to select patients that will benefit from 
fluid administration. We summarized recent publications on FLR to provide the physician 
working with critically-ill patients with an overview of parameters most frequently used in 
FLR and we evaluated their reliability to predict the response in cardiac output to fluid 
loading. Measurements of dynamic parameters, like pulse pressure variation (PPV) and 
stroke volume variation, have consistently shown to be more reliable than central venous 
pressure and pulmonary artery occlusion pressure (PAOP) to predict FLR. Changes in MAP, 
CVP or CO as a result of different challenges (passive leg raising) are also more accurate 
predictors of FLR. However, the definition of FLR lacks consensus as the quantity of 
administered fluids and the cut-off to discriminate (non)responders vary largely. Dynamic 
parameters, and especially PPV, are likely candidates to predict FLR in an everyday ICU 
setting in different patient populations. Moreover, changes in CVP, MAP and CO after 
passive leg raising can be used with equal reliability.
Chapter 6 
Hypovolaemia is a common clinical problem. The Trendelenburg position and passive leg 
raising (PLR) are routinely used in the initial treatment awaiting fluid resuscitation. We 
evaluated the hemodynamic effects of PLR and Trendelenburg. Which position has the 
optimal effect on cardiac output (CO)? Databases were searched for prospective studies in 
normo- or hypovolaemic humans investigating the hemodynamic effects within 10 minutes 
after postural change from supine position published between 1960 and 2010. 21 studies 
were included for PLR (n=431) and 13 for Trendelenburg (n=246) position. Trendelenburg 
position increased mean arterial pressure (MAP). CO increased 9% or 0.4 L∙min-1 after one 
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minute of head down tilt. Between two to ten minutes this increase in CO declined to 4%  
or 0.1 L∙min-1. PLR showed no increase in MAP or heart rate. Central venous pressure 
increased. CO increased after one minute of leg elevation with 6% or 0.2 L∙min-1. 
This effect persisted after this period with 6% or 0.2 L∙min-1. We found that although both 
Trendelenburg and PLR significantly increase cardiac output only PLR seems able to sustain 
this effect after one minute. Since fluid resuscitation during hypovolaemia is not achieved 
within minutes, we advocate the use of autotransfusion with PLR. Studies that directly 
compare effects of the two manoeuvres that are still needed for one of the most often used 
therapies in medicine. 
Chapter 7 
We presented a new physiological model that discriminated between changes in the systemic 
arterial and venous circulation. To test our model, we studied the effects of dobutamine and 
hypovolemia in intact pentabarbitol- anesthetized piglets. Aorta pressure (Pao), central 
venous pressure (CVP), mean systemic filling pressure (MSFP) and cardiac output were 
measured in 10 piglets, before, during and after dobutamine infusion (6 μg∙kg-1∙min-1), as 
well as during hypovolemia (-10 ml∙kg-1), and after fluid resuscitation to normovolemia. 
Venous (Rv) and total systemic (Rsys) resistance were determined from Pao, PCV, MSFP and 
CO. The quotient of Rv/ Rsys was used to determine the predominant location of vascular 
changes (i.e. vasoconstriction or dilatation on either venous or arterial side). Administration 
of dobutamine increased heart rate and CO, whereas it decreased MSFP, Rsys, Rv and  
Rv/Rsys. The decrease in Rv was significantly greater than Rsys. Pao and Pcv did not change. 
Hypovolemia decreased CO, CVP, MSFP, Rv and Rv/Rsys, but kept Rsys constant and 
increased heart rate. Hypovolemia and dobutamine differentially alter MSFP, Rsys, Rv and 
Rv/Rsys ratio. The increase in CO during dobutamine infusion was attributed to the 
combined increased cardiac function and decreased Rv. The decrease in CO with 
hypovolemia was due to a decrease MSFP but was partly compensated for by a decrease in 
Rv tending to preserve venous return and thus CO.
Chapter 8
We aimed to measure the relationship between blood flow and central venous pressure and 
to estimate mean systemic filling pressure (MSFP), circulatory compliance, and stressed 
volume in twelve mechanically ventilated postoperative cardiac surgery patients in the 
intensive care unit. Inspiratory holds were performed during normovolaemia in supine 
position (baseline), relative hypovolemia by placing the patients in 30° head-up position 
(hypo), and relative hypervolaemia by volume loading with 0.5 L colloid (hyper). We 
measured the relationship between blood flow and CVP using 12-second inspiratory-hold 
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manoeuvres transiently increasing CVP to three different steady state levels and monitored 
the resultant blood flow via the pulse contour method during the last 3 seconds. The CVP to 
blood flow relation was linear for all measurements with a slope unaltered by relative volume 
status. MSFP decreased with hypo and increased with hyper (18.8 ± 4.5 mmHg, to 14.5 ± 3.0 
mmHg, to 29.1 ± 5.2 mmHg [baseline, hypo, hyper, respectively, p < 0.05]). Baseline total 
circulatory compliance was 0.98 ml∙mmHg-1∙kg-1 and stressed volume was 1677 ml. 
Conclusions: MSFP can be determined in intensive care patients with an intact circulation 
with use of inspiratory pause procedures, making serial measures of circulatory compliance 
and circulatory stressed volume feasible.
Chapter 9 
Arm occlusion pressure (Parm) is used to study the hemodynamic effects of drugs. It might 
serve as an indicator of static filling pressure. We hypothesized that Parm could be used to 
predict fluid loading responsiveness (FLR) in 24 patients after cardiac surgery.  Fluid loading 
increased cardiac output (CO), Parm, mean arterial pressure (MAP) and central venous 
pressure (CVP). In responders (n=17), CO, Parm, MAP, CVP increased and, stroke volume 
variation (SVV) and pulse pressure variation (PPV) decreased. In non-responders (n=7), 
Parm and CVP increased, PPV decreased. CO, MAP, SVV and heart rate did not change 
significantly. The area under the curve to predict FLR for Parm was 0.786 (95% CI: 
0.567-1.000), at a cut-off of 21.9 mmHg sensitivity is 71% and specificity 88% to predict 
FLR. Parm seems to be a good predictor of FLR in our group of cardiac surgery patients.
Chapter 10 
Changes in central venous pressure (CVP) rather than absolute values may be used to guide 
fluid therapy in critically-ill patients undergoing mechanical ventilation. We conducted a study 
comparing the changes in the CVP produced by an increase in positive end-expiratory 
pressure (PEEP) and stroke volume variation as indicators of fluid responsiveness. Fluid 
responsiveness was assessed by the changes in cardiac output produced by passive leg raising. 
In twenty fully mechanically-ventilated patients after cardiac surgery, PEEP was increased +10 
cmH2O for 5 minutes followed by PLR. CVP, SVV and thermodilution cardiac output (CO) 
were measured before, during and directly after the PEEP challenge and 30º PLR. The 
cardiac output (CO) increase >7% upon PLR was used to define responders. Twenty patients 
were included of whom 10 responded to PLR. The increase in CO by PLR directly related 
(r=0.77, P<0.001) to the increase in CVP by PEEP. PLR responsiveness was predicted by the 
PEEP-induced increase in CVP (area under receiver-operating characteristic [AUROC] curve 
0.99, P<0.001) and by baseline SVV (AUROC 0.90, P=0.003). The AUROC’s for dCVP and 
SVV did not differ significantly (P=0.299). Our data in mechanically-ventilated, cardiac-
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surgery patients suggest that the newly defined parameter, PEEP-induced CVP changes, like 
SVV, appears to be a good parameter to predict fluid responsiveness. 
Chapter 11
In 2006, Vincent and Weil (V&W) reintroduced the fluid-challenge protocol. We studied the 
value of adding pulse contour cardiac output to V&W’s protocol to reduce the amount of 
unnecessary administered fluid and compared it to a fluid loading responsiveness protocol 
with pulse contour CO. We measured the effects of the administration of 10 sequential 50 
ml bolus colloid infusions on CO [Modelflow (COm) and LiDCO (COli)], central venous 
pressure (CVP) and mean arterial pressure (MAP) in twenty-one patients on mechanical 
ventilation after elective cardiothoracic surgery. COli and COm increased after 50, 100 and 
500 ml fluid loading. When COm is increased ≥4.3% after a 100 ml trial administration, 
fluid loading responsiveness with a 10% increase in CO after 500 ml fluid administration 
can be predicted with a sensitivity 67% and specificity of 100%. Addition of COm to V&W’s 
original protocol would have lead to a mean administration of 100 instead of 200 ml fluid to 
non-responders and an increase of 7% in CO. A fluid responsiveness protocol would have 
lead to a 18% increase in CO. The addition of pulse contour CO can improve the reliability 
and robustness of the V&W’s fluid-challenge protocol. It resulted in an increase of cardiac 
output in responders and a decrease of unnecessary fluid loading in non-responders.
Chapter 12 
We evaluated the ability of two pulse contour cardiac output techniques to track cardiac 
output changes during 30° passive leg raising (PLR) to assess fluid loading responsiveness in 
twenty mechanical-ventilated post-operative cardiac surgery patients. We estimated cardiac 
output by three techniques: thermodilution (COtd), arterial pulse power (COli, LiDCO) and 
pulse contour method (COm) based on uncalibrated Modelflow. We measured heart rate 
(HR), central venous pressure, arterial pulse pressure (PP), systolic pressure (SP) and mean 
arterial pressure. Stroke volume (SV), SP, PP and SV variation (PPV and SVV, respectively) 
were calculated over 5 breaths. SVV was measured by both LiDCO (SVVli) and Modelfow 
(SVVm) devices. PLR-induced changes in COtd correlated with COli (p<0.001) and COm 
(p<0.001). Preload dependence was predicted with an area under the ROC curve of 0.968 
for ∆COm, 0.841 for ∆COli, 0.825 for SVVm, 0.873 for SVVli, 0.808 for PPV, 0.778 for ∆SP, 
0.714 for ∆PP and 0.873 for ∆MAP. Changes in COm, COli, SVV and PPV track COtd 
changes during PLR with a high degree of accuracy in sedated ventilated post-operative 




In response to publications by Preisman and co-workers, we evaluated transferability of an 
automated ventilator manoeuvre of successive incremental-pressure-controlled 1.5-second 
breaths, Respiratory Systolic Variation Test (RSVT), in an independent group of 14 patients 
after cardiac surgery to predict fluid loading responsiveness (FLR). Cardiac output, central 
venous pressure and mean arterial pressure increased after 500 ml colloid administration. 
Pulse pressure variation and RSVT-values decreased. CO increased 34% in responders (n=9) 
and did not change in non-responders (n=5). An RSVT-threshold of 0.51 predicted FLR 
correctly in 78% of the patients. Prediction of FLR with an automated RSVT is feasible and 
reliable. 
Discussion 
No gold standard exists to guide hemodynamic management. Fluid loading responsiveness 
is a relatively novel strategy. In general, fluid loading responsiveness can be described as the 
response of CO on an intra-vascular administration of a certain amount of fluid. Even more 
important is the ability to predict FLR, i.e. responders and non-responders without the 
administration of fluids. This strategy could reduce unnecessary fluid administration 
henceforth decreasing related complications and mortality. The idea behind predicting FLR 
is that overall fluid administration will decrease. To our knowledge no study exists to date 
that evaluates the impact of FLR (prediction) on fluid administration or outcome. More 
elaborate research is needed. Consequently a workable algorithm needs to be developed to 
predict FLR and to guide fluid management in a patient followed by a study of its effect on 
outcome. We advocate the use of a single definition to allow comparison of different studies 
in order to ultimately formulate a FLR-protocol and to assess the effect of FLR on mortality 
and morbidity. Moreover, statistical testing needs to improve; receiver operating curve 
characteristics alone are not sufficient and secondary testing in a control population or 
reproducibility testing is necessary. 
The most important issue, however, is the lack of a practical consensus over the definition of 
fluid loading responsiveness; the amount of fluid, type of fluid, timing of the measurement, 
the choice of parameter to define responders, the technique to measure this parameter and 
its cut-off value vary widely in literature. We propose to define fluid loading responsiveness. 
as a clinically significant increase in cardiac output within 5 minutes after a bolus 5 ml∙kg-1 





Patiënten op een intensivecare-afdeling en in de periode gedurende en rondom een operatie, 
zijn afhankelijk van medisch personeel voor hun vloeistofinname. Het optimaliseren van de 
vullingtoestand is noodzakelijk voor een maximaal zuurstofaanbod aan vitale organen. 
Overmatige toediening van vloeistof leidt tot gegeneraliseerd oedeem, longoedeem, 
hartfalen, infecties, verlengde ziekenhuisopnames en zelfs overlijden. Symptomen als 
huidturgor, urineproductie, kleur van de huid, en hemodynamische metingen, zoals centraal 
veneuze druk (CVD) en gemiddelde slagaderlijke bloeddruk (MAP), worden meestal 
gebruikt in het beleid. Deze parameters zijn echter in veel situaties onbetrouwbare 
voorspellers van de effecten van het toedienen van vloeistof.
Cardiac output (CO) is de hoeveelheid bloed die door het hart per minuut in de bloedsomloop 
wordt rondgepompt. Men is er van overtuigd dat een toename in cardiac output ook een 
verbeterde doorbloeding van de vitale organen geeft. Een toegenomen doorbloeding houdt in 
dat het zuurstofaanbod aan deze organen waarschijnlijk verbetert. Dit is de basis van de 
vloeistofresponsiviteitstrategie (FLR). Deze strategie heeft als doel cardiac output te optimali-
seren, de hoeveelheid vloeistoftoediening te minimaliseren en de kans op overvulling te 
verkleinen. 
In het verleden heeft Arthur Guyton een belangrijke stap gezet waardoor het direct meten van 
de vullingtoestand mogelijk zou moeten worden. De weerstand van de bloedvaten, centraal 
veneuze druk (CVD) en statische vullingdruk (MSFP) zijn de primaire determinanten van 
veneuze terugvloed van bloed naar het hart en dus ook cardiac output. Uiteindelijk kan MSFP 
gebruikt worden om het (actieve of) circulerend bloedvolume te bepalen in patiënten. MSFP 
is de druk die in de bloedvaten (aders en slagaders) ontstaat als er geen bloed stroomt dus als 
het hart stil zou staan. 
In dit proefschrift, hebben we een overzicht gemaakt van de publicaties over FLR en we 
hebben getracht het effect van deze publicaties op de Nederlandse intensivecarepraktijk in 
kaart te brengen. Wij bespreken de resultaten van twee onderzoeken naar de nauwkeurigheid 
van pulscontouranalyse om CO en slagvolumevariatie (SVV) te bepalen. Vervolgens 
presenteren we de resultaten van een nieuwe methode om MSFP in mensen te kunnen 
bepalen zonder dat stilstand van het hart noodzakelijk is. Als laatste bediscussiëren wij vijf 
studies waarin de betrouwbaarheid is onderzocht om FLR te voorspellen door middel van een 
manoeuvre met +10 cmH2O piek eind-expiratiedruk (PEEP), een proeftoediening van 
vloeistof, passief benen heffen, een mechanische beademingmanoeuvre en het meten van 
baseline MSFP. De manoeuvres hebben als doel het werkpunt op de hartfunctiecurve te 
bepalen en te kijken of er “ruimte” is voor toediening van vloeistof. 
Hoofdstuk 1 
Er zijn meerdere technieken ontwikkeld om de pompkracht van het hart, ofwel cardiac 
output, te meten. Het aantal technieken dat voor onderzoek in mensen is te gebruiken, is 
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echter beperkt. De ‘heilige graal’ voor het meten van cardiac output zou een techniek zijn die 
nauwkeurig, precies, gebruikeronafhankelijk, snel reagerend, continue, makkelijk in 
gebruik, goedkoop en veilig is. Zo’n methode bestaat momenteel nog niet. In hoofdstuk één 
van dit proefschrift hebben wij een overzicht gemaakt van de meest gebruikte en de 
bruikbare technieken om cardiac output te meten: de Fick, indicatorverdunning, puls-
contouranalyse (waarbij de pulscontour wordt gebruikt om CO te berekenen), echografie en 
bio-impedantiemethoden.
Hoofdstuk 2 
We hebben de nauwkeurigheid en precisie van drie methoden om cardiac output te meten 
bestudeerd - autogekalibreerde FloTrac–Vigileo (COed) en niet-gekalibreerde Modelflow 
(COmf) drukgolfmethoden en een echografische (HemoSonic, COhs) techniek - in 
vergelijking met de thermodilutietechniek (COtd). Bij 13 postoperatieve, mechanisch 
beademde, cardiochirurgische patiënten werden 104 gepaarde CO-waarden beoordeeld voor, 
tijdens en na vier interventies (1) een 50% toename in teugvolume; (2) een 10 cmH2O 
toename in PEEP; (3) 30° benen heffen en (4) hoofd-omhoog-positie. Het verschil  
(bias (2SD)) tussen COed en COtd, COmf en COtd, en COhs en COtd was 0.33 (0.90), 0.30 
(0.69) en (0.41 (1.11) L∙min-1, respectievelijk. Modelflow had de laagste gemiddelde fout, wat 
suggereert dat deze techniek de meest precieze prestaties levert. COed overschat de 
veranderingen in cardiac output terwijl COmf- en COhs-waarden niet significant verschillen 
van COtd. De richting van de veranderingen in thermodilutie cardiac output komt in zeer 
hoge mate overeen met de richting van veranderingen waargenomen met de drie methoden. 
Hoofdstuk 3 
Het doel van de studie beschreven in hoofdstuk drie is het vergelijken van de nauwkeurig-
heid van stroke volume variatie gemeten door het LiDCOplus-systeem (SVVli) en het 
FloTrac-Vigileo-systeem (SVVed). We hebben SVVli en SVVed in 15 postoperatieve cardiochi-
rurgische patiënten geregistreerd tijdens vijf interventies; (1) een 50% toename in teugvo-
lume; (2) een 10 cmH2O toename in positieve eind-expiratoire druk; (3) 30° benen heffen, 
(4) hoofd-omhoog-positie en (5) toediening van vloeistof. Tussen de interventies door zijn 
basismetingen uitgevoerd. 136 gepaarde SVV-waarden werden verzameld. SVVli-waarden 
varieerden van 1.4% tot 26.8% (gemiddeld 8.7% ± 4.6%); SVVed van 2.0% tot 26.0% 
(gemiddeld 10.2% ± 4.7%). De gemiddelde bias bleek significant te verschillen van nul met 
1.5% ± 2.5%, p < 0.001, (95% betrouwbaarheidsinterval 1.1–1.9%). De bovenste en onderste 
grenzen van het betrouwbaarheidsinterval waren 6.4% en 3.5% respectievelijk. De variatieco-
efficiënt voor de verschillen tussen SVVli en SVVed was 26%. Dit resulteert in een relatief 
grote spreiding van de betrouwbaarheidsintervallen van 52%. Analyse van de herhaalde 
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metingen liet een variatiecoëfficiënt van 21% voor SVVli en 22% voor SVVed zien. De 
SVV-waarden van de LiDCOplus en FloTrac- Vigileo-systemen zijn niet uitwisselbaar. 
Daarnaast zijn de metingen van SVVli en SVVed niet eenduidig. Dit kan geconcludeerd 
worden uit de hoge variatiecoëfficiënt bij herhaalde metingen. Deze bevindingen onderstre-
pen de waarschuwing van Michael Pinsky om voorzichtig te zijn om SVV-waarden die via 
pulscontouranalyse verkregen zijn in de kliniek te gebruiken. 
Hoofdstuk 4 
De selectie van patiënten die baat zullen hebben bij het toedienen van vloeistof is essentieel 
voor een verantwoord vullingbeleid. Het onnodig toedienen van vloeistof kan leiden tot het 
ontstaan van longoedeem en hartfalen. Vullingdrukken zoals CVD en MAP, cardiac output 
en klinische symptomen hebben altijd centraal gestaan bij de hemodynamische bewaking 
van patiënten. Wij hebben een enquête afgenomen om de gevolgen van publicaties over 
nieuwe parameters op de dagelijkse praktijkvoering in Nederlandse intensivecareafdelingen 
te bekijken. Enquêtes werden verstuurd naar alle (446) intensivecare-artsen in Nederland. 
39% Van de enquêtes werd ingevuld en teruggezonden. 
In de eerste beoordeling van de vullingtoestand worden de productie van urine en capillary 
refill als meest belangrijk gevonden. De CVD wordt door 70% van de artsen gebruikt om de 
behoefte aan extra vloeistof in te schatten. SVV werd door 47% van de respondenten 
gebruikt, en CO door 20%. 75% Procent gebruikt een proeftoediening van vloeistof om 
vloeistofresponsiviteit in te schatten. Veranderingen in hartslag, MAP, CVD en CO na 
vloeistoftoediening worden vaak gebruikt om vloeistofresponsiviteit te beoordelen. Slechts 
een kwart van alle respondenten geeft aan dat er een protocol beschikbaar is in het 
ziekenhuis om onder- of overvulling te beschrijven/behandelen en slechts de helft van deze 
respondenten zegt dat protocol ook te gebruiken. Relatief veel intensivecare-artsen 
gebruiken recent ontwikkelde variabelen als SVV en polsdrukvariatie (PPV) evenals een 
proeftoediening van vloeistof om te trachten de effecten van vloeistoftoediening te voorspel-
len. Daarentegen wordt door de meerderheid nog een ‘ouderwetse’ variabele als CVD 
gebruikt.
Hoofdstuk 5 
De onnodige toediening van vloeistof verhoogt de kans op complicaties en sterfte, en 
verlengt het verblijf op de intensive care. FLR is een strategie om patiënten te selecteren die 
baat zullen hebben bij het toedienen van vloeistof. Wij hebben recente publicaties over dit 
onderwerp op een rij gezet. We hebben een overzicht gemaakt van de meest gebruikte 
parameters voor FLR en we hebben de nauwkeurigheid om het effect van vloeistoftoediening 
op CO van deze parameters bekeken. Dynamische parameters zoals PPV en SVV hebben 
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veelvuldig en consequent laten zien dat zij meer betrouwbare voorspellers van FLR zijn dan 
centraal veneuze druk en pulmonaal arterie wiggedruk. Veranderingen in MAP, CVD en CO 
ten gevolge van verschillende manoeuvres zoals passief benen heffen (PLR), zijn ook 
voorspellers van FLR. Dynamische parameters, en met name PPV, zijn aan te raden om in 
de praktijk te gebruiken om FLR te voorspellen. Tevens zijn veranderingen in CVD, MAP en 
CO na benen heffen met een zelfde mate van betrouwbaarheid te gebruiken. 
Hoofdstuk 6 
Ondervulling is een veelvoorkomend klinisch probleem. De Trendelenburg (i.e. bed 
gekanteld met hoofd omlaag en benen omhoog) positie en benen heffen worden routinema-
tig gebruikt in afwachting van definitieve behandeling van het probleem en het toedienen 
van vloeistof of bloedproducten. Wij hebben de hemodynamische effecten van PLR en de 
Trendelenburgpositie onderzocht door een literatuur studie over de periode 1960 tot 2010 
naar prospectieve onderzoeken in mensen gedurende de eerste 10 minuten na positieveran-
dering. Welke positie heeft het meest effect op CO? 21 Studies over PLR waren relevant  
(n patiënten=431) en 13 over Trendelenburg (n patiënten=246). Trendelenburgpositionering 
deed MAP toenemen. CO steeg 9% of 0.4 L∙min-1 na 1 minuut Trendelenburg. In de periode 
hierna (2-10 min) daalde deze toename tot 4% of 0.1 L∙min-1. PLR deed noch MAP noch de 
hartslag veranderen. CVD nam toe. CO steeg met 6% of 0.2 L∙min-1 na één minuut. 
Alhoewel zowel Trendelenburg als PLR CO significant doet stijgen, is het alleen PLR dat dit 
effect langer dan enkele minuten laat duren. Wij zouden dus het gebruik van PLR willen 
aanraden voor de eerste behandeling van ondervulling 
Hoofdstuk 7 
Wij introduceren een nieuw fysiologisch model dat onderscheid mogelijk maakt tussen de 
slagaderlijke en aderlijke bloedsomloop. Om ons model te testen hebben we de effecten van 
dobutamine en ondervulling in biggen onder barbituratennarcose onderzocht. Lichaams-
slagaderdruk (Pao), CVD, MSFP en CO werden gemeten in 10 biggen voor, tijdens en na 
dobutamine-infusie (6 μg∙kg-1∙min-1), tijdens hypovolemie (-10 ml∙kg-1), en na herstel van 
normale vullingstatus. Aderlijke (Rv) en systemische (Rsys) vaatweerstanden werden bepaald 
uit Pao, CVD, MSFP en CO. Het quotiënt van Rv/Rsys werd gebruikt om de voornaamste 
verandering van vaatweerstanden te bepalen (verwijden of vernauwen van de aderlijke of 
slagaderlijke kant van de bloedsomloop). Infusie van dobutamine verhoogde de hartslag en 
CO. MSFP, Rsys, Rv en Rv/Rsys daalden. De daling in Rv was significant kleiner dan Rsys. 
Pao en CVD veranderden niet. Ondervulling verminderde CO, CVD, MSFP, Rv en Rv/Rsys, 
maar Rsys bleef onveranderd en de frequentie van de hartslag nam toe. Ondervulling en 
dobutamine veranderen MSFP, Rsys Rv en de Rv/Rsys-ratio variërend. De stijging in CO 
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tijdens dobutamine-infusie wordt geweten aan de gecombineerde verhoging van hartfunctie 
en afgenomen Rv. De afname in CO tijdens ondervulling wordt veroorzaakt door een 
afname in MSFP maar wordt ook deels gecompenseerd door de afname in Rv.
Hoofdstuk 8 
Het doel van deze studie was de relatie tussen CO en CVD te bepalen, en om statische 
vullingdruk en effectief circulerend bloedvolume te berekenen in twaalf mechanisch 
beademde, postoperatieve, cardiochirurgische patiënten. Inademingpauzes met verschil-
lende drukken werden verricht bij normale vulling (rugligging, baseline), relatieve ondervul-
ling door 30° hoofd-omhoog-positie (hypo) en relatieve overvulling (500 ml colloid toedie-
ning, hyper). De relatie tussen CO en CVD werd gemeten m.b.v. deze twaalf seconden 
durende inademingpauzes die de CVD verhoogde en CO verlaagde. De cardiac output werd 
middels pulscontouranalyse gemeten gedurende de laatste drie seconden van de adempauze. 
De relatie tussen CVD en CO was lineair voor alle metingen met een helling die gelijk bleef 
voor de verschillende vullingtoestanden. MSFP verminderde van baseline naar hypovolemie 
en nam toe tijdens hypervolemie (van 18.8 ± 4.5 mmHg naar 14.5 ± 3.0 mmHg, naar 
29.1 ± 5.2 mmHg (p < 0.05)). De baselinecompliantie van de bloedsomloop was 
0.98 ml∙mmHg-1∙kg-1 en het effectief circulerend bloedvolume was 1677 ml. Concluderend: 
statische vullingdruk kan bepaald worden bij ic-patiënten met een intacte bloedsomloop 
door gebruik te maken van de inademingpauzeprocedure met het beademingsapparaat. 
Deze procedure maakt het mogelijk de compliantie van de bloedsomloop en het effectief 
circulerend bloedvolume te volgen bij beademde patiënten.
Hoofdstuk 9 
De druk gemeten met de armocclusiemethode is in het verleden gebruikt om de effecten van 
medicijnen op de bloedsomloop te bestuderen. Wij stellen dat deze armocclusiedruk (Parm) 
ook gebruikt zou kunnen worden als een indirecte indicatie van de vullingstatus. We hebben 
de waarde van Parm bestudeert om FLR te voorspellen in 24 patiënten na cardiochirurgie. 
Vloeistoftoediening vergrootte CO, Parm, MAP en CVD. In responders (n=17) namen CO, 
Parm, MAP en CVD toe en SVV en PPV af. In non-responders (n=7), namen alleen Parm en 
CVD toe. PPV daalde. CO, MAP, SVV en hartslag veranderden niet significant. De 
oppervlakte onder de voorspellingcurve (AUROC) voor Parm was 0.786 (95% betrouwbaar-
heidsinterval 0.567-1.000). Een Parm < 21.9 mmHg had een sensitiviteit van 71% en een 
specificiteit van 88% om FLR te voorspellen. Hiermee lijkt Parm een goede voorspeller van 
FLR in onze bestudeerde groep van patiënten na cardiochirurgie. 
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Hoofdstuk 10 
Niet de absolute waarde maar de verandering in CVD zou wel eens een goede basis kunnen 
zijn voor het vloeistofbeleid bij kritisch zieke patiënten. We hebben een studie uitgevoerd om 
de CO-verandering ten gevolge van 30° PLR te voorspellen op basis van veranderingen in CVD 
na verhoging van PEEP. Twintig mechanische beademde patiënten na cardiochirurgie werden 
bestudeerd. PEEP werd verhoogd met 10 cmH2O gedurende vijf minuten gevolgd door vijf 
minuten benen heffen. CVD, SVV en thermodilution CO werden bepaald voor, gedurende en 
na de PEEP-manoeuvre en PLR. Een toename in thermodilutie CO van >7% na PLR werd 
gebruikt om responders te identificeren. De toename in CO door PLR was direct gerelateerd 
aan de toename in CVD na +10 PEEP (r=0.77, P<0.001). PLR-responsiviteit werd voorspeld 
door de +10 PEEP veranderingen in CVD (AUROC 0.99, P<0.001) en door baseline 
slagvolumevariatie (AUROC 0.90, P=0.003). De resultaten van ons onderzoek suggereren dat 
door PEEP geïnduceerde veranderingen in CVD FLR met ongeveer dezelfde betrouwbaarheid 
als baseline SVV kan voorspellen. 
Hoofdstuk 11 
In 2006, herintroduceerde Vincent en Weil (V&W) de proeftoediening van vloeistof in een 
protocol voor hemodynamisch beleid. In ons onderzoek hebben wij de waarde van de 
toevoeging van CO (middels pulscontourmeting) aan het V&W-protocol geëvalueerd om 
onnodige vloeistoftoediening te reduceren. We hebben in 21 mechanisch beademde 
patiënten na electieve cardiochirurgie de hemodynamische effecten gemeten van de 
toediening van een serie van 10 achtereenvolgende toedieningen van 50 ml colloïde 
oplossing op CO (Modelflow (COm) en LiDCO (COli)), CVD en MAP. COli en COm namen 
toe na 50, 100 en 500 ml vloeistoftoediening. Indien COm ≥4.3% toenam na 100 ml 
proeftoediening dan werd vloeistof responsiviteit (CO > 10% gestegen na 500 ml vloeistof-
toediening) met een sensitiviteit van 67% en specificiteit van 100% voorspeld. Toevoeging 
van COm aan het V&W protocol zou hebben geleid tot een gemiddelde toediening van 100 
in plaats van 200 ml vloeistof in non-responders en een toename van 18% in CO bij 
responders (i.p.v. 7%). De toevoeging van pulscontour-CO zal de betrouwbaarheid en 
robuustheid van het V&W-protocol verbeteren. Samenvattend: de toevoeging resulteerde in 
een grotere stijging in CO in responders en een verminderde onnodige vloeistoftoediening 
bij non-responders.
Hoofdstuk 12 
We hebben de mogelijkheid van twee pulscontourtechnieken onderzocht om veranderingen 
in CO door 30° PLR om vloeistofresponsiviteit te beoordelen in twintig beademde post-
cardiochirurgie patiënten. CO werd gemeten met thermodilutie COtd, pulscontourpower 
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(COli, LiDCO) en pulscontouranalyse (ongekalibreerde modelflow, COm). Verder zijn 
gemeten: hartslag, CVD, slagaderlijke polsdruk (PP), systolische bloeddruk (SP), diastolische 
bloeddruk (DP) en MAP. Slagvolume (SV), SP, PP, PPV, SVV werden berekend over vijf 
ademhalingcycli. SVV werd bepaald met de LiDCO (SVVli) en Modelfowapparaten (SVVm). 
PLR geïnduceerde veranderingen in COtd correleerden met veranderingen in COli 
(p<0.001) en COm (p<0.001). COtd-verandering werd voorspeld met een AUROC van 
0.968 door ∆COm, 0.841 door ∆COli, 0.825 door SVVm, 0.873 door SVVli, 0.808 door PPV, 
0.778 door ∆SP, 0.714 door ∆PP en 0.873 door ∆MAP. Dus: veranderingen in COm, COli, 
SVV en PPV volgen de veranderingen in COtd gedurende PLR met een hoge graad van 
nauwkeurigheid in gesedeerde en beademde patiënten na cardiochirurgie. Veranderingen in 
pulse contour CO na PLR kan worden gebruikt om vloeistofresponsiviteit te voorspellen.
Hoofdstuk 13 
Als reactie op de publicaties van Preisman et al. hebben wij de herhaalbaarheid onderzocht 
van een beademingsapparaatmanoeuvre met drukgecontroleerde 1.5 seconde durende 
ademteugen met toenemende druk. Deze ‘Respiratory Systolic Variation Test (RSVT)’ 
hebben wij bovendien geautomatiseerd. In een onafhankelijke groep van 14 patiënten na 
cardiochirurgie hebben wij de waarde van RSVT om vloeistofresponsiviteit te voorspellen 
onderzocht. CO, CVD en MAP namen toe na 500 ml colloïdeoplossing was toegediend. 
PPV- en RSVT-waarden daalden. CO steeg 34% in responders (n=9) en veranderde niet in 
non-responders (n=5). Een RSVT-drempelwaarde van 0.51 voorspelde FLR in 78% of de 
patiënten. Voorspellen van FLR met de RSVT lijkt betrouwbaar, herhaalbaar en geautomati-
seerd goed uit te voeren. 
Discussie 
Er is geen goudstandaard voor hemodynamisch beleid. Vloeistofresponsiviteit is een 
relatieve nieuwe strategie. In het algemeen kan FLR beschreven worden als het effect van 
cardiac output op een intraveneuze toediening van een bepaalde hoeveelheid vocht. Nog 
belangrijker is het om dit effect te kunnen voorspellen. Dit betekent dat men responders en 
non-responders op een vloeistoftoediening van tevoren zou kunnen onderscheiden. Deze 
strategie heeft als doel onnodige vloeistoftoediening te voorkomen en dientengevolge de 
kans aan overvulling gerelateerde complicaties en sterfte te verminderen. Tot op heden 
bestaat er nog geen studie die de gevolgen op een systematische toepassing van FLR in de 
praktijk op totale vloeistoftoediening of complicaties heeft onderzocht. Meer onderzoek is 
nodig. Het nog niet gelukt om een praktisch en uitvoerbaar protocol vast te stellen om FLR 
te voorspellen en als leidraad te dienen voor vloeistofbeleid. Bovendien dient de analyse van 
FLR studies meer diepte te krijgen. Het bepalen van de AUROC lijkt niet afdoende. Ook 
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dient de herhaalbaarheid van studieresultaten onderzocht te worden in een controlegroep. 
Het belangrijkste probleem blijft dat er geen consensus is over de definitie van vloeistofres-
ponsiviteit; de hoeveelheid vloeistof, de samenstelling van de vloeistof, het tijdstip van de 
metingen, de parameter om responders te definiëren, de techniek om deze parameter te 
meten en de afkapwaarde voor responders variëren enorm in de literatuur. Wij willen de 
definitie van vloeistofresponsiviteit definiëren als een klinisch relevante toename in cardiac 
output (afkap waarde dus gerelateerd aan de nauwkeurigheid van de meetmethode) binnen 




A  Area under the systolic part of the pressure curve
ABF Aortic blood flow
ARDS  Adult respiratory distress syndrome
AUC Area under the curve
AVR Aortic valve replacement
BP Blood pressure
BSA  Body surface area 
C  Velocity of ultra-sound in blood
CABG Coronary artery bypass grafting
CaCO2  Arterial carbon dioxide content in blood
CaO2 Oxygen content of arterial blood
CBV Circulating blood volume 
Cc  Computation constant
CCO Continuous cardiac output 
CI Cardiac index 
CO  Cardiac output 
CO2 Carbon dioxide
COed Cardiac output measured with the Flo-trac Vigileo system
COem Cardiac output measured with an electromagnetic flow probe 
COhs Cardiac output measured with the hemosonic syste
COm Cardiac output measured with the modelflow system
COmf Cardiac output measured with the modelflow system
COpi Cardiac output measured with the PiCCO system
COPD Chronic obstructive pulmonary disease
Cosθ  Angle between the direction of the ultra-sound beam and blood flow 
COtd Thermodilution cardiac output
C(P)  Pressure dependent arterial compliance
C(t)  Concentration as a function of time. 
CSA  Cross sectional area
CvCO2  Mixed venous carbon dioxide content in blood.
CvO2  Oxygen content of venous blood 
CVP  Central venous pressure





EtCO2 End-tidal carbon dioxide
Fd  Change in frequency (i.e. Doppler shift)
FLR Fluid loading responsiveness 
Fo  Transmitted frequency 




ICU  Intensive care unit 
K A calibration factor
Khi  Conversion factor 
LiCl Lithium chloride solution 
LVEDA Left ventricular end-diastolic area 
LVEDAI Left ventricular end diastolic area index
MAP  Mean arterial pressure 
Mi Amount of indicator injected
MSFP Mean systemic filling pressure
MVP Mitral valve plastique
Nor Norepinephrine
NPN Nitroprusside sodium
NVIC  Dutch Society of Intensive Care 
NYHA New York Heart Association
O2 Oxygen
OR Operating room 
P Pressure
Pa Arterial pressure
PAC Pulmonary artery catheter
PaCO2 Arterial carbon dioxide pressure 
PAP Pulmonary artery pressure
Pao  Aorta pressure 
PAOP Pulmonary artery occlusion pressure 
Parm Arm equilibrium pressure
Paw Airway pressure
PAWP  Pulmonary artery wedge pressure 
PEEP Positive end-expiratory pressure
PLR  Passive leg raising 
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MSFP Mean systemic filling pressure
Prad  Radial artery pressure 
PRAM Pressure recording analytical method
PP  Pulse pressure
Ppa  Pulmonary artery pressure
PPV Pulse pressure variation 
PPVli Pulse pressure variation with LiDCO system
Pra Radial artery pressure
Pvent Ventilator pressure
Pvr Pressure difference between MSFP and CVP
Q(t) Instantaneous blood flow
Ra Arterial resistance
ROC Receiver operating curve
RSVT Respiratory systolic variation test
Rsys Total systemic resistance
Rv Venous resistance 
RVEDAI  Right ventricular end diastolic area index
Rvr Resistance for venous return
S  A constant




SVI Stroke volume index
SVR Systemic vascular resistance
SVV  Stroke volume variation
Sys Systolic arterial blood pressure
SP Systolic arterial pressure 
SPV  Systolic pressure variation
SVVli Stroke volume variation measured with LiDCO system
SVVed Stroke volume variation measured with FloTrac-Vigileo system 
Temp Body temperature 
Tb  Temperature of blood in the pulmonary artery before injection of injectate
Ti  Temperature of injectate
TI Tricuspid insufficiency
TOD  Transoesophageal Doppler 
TTD Transthoracic Doppler 
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TVP Tricuspid valve plastique
V  Velocity of blood




V&W Vincent and Weil
Vload  Amount of fluid administrated
VR Venous return
V(s) Stressed vascular volume 
V&W Vincent and Weil
Z  Characteristic impedance
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